id	sid	tid	token	lemma	pos
iajs-2017	1	1	microsoft	microsoft	PROPN
iajs-2017	1	2	word	word	NOUN
iajs-2017	1	3	79	79	NUM
iajs-2017	1	4	-	-	SYM
iajs-2017	1	5	87	87	NUM
iajs-2017	1	6	chemistry	chemistry	NOUN
iajs-2017	1	7	|	|	ADV
iajs-2017	1	8	79	79	NUM
iajs-2017	1	9	ibn	ibn	PROPN
iajs-2017	1	10	al	al	PROPN
iajs-2017	1	11	-	-	PUNCT
iajs-2017	1	12	haitham	haitham	PROPN
iajs-2017	1	13	jour	jour	X
iajs-2017	1	14	.	.	PROPN
iajs-2017	2	1	for	for	ADP
iajs-2017	2	2	pure	pure	ADJ
iajs-2017	2	3	&	&	CCONJ
iajs-2017	2	4	appl	appl	PROPN
iajs-2017	2	5	.	.	PUNCT
iajs-2017	3	1	sci	sci	PROPN
iajs-2017	3	2	.	.	PROPN
iajs-2017	3	3	ihjpas	ihjpas	PROPN
iajs-2017	3	4	https://doi.org/10.30526/31.3.2017	https://doi.org/10.30526/31.3.2017	ADP
iajs-2017	3	5	vol	vol	NOUN
iajs-2017	3	6	.	.	PUNCT
iajs-2017	4	1	31	31	NUM
iajs-2017	5	1	(	(	PUNCT
iajs-2017	5	2	3	3	NUM
iajs-2017	5	3	)	)	SYM
iajs-2017	5	4	2018	2018	NUM
iajs-2017	5	5	comparative	comparative	ADJ
iajs-2017	5	6	study	study	NOUN
iajs-2017	5	7	of	of	ADP
iajs-2017	5	8	thymidine	thymidine	ADJ
iajs-2017	5	9	kinase	kinase	PROPN
iajs-2017	5	10	-1	-1	PROPN
iajs-2017	5	11	and	and	CCONJ
iajs-2017	5	12	total	total	ADJ
iajs-2017	5	13	antioxidant	antioxidant	ADJ
iajs-2017	5	14	capacity	capacity	NOUN
iajs-2017	5	15	in	in	ADP
iajs-2017	5	16	iraqi	iraqi	ADJ
iajs-2017	5	17	children	child	NOUN
iajs-2017	5	18	with	with	ADP
iajs-2017	5	19	platelet	platelet	NOUN
iajs-2017	5	20	count	count	NOUN
iajs-2017	5	21	disorder	disorder	NOUN
iajs-2017	5	22	manar	manar	PROPN
iajs-2017	5	23	satar	satar	NOUN
iajs-2017	5	24	jabar	jabar	PROPN
iajs-2017	5	25	mmanolamanola2468@gmail.co	mmanolamanola2468@gmail.co	PROPN
iajs-2017	5	26	eiman	eiman	NOUN
iajs-2017	5	27	a	a	DET
iajs-2017	5	28	a.	a.	NOUN
iajs-2017	5	29	abass	abass	PROPN
iajs-2017	5	30	drbiochem2007@gmail.com	drbiochem2007@gmail.com	PROPN
iajs-2017	5	31	department	department	PROPN
iajs-2017	5	32	of	of	ADP
iajs-2017	5	33	chemistry	chemistry	NOUN
iajs-2017	5	34	,	,	PUNCT
iajs-2017	5	35	collage	collage	NOUN
iajs-2017	5	36	of	of	ADP
iajs-2017	5	37	education	education	NOUN
iajs-2017	5	38	for	for	ADP
iajs-2017	5	39	pure	pure	ADJ
iajs-2017	5	40	sciences	science	NOUN
iajs-2017	5	41	ibn	ibn	PROPN
iajs-2017	5	42	al	al	PROPN
iajs-2017	5	43	-	-	PUNCT
iajs-2017	5	44	haitham	haitham	PROPN
iajs-2017	5	45	,	,	PUNCT
iajs-2017	5	46	university	university	PROPN
iajs-2017	5	47	of	of	ADP
iajs-2017	5	48	baghdad	baghdad	PROPN
iajs-2017	5	49	,	,	PUNCT
iajs-2017	5	50	baghdad	baghdad	PROPN
iajs-2017	5	51	,	,	PUNCT
iajs-2017	5	52	iraq	iraq	PROPN
iajs-2017	5	53	article	article	NOUN
iajs-2017	5	54	history	history	NOUN
iajs-2017	5	55	:	:	PUNCT
iajs-2017	5	56	received	receive	VERB
iajs-2017	5	57	3	3	NUM
iajs-2017	5	58	july	july	PROPN
iajs-2017	5	59	2018	2018	NUM
iajs-2017	5	60	,	,	PUNCT
iajs-2017	5	61	accepted	accept	VERB
iajs-2017	5	62	4	4	NUM
iajs-2017	5	63	september	september	PROPN
iajs-2017	5	64	2018	2018	NUM
iajs-2017	5	65	,	,	PUNCT
iajs-2017	5	66	published	publish	VERB
iajs-2017	5	67	december	december	PROPN
iajs-2017	5	68	2018	2018	NUM
iajs-2017	5	69	abstract	abstract	ADV
iajs-2017	5	70	this	this	DET
iajs-2017	5	71	study	study	NOUN
iajs-2017	5	72	aimed	aim	VERB
iajs-2017	5	73	to	to	PART
iajs-2017	5	74	find	find	VERB
iajs-2017	5	75	relationship	relationship	NOUN
iajs-2017	5	76	between	between	ADP
iajs-2017	5	77	thymidine	thymidine	ADJ
iajs-2017	5	78	kinase-1	kinase-1	PROPN
iajs-2017	5	79	(	(	PUNCT
iajs-2017	5	80	tk-1	tk-1	ADP
iajs-2017	5	81	)	)	PUNCT
iajs-2017	5	82	as	as	ADP
iajs-2017	5	83	tumor	tumor	NOUN
iajs-2017	5	84	marker	marker	NOUN
iajs-2017	5	85	and	and	CCONJ
iajs-2017	5	86	total	total	ADJ
iajs-2017	5	87	antioxidant	antioxidant	ADJ
iajs-2017	5	88	capacity	capacity	NOUN
iajs-2017	5	89	(	(	PUNCT
iajs-2017	5	90	tac	tac	NOUN
iajs-2017	5	91	)	)	PUNCT
iajs-2017	5	92	in	in	ADP
iajs-2017	5	93	iraqi	iraqi	ADJ
iajs-2017	5	94	children	child	NOUN
iajs-2017	5	95	patients	patient	NOUN
iajs-2017	5	96	with	with	ADP
iajs-2017	5	97	thrombocytopenia	thrombocytopenia	NOUN
iajs-2017	5	98	and	and	CCONJ
iajs-2017	5	99	with	with	ADP
iajs-2017	5	100	thrombocytosis	thrombocytosis	NOUN
iajs-2017	5	101	.	.	PUNCT
iajs-2017	6	1	the	the	DET
iajs-2017	6	2	present	present	ADJ
iajs-2017	6	3	study	study	NOUN
iajs-2017	6	4	conducted	conduct	VERB
iajs-2017	6	5	60	60	NUM
iajs-2017	6	6	children	child	NOUN
iajs-2017	6	7	patients	patient	NOUN
iajs-2017	6	8	(	(	PUNCT
iajs-2017	6	9	30	30	NUM
iajs-2017	6	10	patients	patient	NOUN
iajs-2017	6	11	with	with	ADP
iajs-2017	6	12	idiopathic	idiopathic	ADJ
iajs-2017	6	13	thrombocytopenia	thrombocytopenia	PROPN
iajs-2017	6	14	purpura	purpura	NOUN
iajs-2017	6	15	(	(	PUNCT
iajs-2017	6	16	itp	itp	PROPN
iajs-2017	6	17	)	)	PUNCT
iajs-2017	6	18	and	and	CCONJ
iajs-2017	6	19	30	30	NUM
iajs-2017	6	20	patients	patient	NOUN
iajs-2017	6	21	with	with	ADP
iajs-2017	6	22	thrombocytosis	thrombocytosis	NOUN
iajs-2017	6	23	caused	cause	VERB
iajs-2017	6	24	by	by	ADP
iajs-2017	6	25	leukemia	leukemia	NOUN
iajs-2017	6	26	)	)	PUNCT
iajs-2017	6	27	attending	attend	VERB
iajs-2017	6	28	the	the	DET
iajs-2017	6	29	children	child	NOUN
iajs-2017	6	30	fever	fever	NOUN
iajs-2017	6	31	hospital	hospital	NOUN
iajs-2017	6	32	in	in	ADP
iajs-2017	6	33	the	the	DET
iajs-2017	6	34	medical	medical	ADJ
iajs-2017	6	35	city	city	NOUN
iajs-2017	6	36	/	/	SYM
iajs-2017	6	37	baghdad	baghdad	PROPN
iajs-2017	6	38	,	,	PUNCT
iajs-2017	6	39	and	and	CCONJ
iajs-2017	6	40	30	30	NUM
iajs-2017	6	41	healthy	healthy	ADJ
iajs-2017	6	42	children	child	NOUN
iajs-2017	6	43	as	as	ADP
iajs-2017	6	44	a	a	DET
iajs-2017	6	45	control	control	NOUN
iajs-2017	6	46	group	group	NOUN
iajs-2017	6	47	.	.	PUNCT
iajs-2017	7	1	all	all	DET
iajs-2017	7	2	study	study	NOUN
iajs-2017	7	3	groups	group	NOUN
iajs-2017	7	4	were	be	AUX
iajs-2017	7	5	with	with	ADP
iajs-2017	7	6	range	range	NOUN
iajs-2017	7	7	ages	age	NOUN
iajs-2017	7	8	(	(	PUNCT
iajs-2017	7	9	1	1	NUM
iajs-2017	7	10	-	-	SYM
iajs-2017	7	11	15	15	NUM
iajs-2017	7	12	)	)	PUNCT
iajs-2017	7	13	years	year	NOUN
iajs-2017	7	14	,	,	PUNCT
iajs-2017	7	15	and	and	CCONJ
iajs-2017	7	16	they	they	PRON
iajs-2017	7	17	were	be	AUX
iajs-2017	7	18	diagnosed	diagnose	VERB
iajs-2017	7	19	by	by	ADP
iajs-2017	7	20	assay	assay	NOUN
iajs-2017	7	21	of	of	ADP
iajs-2017	7	22	platelet	platelet	NOUN
iajs-2017	7	23	count	count	NOUN
iajs-2017	7	24	,	,	PUNCT
iajs-2017	7	25	prothrombin	prothrombin	ADJ
iajs-2017	7	26	time	time	NOUN
iajs-2017	7	27	(	(	PUNCT
iajs-2017	7	28	pt	pt	NOUN
iajs-2017	7	29	)	)	PUNCT
iajs-2017	7	30	,	,	PUNCT
iajs-2017	7	31	and	and	CCONJ
iajs-2017	7	32	partial	partial	ADJ
iajs-2017	7	33	thromboplastin	thromboplastin	NOUN
iajs-2017	7	34	time	time	NOUN
iajs-2017	7	35	(	(	PUNCT
iajs-2017	7	36	ptt	ptt	NOUN
iajs-2017	7	37	)	)	PUNCT
iajs-2017	7	38	.	.	PUNCT
iajs-2017	8	1	the	the	DET
iajs-2017	8	2	results	result	NOUN
iajs-2017	8	3	shown	show	VERB
iajs-2017	8	4	elevation	elevation	NOUN
iajs-2017	8	5	in	in	ADP
iajs-2017	8	6	plasma	plasma	NOUN
iajs-2017	8	7	tk-1	tk-1	ADP
iajs-2017	8	8	and	and	CCONJ
iajs-2017	8	9	tac	tac	PROPN
iajs-2017	8	10	values	value	NOUN
iajs-2017	8	11	in	in	ADP
iajs-2017	8	12	children	child	NOUN
iajs-2017	8	13	patients	patient	NOUN
iajs-2017	8	14	with	with	ADP
iajs-2017	8	15	thrombocytopenia	thrombocytopenia	NOUN
iajs-2017	8	16	and	and	CCONJ
iajs-2017	8	17	with	with	ADP
iajs-2017	8	18	thrombocytosis	thrombocytosis	NOUN
iajs-2017	8	19	when	when	SCONJ
iajs-2017	8	20	compared	compare	VERB
iajs-2017	8	21	with	with	ADP
iajs-2017	8	22	control	control	NOUN
iajs-2017	8	23	group	group	NOUN
iajs-2017	8	24	,	,	PUNCT
iajs-2017	8	25	and	and	CCONJ
iajs-2017	8	26	there	there	PRON
iajs-2017	8	27	was	be	VERB
iajs-2017	8	28	no	no	DET
iajs-2017	8	29	significant	significant	ADJ
iajs-2017	8	30	different	different	ADJ
iajs-2017	8	31	in	in	ADP
iajs-2017	8	32	tk-1	tk-1	ADP
iajs-2017	8	33	level	level	NOUN
iajs-2017	8	34	and	and	CCONJ
iajs-2017	8	35	a	a	DET
iajs-2017	8	36	significant	significant	ADJ
iajs-2017	8	37	different	different	ADJ
iajs-2017	8	38	in	in	ADP
iajs-2017	8	39	tac	tac	PROPN
iajs-2017	8	40	level	level	NOUN
iajs-2017	8	41	in	in	ADP
iajs-2017	8	42	two	two	NUM
iajs-2017	8	43	patient	patient	NOUN
iajs-2017	8	44	’s	’s	PART
iajs-2017	8	45	groups	group	NOUN
iajs-2017	8	46	.	.	PUNCT
iajs-2017	9	1	there	there	PRON
iajs-2017	9	2	was	be	VERB
iajs-2017	9	3	a	a	DET
iajs-2017	9	4	highly	highly	ADV
iajs-2017	9	5	significant	significant	ADJ
iajs-2017	9	6	positive	positive	ADJ
iajs-2017	9	7	correlation	correlation	NOUN
iajs-2017	9	8	between	between	ADP
iajs-2017	9	9	tk-1	tk-1	ADP
iajs-2017	9	10	and	and	CCONJ
iajs-2017	9	11	tac	tac	PROPN
iajs-2017	9	12	levels	level	NOUN
iajs-2017	9	13	in	in	ADP
iajs-2017	9	14	both	both	CCONJ
iajs-2017	9	15	iraqi	iraqi	ADJ
iajs-2017	9	16	children	child	NOUN
iajs-2017	9	17	patients	patient	NOUN
iajs-2017	9	18	with	with	ADP
iajs-2017	9	19	thrombocytopenia	thrombocytopenia	NOUN
iajs-2017	9	20	and	and	CCONJ
iajs-2017	9	21	with	with	ADP
iajs-2017	9	22	thrombocytosis	thrombocytosis	NOUN
iajs-2017	9	23	.	.	PUNCT
iajs-2017	10	1	the	the	DET
iajs-2017	10	2	current	current	ADJ
iajs-2017	10	3	study	study	NOUN
iajs-2017	10	4	concluded	conclude	VERB
iajs-2017	10	5	that	that	SCONJ
iajs-2017	10	6	tk-1	tk-1	ADP
iajs-2017	10	7	may	may	AUX
iajs-2017	10	8	be	be	AUX
iajs-2017	10	9	a	a	DET
iajs-2017	10	10	novel	novel	ADJ
iajs-2017	10	11	biomarker	biomarker	NOUN
iajs-2017	10	12	for	for	ADP
iajs-2017	10	13	platelet	platelet	NOUN
iajs-2017	10	14	count	count	NOUN
iajs-2017	10	15	disorder	disorder	NOUN
iajs-2017	10	16	disease	disease	NOUN
iajs-2017	10	17	and	and	CCONJ
iajs-2017	10	18	there	there	PRON
iajs-2017	10	19	was	be	VERB
iajs-2017	10	20	a	a	DET
iajs-2017	10	21	probability	probability	NOUN
iajs-2017	10	22	of	of	ADP
iajs-2017	10	23	expose	expose	VERB
iajs-2017	10	24	these	these	DET
iajs-2017	10	25	patients	patient	NOUN
iajs-2017	10	26	for	for	ADP
iajs-2017	10	27	tumor	tumor	NOUN
iajs-2017	10	28	diseases	disease	NOUN
iajs-2017	10	29	.	.	PUNCT
iajs-2017	11	1	keywords	keyword	NOUN
iajs-2017	11	2	:	:	PUNCT
iajs-2017	11	3	thrombocytopenia	thrombocytopenia	NOUN
iajs-2017	11	4	,	,	PUNCT
iajs-2017	11	5	thrombocytosis	thrombocytosis	NOUN
iajs-2017	11	6	,	,	PUNCT
iajs-2017	11	7	thymidine	thymidine	NOUN
iajs-2017	11	8	kinase-1	kinase-1	PROPN
iajs-2017	11	9	,	,	PUNCT
iajs-2017	11	10	total	total	ADJ
iajs-2017	11	11	antioxidant	antioxidant	ADJ
iajs-2017	11	12	capacity	capacity	NOUN
iajs-2017	11	13	.	.	PUNCT
iajs-2017	12	1	1	1	X
iajs-2017	12	2	.	.	X
iajs-2017	12	3	introduction	introduction	NOUN
iajs-2017	12	4	platelets	platelet	NOUN
iajs-2017	12	5	assume	assume	VERB
iajs-2017	12	6	a	a	DET
iajs-2017	12	7	basic	basic	ADJ
iajs-2017	12	8	part	part	NOUN
iajs-2017	12	9	in	in	ADP
iajs-2017	12	10	hemostasis	hemostasis	NOUN
iajs-2017	12	11	and	and	CCONJ
iajs-2017	12	12	thrombosis	thrombosis	NOUN
iajs-2017	12	13	,	,	PUNCT
iajs-2017	12	14	additionally	additionally	ADV
iajs-2017	12	15	are	be	AUX
iajs-2017	12	16	critical	critical	ADJ
iajs-2017	12	17	in	in	ADP
iajs-2017	12	18	the	the	DET
iajs-2017	12	19	improvement	improvement	NOUN
iajs-2017	12	20	of	of	ADP
iajs-2017	12	21	obsessive	obsessive	ADJ
iajs-2017	12	22	procedures	procedure	NOUN
iajs-2017	12	23	including	include	VERB
iajs-2017	12	24	atherosclerosis	atherosclerosis	NOUN
iajs-2017	12	25	and	and	CCONJ
iajs-2017	12	26	blood	blood	NOUN
iajs-2017	12	27	vessel	vessel	NOUN
iajs-2017	12	28	thrombosis	thrombosis	NOUN
iajs-2017	13	1	[	[	X
iajs-2017	13	2	1	1	NUM
iajs-2017	13	3	]	]	PUNCT
iajs-2017	13	4	.	.	PUNCT
iajs-2017	14	1	platelets	platelet	NOUN
iajs-2017	14	2	are	be	AUX
iajs-2017	14	3	created	create	VERB
iajs-2017	14	4	in	in	ADP
iajs-2017	14	5	the	the	DET
iajs-2017	14	6	bone	bone	NOUN
iajs-2017	14	7	marrow	marrow	NOUN
iajs-2017	14	8	by	by	ADP
iajs-2017	14	9	megakaryocytes	megakaryocyte	NOUN
iajs-2017	14	10	in	in	ADP
iajs-2017	14	11	a	a	DET
iajs-2017	14	12	procedure	procedure	NOUN
iajs-2017	14	13	that	that	PRON
iajs-2017	14	14	is	be	AUX
iajs-2017	14	15	managed	manage	VERB
iajs-2017	14	16	principally	principally	ADV
iajs-2017	14	17	by	by	ADP
iajs-2017	14	18	thrombopoietin	thrombopoietin	PROPN
iajs-2017	14	19	(	(	PUNCT
iajs-2017	14	20	tpo	tpo	NOUN
iajs-2017	14	21	)	)	PUNCT
iajs-2017	14	22	.	.	PUNCT
iajs-2017	15	1	tpo	tpo	PROPN
iajs-2017	15	2	is	be	AUX
iajs-2017	15	3	created	create	VERB
iajs-2017	15	4	mostly	mostly	ADV
iajs-2017	15	5	by	by	ADP
iajs-2017	15	6	the	the	DET
iajs-2017	15	7	liver	liver	NOUN
iajs-2017	15	8	[	[	X
iajs-2017	15	9	2	2	NUM
iajs-2017	15	10	]	]	PUNCT
iajs-2017	15	11	.	.	PUNCT
iajs-2017	16	1	both	both	PRON
iajs-2017	16	2	strangely	strangely	ADV
iajs-2017	16	3	low	low	ADJ
iajs-2017	16	4	(	(	PUNCT
iajs-2017	16	5	thrombocytopenia	thrombocytopenia	PROPN
iajs-2017	16	6	)	)	PUNCT
iajs-2017	16	7	and	and	CCONJ
iajs-2017	16	8	lifted	lift	VERB
iajs-2017	16	9	(	(	PUNCT
iajs-2017	16	10	thrombocytosis	thrombocytosis	NOUN
iajs-2017	16	11	)	)	PUNCT
iajs-2017	16	12	platelet	platelet	NOUN
iajs-2017	16	13	include	include	VERB
iajs-2017	16	14	are	be	AUX
iajs-2017	16	15	regular	regular	ADJ
iajs-2017	16	16	discoveries	discovery	NOUN
iajs-2017	16	17	a	a	DET
iajs-2017	16	18	few	few	ADJ
iajs-2017	16	19	sicknesses	sickness	NOUN
iajs-2017	16	20	including	include	VERB
iajs-2017	16	21	liver	liver	NOUN
iajs-2017	16	22	maladies	malady	NOUN
iajs-2017	16	23	,	,	PUNCT
iajs-2017	16	24	contaminations	contamination	NOUN
iajs-2017	16	25	,	,	PUNCT
iajs-2017	16	26	immune	immune	ADJ
iajs-2017	16	27	system	system	NOUN
iajs-2017	16	28	issue	issue	NOUN
iajs-2017	16	29	and	and	CCONJ
iajs-2017	16	30	malignancies	malignancy	NOUN
iajs-2017	16	31	[	[	X
iajs-2017	16	32	3	3	NUM
iajs-2017	16	33	]	]	PUNCT
iajs-2017	16	34	.	.	PUNCT
iajs-2017	17	1	idiopathic	idiopathic	ADJ
iajs-2017	17	2	thrombocytopenic	thrombocytopenic	ADJ
iajs-2017	17	3	purpura	purpura	NOUN
iajs-2017	17	4	(	(	PUNCT
iajs-2017	17	5	itp	itp	PROPN
iajs-2017	17	6	)	)	PUNCT
iajs-2017	17	7	is	be	AUX
iajs-2017	17	8	an	an	DET
iajs-2017	17	9	immune	immune	ADJ
iajs-2017	17	10	system	system	NOUN
iajs-2017	17	11	infection	infection	NOUN
iajs-2017	17	12	in	in	ADP
iajs-2017	17	13	which	which	PRON
iajs-2017	17	14	the	the	DET
iajs-2017	17	15	resistant	resistant	ADJ
iajs-2017	17	16	framework	framework	NOUN
iajs-2017	17	17	botches	botch	VERB
iajs-2017	17	18	the	the	DET
iajs-2017	17	19	platelets	platelet	NOUN
iajs-2017	17	20	as	as	ADP
iajs-2017	17	21	being	be	AUX
iajs-2017	17	22	remote	remote	ADJ
iajs-2017	17	23	and	and	CCONJ
iajs-2017	17	24	crushes	crush	VERB
iajs-2017	17	25	them	they	PRON
iajs-2017	17	26	.	.	PUNCT
iajs-2017	18	1	it	it	PRON
iajs-2017	18	2	can	can	AUX
iajs-2017	18	3	take	take	VERB
iajs-2017	18	4	after	after	ADP
iajs-2017	18	5	an	an	DET
iajs-2017	18	6	infection	infection	NOUN
iajs-2017	18	7	,	,	PUNCT
iajs-2017	18	8	immunization	immunization	NOUN
iajs-2017	18	9	or	or	CCONJ
iajs-2017	18	10	certain	certain	ADJ
iajs-2017	18	11	medicines	medicine	NOUN
iajs-2017	18	12	,	,	PUNCT
iajs-2017	18	13	however	however	ADV
iajs-2017	18	14	for	for	ADP
iajs-2017	18	15	the	the	DET
iajs-2017	18	16	vast	vast	ADJ
iajs-2017	18	17	majority	majority	NOUN
iajs-2017	18	18	the	the	DET
iajs-2017	18	19	reason	reason	NOUN
iajs-2017	18	20	is	be	AUX
iajs-2017	18	21	obscure	obscure	ADJ
iajs-2017	18	22	.	.	PUNCT
iajs-2017	19	1	itp	itp	PROPN
iajs-2017	19	2	is	be	AUX
iajs-2017	19	3	now	now	ADV
iajs-2017	19	4	and	and	CCONJ
iajs-2017	19	5	again	again	ADV
iajs-2017	19	6	called	call	VERB
iajs-2017	19	7	insusceptible	insusceptible	ADJ
iajs-2017	19	8	thrombocytopenic	thrombocytopenic	ADJ
iajs-2017	19	9	purpura	purpura	NOUN
iajs-2017	19	10	or	or	CCONJ
iajs-2017	19	11	just	just	ADV
iajs-2017	19	12	,	,	PUNCT
iajs-2017	19	13	safe	safe	ADJ
iajs-2017	19	14	thrombocytopenia	thrombocytopenia	PROPN
iajs-2017	19	15	.	.	PUNCT
iajs-2017	20	1	childhood	childhood	NOUN
iajs-2017	20	2	resistant	resistant	ADJ
iajs-2017	20	3	thrombocytopenia	thrombocytopenia	PROPN
iajs-2017	20	4	(	(	PUNCT
iajs-2017	20	5	itp	itp	PROPN
iajs-2017	20	6	)	)	PUNCT
iajs-2017	20	7	is	be	AUX
iajs-2017	20	8	a	a	DET
iajs-2017	20	9	gained	gain	VERB
iajs-2017	20	10	immune	immune	ADJ
iajs-2017	20	11	system	system	NOUN
iajs-2017	20	12	issue	issue	NOUN
iajs-2017	20	13	described	describe	VERB
iajs-2017	20	14	by	by	ADP
iajs-2017	20	15	confined	confine	VERB
iajs-2017	20	16	thrombocytopenia	thrombocytopenia	NOUN
iajs-2017	20	17	(	(	PUNCT
iajs-2017	20	18	fringe	fringe	NOUN
iajs-2017	20	19	blood	blood	NOUN
iajs-2017	20	20	platelet	platelet	NOUN
iajs-2017	20	21	check	check	NOUN
iajs-2017	20	22	<	<	X
iajs-2017	20	23	100	100	NUM
iajs-2017	20	24	x	x	SYM
iajs-2017	20	25	109	109	NUM
iajs-2017	20	26	/	/	SYM
iajs-2017	20	27	l	l	NOUN
iajs-2017	20	28	)	)	PUNCT
iajs-2017	20	29	.	.	PUNCT
iajs-2017	21	1	itp	itp	PROPN
iajs-2017	21	2	is	be	AUX
iajs-2017	21	3	a	a	DET
iajs-2017	21	4	standout	standout	NOUN
iajs-2017	21	5	amongst	amongst	ADP
iajs-2017	21	6	the	the	DET
iajs-2017	21	7	most	most	ADV
iajs-2017	21	8	widely	widely	ADV
iajs-2017	21	9	recognized	recognize	VERB
iajs-2017	21	10	draining	drain	VERB
iajs-2017	21	11	issue	issue	NOUN
iajs-2017	21	12	in	in	ADP
iajs-2017	21	13	youngsters	youngster	NOUN
iajs-2017	21	14	,	,	PUNCT
iajs-2017	21	15	with	with	ADP
iajs-2017	21	16	a	a	DET
iajs-2017	21	17	rate	rate	NOUN
iajs-2017	21	18	of	of	ADP
iajs-2017	21	19	roughly	roughly	ADV
iajs-2017	21	20	four	four	NUM
iajs-2017	21	21	for	for	ADP
iajs-2017	21	22	every	every	DET
iajs-2017	21	23	100.000	100.000	NUM
iajs-2017	21	24	every	every	DET
iajs-2017	21	25	year	year	NOUN
iajs-2017	21	26	[	[	X
iajs-2017	21	27	4,5	4,5	NUM
iajs-2017	21	28	]	]	PUNCT
iajs-2017	21	29	.	.	PUNCT
iajs-2017	22	1	thrombocytosis	thrombocytosis	NOUN
iajs-2017	22	2	(	(	PUNCT
iajs-2017	22	3	ts	ts	NOUN
iajs-2017	22	4	)	)	PUNCT
iajs-2017	22	5	or	or	CCONJ
iajs-2017	22	6	height	height	NOUN
iajs-2017	22	7	in	in	ADP
iajs-2017	22	8	the	the	DET
iajs-2017	22	9	fringe	fringe	NOUN
iajs-2017	22	10	blood	blood	NOUN
iajs-2017	22	11	platelet	platelet	NOUN
iajs-2017	22	12	tally	tally	NOUN
iajs-2017	22	13	to	to	ADP
iajs-2017	22	14	values	value	NOUN
iajs-2017	22	15	>	>	PUNCT
iajs-2017	22	16	400,000/µ	400,000/µ	PROPN
iajs-2017	22	17	l	l	NOUN
iajs-2017	22	18	is	be	AUX
iajs-2017	22	19	basic	basic	ADJ
iajs-2017	22	20	in	in	ADP
iajs-2017	22	21	outset	outset	NOUN
iajs-2017	22	22	and	and	CCONJ
iajs-2017	22	23	chemistry	chemistry	NOUN
iajs-2017	22	24	|	|	ADV
iajs-2017	22	25	80	80	NUM
iajs-2017	22	26	ibn	ibn	PROPN
iajs-2017	22	27	al	al	PROPN
iajs-2017	22	28	-	-	PUNCT
iajs-2017	22	29	haitham	haitham	PROPN
iajs-2017	22	30	jour	jour	X
iajs-2017	22	31	.	.	PROPN
iajs-2017	23	1	for	for	ADP
iajs-2017	23	2	pure	pure	ADJ
iajs-2017	23	3	&	&	CCONJ
iajs-2017	23	4	appl	appl	PROPN
iajs-2017	23	5	.	.	PUNCT
iajs-2017	24	1	sci	sci	PROPN
iajs-2017	24	2	.	.	PROPN
iajs-2017	24	3	ihjpas	ihjpas	PROPN
iajs-2017	24	4	https://doi.org/10.30526/31.3.2017	https://doi.org/10.30526/31.3.2017	ADP
iajs-2017	24	5	vol	vol	NOUN
iajs-2017	24	6	.	.	PUNCT
iajs-2017	25	1	31	31	NUM
iajs-2017	26	1	(	(	PUNCT
iajs-2017	26	2	3	3	NUM
iajs-2017	26	3	)	)	SYM
iajs-2017	26	4	2018	2018	NUM
iajs-2017	26	5	youth	youth	NOUN
iajs-2017	26	6	,	,	PUNCT
iajs-2017	26	7	happening	happen	VERB
iajs-2017	26	8	in	in	ADP
iajs-2017	26	9	3	3	NUM
iajs-2017	26	10	to	to	PART
iajs-2017	26	11	13	13	NUM
iajs-2017	26	12	%	%	NOUN
iajs-2017	26	13	of	of	ADP
iajs-2017	26	14	youngsters	youngster	NOUN
iajs-2017	26	15	.	.	PUNCT
iajs-2017	27	1	in	in	ADP
iajs-2017	27	2	youngsters	youngster	NOUN
iajs-2017	27	3	in	in	ADP
iajs-2017	27	4	relatively	relatively	ADV
iajs-2017	27	5	every	every	PRON
iajs-2017	27	6	case	case	NOUN
iajs-2017	27	7	the	the	DET
iajs-2017	27	8	raised	raise	VERB
iajs-2017	27	9	platelet	platelet	NOUN
iajs-2017	27	10	check	check	NOUN
iajs-2017	27	11	is	be	AUX
iajs-2017	27	12	because	because	SCONJ
iajs-2017	27	13	of	of	ADP
iajs-2017	27	14	another	another	DET
iajs-2017	27	15	therapeutic	therapeutic	ADJ
iajs-2017	27	16	condition	condition	NOUN
iajs-2017	27	17	,	,	PUNCT
iajs-2017	27	18	for	for	ADP
iajs-2017	27	19	example	example	NOUN
iajs-2017	27	20	,	,	PUNCT
iajs-2017	27	21	intense	intense	ADJ
iajs-2017	27	22	contamination	contamination	NOUN
iajs-2017	27	23	,	,	PUNCT
iajs-2017	27	24	interminable	interminable	ADJ
iajs-2017	27	25	aggravation	aggravation	NOUN
iajs-2017	27	26	,	,	PUNCT
iajs-2017	27	27	collagen	collagen	NOUN
iajs-2017	27	28	vascular	vascular	ADJ
iajs-2017	27	29	and	and	CCONJ
iajs-2017	27	30	renal	renal	ADJ
iajs-2017	27	31	ailments	ailment	NOUN
iajs-2017	27	32	,	,	PUNCT
iajs-2017	27	33	langerhans	langerhans	PROPN
iajs-2017	27	34	cell	cell	NOUN
iajs-2017	27	35	histiocytosis	histiocytosis	NOUN
iajs-2017	27	36	,	,	PUNCT
iajs-2017	27	37	press	press	NOUN
iajs-2017	27	38	insufficiency	insufficiency	NOUN
iajs-2017	27	39	,	,	PUNCT
iajs-2017	27	40	hemolytic	hemolytic	ADJ
iajs-2017	27	41	sickliness	sickliness	NOUN
iajs-2017	27	42	,	,	PUNCT
iajs-2017	27	43	and	and	CCONJ
iajs-2017	27	44	kawasaki	kawasaki	PROPN
iajs-2017	27	45	malady	malady	PROPN
iajs-2017	27	46	(	(	PUNCT
iajs-2017	27	47	kd	kd	PROPN
iajs-2017	27	48	)	)	PUNCT
iajs-2017	28	1	[	[	X
iajs-2017	28	2	6	6	NUM
iajs-2017	28	3	]	]	PUNCT
iajs-2017	28	4	.	.	PUNCT
iajs-2017	29	1	thymidine	thymidine	PROPN
iajs-2017	29	2	kinases	kinase	NOUN
iajs-2017	29	3	have	have	VERB
iajs-2017	29	4	a	a	DET
iajs-2017	29	5	key	key	ADJ
iajs-2017	29	6	capacity	capacity	NOUN
iajs-2017	29	7	in	in	ADP
iajs-2017	29	8	the	the	DET
iajs-2017	29	9	combination	combination	NOUN
iajs-2017	29	10	of	of	ADP
iajs-2017	29	11	dna	dna	NOUN
iajs-2017	29	12	and	and	CCONJ
iajs-2017	29	13	along	along	ADP
iajs-2017	29	14	these	these	DET
iajs-2017	29	15	lines	line	NOUN
iajs-2017	29	16	in	in	ADP
iajs-2017	29	17	cell	cell	NOUN
iajs-2017	29	18	division	division	NOUN
iajs-2017	29	19	,	,	PUNCT
iajs-2017	29	20	as	as	SCONJ
iajs-2017	29	21	they	they	PRON
iajs-2017	29	22	are	be	AUX
iajs-2017	29	23	a	a	DET
iajs-2017	29	24	piece	piece	NOUN
iajs-2017	29	25	of	of	ADP
iajs-2017	29	26	the	the	DET
iajs-2017	29	27	special	special	ADJ
iajs-2017	29	28	response	response	NOUN
iajs-2017	29	29	tie	tie	VERB
iajs-2017	29	30	to	to	PART
iajs-2017	29	31	bring	bring	VERB
iajs-2017	29	32	thymidine	thymidine	NOUN
iajs-2017	29	33	into	into	ADP
iajs-2017	29	34	the	the	DET
iajs-2017	29	35	dna	dna	PROPN
iajs-2017	29	36	.	.	PUNCT
iajs-2017	30	1	thymidine	thymidine	PROPN
iajs-2017	30	2	is	be	AUX
iajs-2017	30	3	available	available	ADJ
iajs-2017	30	4	in	in	ADP
iajs-2017	30	5	the	the	DET
iajs-2017	30	6	body	body	NOUN
iajs-2017	30	7	liquids	liquid	NOUN
iajs-2017	30	8	because	because	SCONJ
iajs-2017	30	9	of	of	ADP
iajs-2017	30	10	debasement	debasement	NOUN
iajs-2017	30	11	of	of	ADP
iajs-2017	30	12	dna	dna	NOUN
iajs-2017	30	13	from	from	ADP
iajs-2017	30	14	nourishment	nourishment	NOUN
iajs-2017	30	15	and	and	CCONJ
iajs-2017	30	16	from	from	ADP
iajs-2017	30	17	dead	dead	ADJ
iajs-2017	30	18	cells	cell	NOUN
iajs-2017	30	19	.	.	PUNCT
iajs-2017	31	1	thymidine	thymidine	PROPN
iajs-2017	31	2	kinase	kinase	PROPN
iajs-2017	31	3	has	have	AUX
iajs-2017	31	4	been	be	AUX
iajs-2017	31	5	having	have	VERB
iajs-2017	31	6	a	a	DET
iajs-2017	31	7	developing	develop	VERB
iajs-2017	31	8	effect	effect	NOUN
iajs-2017	31	9	in	in	ADP
iajs-2017	31	10	the	the	DET
iajs-2017	31	11	disease	disease	NOUN
iajs-2017	31	12	investigate	investigate	VERB
iajs-2017	31	13	network	network	NOUN
iajs-2017	31	14	.	.	PUNCT
iajs-2017	32	1	it	it	PRON
iajs-2017	32	2	has	have	AUX
iajs-2017	32	3	been	be	AUX
iajs-2017	32	4	discovered	discover	VERB
iajs-2017	32	5	that	that	SCONJ
iajs-2017	32	6	hoisted	hoist	VERB
iajs-2017	32	7	blood	blood	NOUN
iajs-2017	32	8	serum	serum	NOUN
iajs-2017	32	9	levels	level	NOUN
iajs-2017	32	10	of	of	ADP
iajs-2017	32	11	tk-1	tk-1	ADP
iajs-2017	32	12	relates	relate	VERB
iajs-2017	32	13	with	with	ADP
iajs-2017	32	14	metastatic	metastatic	ADJ
iajs-2017	32	15	abilities	ability	NOUN
iajs-2017	32	16	of	of	ADP
iajs-2017	32	17	the	the	DET
iajs-2017	32	18	growth	growth	NOUN
iajs-2017	32	19	and	and	CCONJ
iajs-2017	32	20	in	in	ADP
iajs-2017	32	21	this	this	DET
iajs-2017	32	22	way	way	NOUN
iajs-2017	32	23	can	can	AUX
iajs-2017	32	24	be	be	AUX
iajs-2017	32	25	utilized	utilize	VERB
iajs-2017	32	26	to	to	PART
iajs-2017	32	27	recognize	recognize	VERB
iajs-2017	32	28	threatening	threaten	VERB
iajs-2017	32	29	kinds	kind	NOUN
iajs-2017	32	30	of	of	ADP
iajs-2017	32	31	tumor	tumor	NOUN
iajs-2017	32	32	,	,	PUNCT
iajs-2017	32	33	moreover	moreover	ADV
iajs-2017	32	34	tk-1	tk-1	ADP
iajs-2017	32	35	has	have	AUX
iajs-2017	32	36	been	be	AUX
iajs-2017	32	37	found	find	VERB
iajs-2017	32	38	to	to	PART
iajs-2017	32	39	appear	appear	VERB
iajs-2017	32	40	in	in	ADP
iajs-2017	32	41	blood	blood	NOUN
iajs-2017	32	42	serum	serum	NOUN
iajs-2017	32	43	even	even	ADV
iajs-2017	32	44	before	before	SCONJ
iajs-2017	32	45	clinical	clinical	ADJ
iajs-2017	32	46	side	side	NOUN
iajs-2017	32	47	effects	effect	NOUN
iajs-2017	32	48	even	even	ADV
iajs-2017	32	49	begin	begin	VERB
iajs-2017	32	50	to	to	PART
iajs-2017	32	51	demonstrate	demonstrate	VERB
iajs-2017	32	52	[	[	X
iajs-2017	32	53	7	7	NUM
iajs-2017	32	54	]	]	PUNCT
iajs-2017	32	55	.	.	PUNCT
iajs-2017	33	1	in	in	ADP
iajs-2017	33	2	clinical	clinical	ADJ
iajs-2017	33	3	science	science	NOUN
iajs-2017	33	4	tk	tk	PROPN
iajs-2017	33	5	is	be	AUX
iajs-2017	33	6	utilized	utilize	VERB
iajs-2017	33	7	as	as	ADP
iajs-2017	33	8	an	an	DET
iajs-2017	33	9	expansion	expansion	NOUN
iajs-2017	33	10	marker	marker	NOUN
iajs-2017	33	11	in	in	ADP
iajs-2017	33	12	the	the	DET
iajs-2017	33	13	analysis	analysis	NOUN
iajs-2017	33	14	,	,	PUNCT
iajs-2017	33	15	control	control	NOUN
iajs-2017	33	16	of	of	ADP
iajs-2017	33	17	treatment	treatment	NOUN
iajs-2017	33	18	and	and	CCONJ
iajs-2017	33	19	follow	follow	NOUN
iajs-2017	33	20	-	-	PUNCT
iajs-2017	33	21	up	up	NOUN
iajs-2017	33	22	of	of	ADP
iajs-2017	33	23	dangerous	dangerous	ADJ
iajs-2017	33	24	malady	malady	NOUN
iajs-2017	33	25	,	,	PUNCT
iajs-2017	33	26	chiefly	chiefly	ADV
iajs-2017	33	27	of	of	ADP
iajs-2017	33	28	hematological	hematological	ADJ
iajs-2017	33	29	malignancies	malignancy	NOUN
iajs-2017	33	30	[	[	X
iajs-2017	33	31	8	8	NUM
iajs-2017	33	32	]	]	PUNCT
iajs-2017	33	33	.	.	PUNCT
iajs-2017	34	1	well	well	INTJ
iajs-2017	34	2	evolved	evolve	VERB
iajs-2017	34	3	creatures	creature	NOUN
iajs-2017	34	4	have	have	VERB
iajs-2017	34	5	two	two	NUM
iajs-2017	34	6	isoenzymes	isoenzyme	NOUN
iajs-2017	34	7	that	that	PRON
iajs-2017	34	8	are	be	AUX
iajs-2017	34	9	artificially	artificially	ADV
iajs-2017	34	10	altogether	altogether	ADV
iajs-2017	34	11	different	different	ADJ
iajs-2017	34	12	,	,	PUNCT
iajs-2017	34	13	tk1	tk1	PROPN
iajs-2017	34	14	and	and	CCONJ
iajs-2017	34	15	tk2	tk2	PROPN
iajs-2017	34	16	.	.	PUNCT
iajs-2017	35	1	the	the	DET
iajs-2017	35	2	previous	previous	ADJ
iajs-2017	35	3	was	be	AUX
iajs-2017	35	4	first	first	ADV
iajs-2017	35	5	found	find	VERB
iajs-2017	35	6	in	in	ADP
iajs-2017	35	7	fetal	fetal	ADJ
iajs-2017	35	8	tissue	tissue	NOUN
iajs-2017	35	9	,	,	PUNCT
iajs-2017	35	10	the	the	DET
iajs-2017	35	11	second	second	ADJ
iajs-2017	35	12	was	be	AUX
iajs-2017	35	13	observed	observe	VERB
iajs-2017	35	14	to	to	PART
iajs-2017	35	15	be	be	AUX
iajs-2017	35	16	more	more	ADV
iajs-2017	35	17	inexhaustible	inexhaustible	ADJ
iajs-2017	35	18	in	in	ADP
iajs-2017	35	19	grown	grow	VERB
iajs-2017	35	20	-	-	PUNCT
iajs-2017	35	21	up	up	ADP
iajs-2017	35	22	tissue	tissue	NOUN
iajs-2017	35	23	,	,	PUNCT
iajs-2017	35	24	and	and	CCONJ
iajs-2017	35	25	at	at	ADP
iajs-2017	35	26	first	first	ADV
iajs-2017	35	27	they	they	PRON
iajs-2017	35	28	were	be	AUX
iajs-2017	35	29	named	name	VERB
iajs-2017	35	30	fetal	fetal	ADJ
iajs-2017	35	31	and	and	CCONJ
iajs-2017	35	32	grown	grow	VERB
iajs-2017	35	33	-	-	PUNCT
iajs-2017	35	34	up	up	ADP
iajs-2017	35	35	thymidine	thymidine	PROPN
iajs-2017	35	36	kinase	kinase	PROPN
iajs-2017	35	37	.	.	PUNCT
iajs-2017	36	1	before	before	ADP
iajs-2017	36	2	long	long	ADV
iajs-2017	36	3	it	it	PRON
iajs-2017	36	4	was	be	AUX
iajs-2017	36	5	demonstrated	demonstrate	VERB
iajs-2017	36	6	that	that	SCONJ
iajs-2017	36	7	tk1	tk1	PROPN
iajs-2017	36	8	is	be	AUX
iajs-2017	36	9	available	available	ADJ
iajs-2017	36	10	in	in	ADP
iajs-2017	36	11	the	the	DET
iajs-2017	36	12	cytoplasm	cytoplasm	NOUN
iajs-2017	36	13	just	just	ADV
iajs-2017	36	14	fully	fully	ADV
iajs-2017	36	15	expecting	expect	VERB
iajs-2017	36	16	cell	cell	NOUN
iajs-2017	36	17	division	division	NOUN
iajs-2017	36	18	(	(	PUNCT
iajs-2017	36	19	cell	cell	NOUN
iajs-2017	36	20	cycle	cycle	NOUN
iajs-2017	36	21	-	-	PUNCT
iajs-2017	36	22	subordinate	subordinate	NOUN
iajs-2017	36	23	)	)	PUNCT
iajs-2017	37	1	[	[	X
iajs-2017	37	2	9	9	NUM
iajs-2017	37	3	]	]	PUNCT
iajs-2017	37	4	.	.	PUNCT
iajs-2017	38	1	total	total	ADJ
iajs-2017	38	2	antioxidant	antioxidant	ADJ
iajs-2017	38	3	capacity	capacity	NOUN
iajs-2017	38	4	is	be	AUX
iajs-2017	38	5	the	the	DET
iajs-2017	38	6	term	term	NOUN
iajs-2017	38	7	used	use	VERB
iajs-2017	38	8	to	to	PART
iajs-2017	38	9	portray	portray	VERB
iajs-2017	38	10	the	the	DET
iajs-2017	38	11	capacity	capacity	NOUN
iajs-2017	38	12	of	of	ADP
iajs-2017	38	13	cancer	cancer	NOUN
iajs-2017	38	14	prevention	prevention	NOUN
iajs-2017	38	15	agents	agent	NOUN
iajs-2017	38	16	in	in	ADP
iajs-2017	38	17	various	various	ADJ
iajs-2017	38	18	sustenances	sustenance	NOUN
iajs-2017	38	19	to	to	PART
iajs-2017	38	20	clean	clean	VERB
iajs-2017	38	21	unsafe	unsafe	ADJ
iajs-2017	38	22	free	free	ADJ
iajs-2017	38	23	radicals	radical	NOUN
iajs-2017	38	24	in	in	ADP
iajs-2017	38	25	the	the	DET
iajs-2017	38	26	blood	blood	NOUN
iajs-2017	38	27	and	and	CCONJ
iajs-2017	38	28	cells	cell	NOUN
iajs-2017	38	29	.	.	PUNCT
iajs-2017	39	1	restricted	restrict	VERB
iajs-2017	39	2	examinations	examination	NOUN
iajs-2017	39	3	in	in	ADP
iajs-2017	39	4	which	which	PRON
iajs-2017	39	5	plasma	plasma	NOUN
iajs-2017	39	6	add	add	VERB
iajs-2017	39	7	up	up	ADP
iajs-2017	39	8	to	to	ADP
iajs-2017	39	9	cell	cell	NOUN
iajs-2017	39	10	reinforcement	reinforcement	NOUN
iajs-2017	39	11	status	status	NOUN
iajs-2017	39	12	(	(	PUNCT
iajs-2017	39	13	tas	ta	NOUN
iajs-2017	39	14	)	)	PUNCT
iajs-2017	39	15	was	be	AUX
iajs-2017	39	16	explored	explore	VERB
iajs-2017	39	17	show	show	NOUN
iajs-2017	39	18	that	that	SCONJ
iajs-2017	39	19	platelet	platelet	NOUN
iajs-2017	39	20	work	work	NOUN
iajs-2017	39	21	changes	change	NOUN
iajs-2017	39	22	initiated	initiate	VERB
iajs-2017	39	23	by	by	ADP
iajs-2017	39	24	intense	intense	ADJ
iajs-2017	39	25	and	and	CCONJ
iajs-2017	39	26	interminable	interminable	ADJ
iajs-2017	39	27	exercise	exercise	NOUN
iajs-2017	39	28	might	might	AUX
iajs-2017	39	29	be	be	AUX
iajs-2017	39	30	identified	identify	VERB
iajs-2017	39	31	with	with	ADP
iajs-2017	39	32	modifications	modification	NOUN
iajs-2017	39	33	in	in	ADP
iajs-2017	39	34	cancer	cancer	NOUN
iajs-2017	39	35	prevention	prevention	NOUN
iajs-2017	39	36	agent	agent	NOUN
iajs-2017	39	37	limit	limit	NOUN
iajs-2017	39	38	[	[	X
iajs-2017	39	39	10,11	10,11	NOUN
iajs-2017	39	40	]	]	PUNCT
iajs-2017	39	41	.	.	PUNCT
iajs-2017	40	1	add	add	VERB
iajs-2017	40	2	up	up	ADP
iajs-2017	40	3	to	to	ADP
iajs-2017	40	4	cancer	cancer	NOUN
iajs-2017	40	5	prevention	prevention	NOUN
iajs-2017	40	6	agent	agent	NOUN
iajs-2017	40	7	limit	limit	NOUN
iajs-2017	40	8	(	(	PUNCT
iajs-2017	40	9	tac	tac	NOUN
iajs-2017	40	10	)	)	PUNCT
iajs-2017	40	11	test	test	NOUN
iajs-2017	40	12	use	use	NOUN
iajs-2017	40	13	as	as	ADP
iajs-2017	40	14	a	a	DET
iajs-2017	40	15	biomarker	biomarker	NOUN
iajs-2017	40	16	of	of	ADP
iajs-2017	40	17	sickness	sickness	NOUN
iajs-2017	40	18	in	in	ADP
iajs-2017	40	19	organic	organic	ADJ
iajs-2017	40	20	chemistry	chemistry	NOUN
iajs-2017	40	21	,	,	PUNCT
iajs-2017	40	22	prescription	prescription	NOUN
iajs-2017	40	23	,	,	PUNCT
iajs-2017	40	24	sustenance	sustenance	NOUN
iajs-2017	40	25	and	and	CCONJ
iajs-2017	40	26	nutritious	nutritious	ADJ
iajs-2017	40	27	sciences	science	NOUN
iajs-2017	40	28	.	.	PUNCT
iajs-2017	41	1	in	in	ADP
iajs-2017	41	2	a	a	DET
iajs-2017	41	3	wide	wide	ADJ
iajs-2017	41	4	range	range	NOUN
iajs-2017	41	5	of	of	ADP
iajs-2017	41	6	pathophysiological	pathophysiological	ADJ
iajs-2017	41	7	conditions	condition	NOUN
iajs-2017	41	8	(	(	PUNCT
iajs-2017	41	9	heart	heart	NOUN
iajs-2017	41	10	and	and	CCONJ
iajs-2017	41	11	vascular	vascular	ADJ
iajs-2017	41	12	illnesses	illness	NOUN
iajs-2017	41	13	,	,	PUNCT
iajs-2017	41	14	diabetes	diabetes	NOUN
iajs-2017	41	15	mellitus	mellitus	NOUN
iajs-2017	41	16	,	,	PUNCT
iajs-2017	41	17	neurological	neurological	ADJ
iajs-2017	41	18	and	and	CCONJ
iajs-2017	41	19	mental	mental	ADJ
iajs-2017	41	20	clutters	clutter	VERB
iajs-2017	41	21	,	,	PUNCT
iajs-2017	41	22	renal	renal	ADJ
iajs-2017	41	23	disarranges	disarrange	NOUN
iajs-2017	41	24	and	and	CCONJ
iajs-2017	41	25	lung	lung	NOUN
iajs-2017	41	26	sicknesses	sickness	NOUN
iajs-2017	41	27	)	)	PUNCT
iajs-2017	41	28	,	,	PUNCT
iajs-2017	41	29	tac	tac	PROPN
iajs-2017	41	30	could	could	AUX
iajs-2017	41	31	be	be	AUX
iajs-2017	41	32	a	a	DET
iajs-2017	41	33	solid	solid	ADJ
iajs-2017	41	34	biomarker	biomarker	NOUN
iajs-2017	41	35	of	of	ADP
iajs-2017	41	36	diagnostics	diagnostic	NOUN
iajs-2017	41	37	and	and	CCONJ
iajs-2017	41	38	prognostics.tac	prognostics.tac	PROPN
iajs-2017	41	39	could	could	AUX
iajs-2017	41	40	be	be	AUX
iajs-2017	41	41	helpful	helpful	ADJ
iajs-2017	41	42	to	to	PART
iajs-2017	41	43	assess	assess	VERB
iajs-2017	41	44	nutritious	nutritious	ADJ
iajs-2017	41	45	mediations	mediation	NOUN
iajs-2017	41	46	with	with	ADP
iajs-2017	41	47	tac	tac	NOUN
iajs-2017	41	48	-	-	ADJ
iajs-2017	41	49	rich	rich	ADJ
iajs-2017	41	50	sustenances	sustenance	NOUN
iajs-2017	41	51	on	on	ADP
iajs-2017	41	52	ailment	ailment	ADJ
iajs-2017	41	53	hazard	hazard	NOUN
iajs-2017	41	54	and	and	CCONJ
iajs-2017	41	55	avoidance	avoidance	NOUN
iajs-2017	41	56	,	,	PUNCT
iajs-2017	41	57	including	include	VERB
iajs-2017	41	58	hostile	hostile	ADJ
iajs-2017	41	59	to	to	ADP
iajs-2017	41	60	maturing	mature	VERB
iajs-2017	41	61	techniques	technique	NOUN
iajs-2017	41	62	[	[	X
iajs-2017	41	63	12	12	NUM
iajs-2017	41	64	]	]	PUNCT
iajs-2017	41	65	.	.	PUNCT
iajs-2017	42	1	this	this	DET
iajs-2017	42	2	study	study	NOUN
iajs-2017	42	3	aimed	aim	VERB
iajs-2017	42	4	to	to	PART
iajs-2017	42	5	find	find	VERB
iajs-2017	42	6	relationship	relationship	NOUN
iajs-2017	42	7	between	between	ADP
iajs-2017	42	8	thymidine	thymidine	ADJ
iajs-2017	42	9	kinase-1	kinase-1	PROPN
iajs-2017	42	10	as	as	ADP
iajs-2017	42	11	tumor	tumor	NOUN
iajs-2017	42	12	marker	marker	NOUN
iajs-2017	42	13	and	and	CCONJ
iajs-2017	42	14	total	total	ADJ
iajs-2017	42	15	antioxidant	antioxidant	ADJ
iajs-2017	42	16	capacity	capacity	NOUN
iajs-2017	42	17	in	in	ADP
iajs-2017	42	18	iraqi	iraqi	ADJ
iajs-2017	42	19	children	child	NOUN
iajs-2017	42	20	patients	patient	NOUN
iajs-2017	42	21	with	with	ADP
iajs-2017	42	22	thrombocytopenia	thrombocytopenia	NOUN
iajs-2017	42	23	and	and	CCONJ
iajs-2017	42	24	with	with	ADP
iajs-2017	42	25	thrombocytosis	thrombocytosis	NOUN
iajs-2017	42	26	.	.	PUNCT
iajs-2017	43	1	2	2	X
iajs-2017	43	2	.	.	X
iajs-2017	43	3	materials	material	NOUN
iajs-2017	43	4	and	and	CCONJ
iajs-2017	43	5	methods	method	NOUN
iajs-2017	43	6	2.1	2.1	NUM
iajs-2017	43	7	subjects	subject	NOUN
iajs-2017	43	8	during	during	ADP
iajs-2017	43	9	the	the	DET
iajs-2017	43	10	period	period	NOUN
iajs-2017	43	11	from	from	ADP
iajs-2017	43	12	november	november	PROPN
iajs-2017	43	13	2017	2017	NUM
iajs-2017	43	14	to	to	ADP
iajs-2017	43	15	april	april	PROPN
iajs-2017	43	16	2018	2018	NUM
iajs-2017	43	17	,	,	PUNCT
iajs-2017	43	18	blood	blood	NOUN
iajs-2017	43	19	samples	sample	NOUN
iajs-2017	43	20	were	be	AUX
iajs-2017	43	21	collected	collect	VERB
iajs-2017	43	22	from	from	ADP
iajs-2017	43	23	(	(	PUNCT
iajs-2017	43	24	60	60	NUM
iajs-2017	43	25	)	)	PUNCT
iajs-2017	43	26	children	child	NOUN
iajs-2017	43	27	patients	patient	NOUN
iajs-2017	43	28	were	be	AUX
iajs-2017	43	29	divided	divide	VERB
iajs-2017	43	30	into	into	ADP
iajs-2017	43	31	(	(	PUNCT
iajs-2017	43	32	30	30	NUM
iajs-2017	43	33	)	)	PUNCT
iajs-2017	43	34	patients	patient	NOUN
iajs-2017	43	35	with	with	ADP
iajs-2017	43	36	idiopathic	idiopathic	ADJ
iajs-2017	43	37	thrombocytopenia	thrombocytopenia	PROPN
iajs-2017	43	38	purpura	purpura	NOUN
iajs-2017	43	39	(	(	PUNCT
iajs-2017	43	40	itp	itp	PROPN
iajs-2017	43	41	)	)	PUNCT
iajs-2017	43	42	and	and	CCONJ
iajs-2017	43	43	(	(	PUNCT
iajs-2017	43	44	30	30	X
iajs-2017	43	45	)	)	PUNCT
iajs-2017	43	46	patients	patient	NOUN
iajs-2017	43	47	with	with	ADP
iajs-2017	43	48	thrombocytosis	thrombocytosis	NOUN
iajs-2017	43	49	caused	cause	VERB
iajs-2017	43	50	by	by	ADP
iajs-2017	43	51	leukemia	leukemia	NOUN
iajs-2017	43	52	,	,	PUNCT
iajs-2017	43	53	in	in	ADP
iajs-2017	43	54	addition	addition	NOUN
iajs-2017	43	55	to	to	ADP
iajs-2017	43	56	(	(	PUNCT
iajs-2017	43	57	30	30	NUM
iajs-2017	43	58	)	)	PUNCT
iajs-2017	43	59	healthy	healthy	ADJ
iajs-2017	43	60	children	child	NOUN
iajs-2017	43	61	as	as	ADP
iajs-2017	43	62	control	control	NOUN
iajs-2017	43	63	in	in	ADP
iajs-2017	43	64	children	child	NOUN
iajs-2017	43	65	fever	fever	NOUN
iajs-2017	43	66	hospital	hospital	NOUN
iajs-2017	43	67	in	in	ADP
iajs-2017	43	68	the	the	DET
iajs-2017	43	69	medical	medical	ADJ
iajs-2017	43	70	city	city	NOUN
iajs-2017	43	71	/	/	SYM
iajs-2017	43	72	baghdad	baghdad	PROPN
iajs-2017	43	73	.	.	PUNCT
iajs-2017	44	1	all	all	DET
iajs-2017	44	2	study	study	NOUN
iajs-2017	44	3	groups	group	NOUN
iajs-2017	44	4	were	be	AUX
iajs-2017	44	5	with	with	ADP
iajs-2017	44	6	range	range	NOUN
iajs-2017	44	7	ages	age	NOUN
iajs-2017	44	8	(	(	PUNCT
iajs-2017	44	9	1	1	NUM
iajs-2017	44	10	-	-	SYM
iajs-2017	44	11	15	15	NUM
iajs-2017	44	12	)	)	PUNCT
iajs-2017	44	13	years	year	NOUN
iajs-2017	44	14	,	,	PUNCT
iajs-2017	44	15	and	and	CCONJ
iajs-2017	44	16	they	they	PRON
iajs-2017	44	17	were	be	AUX
iajs-2017	44	18	diagnosed	diagnose	VERB
iajs-2017	44	19	by	by	ADP
iajs-2017	44	20	assay	assay	NOUN
iajs-2017	44	21	of	of	ADP
iajs-2017	44	22	platelet	platelet	NOUN
iajs-2017	44	23	count	count	NOUN
iajs-2017	44	24	,	,	PUNCT
iajs-2017	44	25	prothrombin	prothrombin	ADJ
iajs-2017	44	26	time	time	NOUN
iajs-2017	44	27	(	(	PUNCT
iajs-2017	44	28	pt	pt	NOUN
iajs-2017	44	29	)	)	PUNCT
iajs-2017	44	30	,	,	PUNCT
iajs-2017	44	31	and	and	CCONJ
iajs-2017	44	32	partial	partial	ADJ
iajs-2017	44	33	thromboplastin	thromboplastin	NOUN
iajs-2017	44	34	time	time	NOUN
iajs-2017	44	35	(	(	PUNCT
iajs-2017	44	36	ptt	ptt	NOUN
iajs-2017	44	37	)	)	PUNCT
iajs-2017	44	38	.	.	PUNCT
iajs-2017	45	1	chemistry	chemistry	NOUN
iajs-2017	46	1	|	|	ADV
iajs-2017	46	2	81	81	NUM
iajs-2017	46	3	ibn	ibn	PROPN
iajs-2017	46	4	al	al	PROPN
iajs-2017	46	5	-	-	PUNCT
iajs-2017	46	6	haitham	haitham	PROPN
iajs-2017	46	7	jour	jour	X
iajs-2017	46	8	.	.	PROPN
iajs-2017	47	1	for	for	ADP
iajs-2017	47	2	pure	pure	ADJ
iajs-2017	47	3	&	&	CCONJ
iajs-2017	47	4	appl	appl	PROPN
iajs-2017	47	5	.	.	PUNCT
iajs-2017	48	1	sci	sci	PROPN
iajs-2017	48	2	.	.	PROPN
iajs-2017	48	3	ihjpas	ihjpas	PROPN
iajs-2017	48	4	https://doi.org/10.30526/31.3.2017	https://doi.org/10.30526/31.3.2017	ADP
iajs-2017	48	5	vol	vol	NOUN
iajs-2017	48	6	.	.	PUNCT
iajs-2017	49	1	31	31	NUM
iajs-2017	50	1	(	(	PUNCT
iajs-2017	50	2	3	3	NUM
iajs-2017	50	3	)	)	PUNCT
iajs-2017	50	4	2018	2018	NUM
iajs-2017	50	5	2.2	2.2	NUM
iajs-2017	50	6	estimation	estimation	NOUN
iajs-2017	50	7	of	of	ADP
iajs-2017	50	8	platelet	platelet	NOUN
iajs-2017	50	9	count	count	NOUN
iajs-2017	50	10	in	in	ADP
iajs-2017	50	11	blood	blood	NOUN
iajs-2017	50	12	evaluation	evaluation	NOUN
iajs-2017	50	13	of	of	ADP
iajs-2017	50	14	platelets	platelet	NOUN
iajs-2017	50	15	in	in	ADP
iajs-2017	50	16	venous	venous	ADJ
iajs-2017	50	17	blood	blood	NOUN
iajs-2017	50	18	is	be	AUX
iajs-2017	50	19	a	a	DET
iajs-2017	50	20	typical	typical	ADJ
iajs-2017	50	21	research	research	NOUN
iajs-2017	50	22	facility	facility	NOUN
iajs-2017	50	23	estimation	estimation	NOUN
iajs-2017	50	24	,	,	PUNCT
iajs-2017	50	25	performed	perform	VERB
iajs-2017	50	26	via	via	ADP
iajs-2017	50	27	mechanized	mechanized	ADJ
iajs-2017	50	28	hematology	hematology	NOUN
iajs-2017	50	29	analyzers	analyzer	NOUN
iajs-2017	50	30	which	which	PRON
iajs-2017	50	31	use	use	VERB
iajs-2017	50	32	a	a	DET
iajs-2017	50	33	reference	reference	NOUN
iajs-2017	50	34	extend	extend	VERB
iajs-2017	50	35	for	for	ADP
iajs-2017	50	36	an	an	DET
iajs-2017	50	37	ordinary	ordinary	ADJ
iajs-2017	50	38	platelet	platelet	NOUN
iajs-2017	50	39	check	check	NOUN
iajs-2017	50	40	between	between	ADP
iajs-2017	50	41	150,000	150,000	NUM
iajs-2017	50	42	to	to	PART
iajs-2017	50	43	450,000	450,000	NUM
iajs-2017	50	44	platelets	platelet	NOUN
iajs-2017	50	45	/	/	SYM
iajs-2017	50	46	μl	μl	NOUN
iajs-2017	50	47	of	of	ADP
iajs-2017	50	48	blood	blood	NOUN
iajs-2017	50	49	.	.	PUNCT
iajs-2017	51	1	2.3	2.3	NUM
iajs-2017	51	2	estimation	estimation	NOUN
iajs-2017	51	3	of	of	ADP
iajs-2017	51	4	plasma	plasma	NOUN
iajs-2017	51	5	thymidine	thymidine	NOUN
iajs-2017	51	6	kinase	kinase	PROPN
iajs-2017	51	7	-1	-1	PROPN
iajs-2017	51	8	(	(	PUNCT
iajs-2017	51	9	tk-1	tk-1	ADP
iajs-2017	51	10	)	)	PUNCT
iajs-2017	51	11	(	(	PUNCT
iajs-2017	51	12	ng/	ng/	ADJ
iajs-2017	51	13	ml	ml	NOUN
iajs-2017	51	14	)	)	PUNCT
iajs-2017	51	15	human	human	ADJ
iajs-2017	51	16	thymidine	thymidine	NOUN
iajs-2017	51	17	kinase	kinase	PROPN
iajs-2017	51	18	-1	-1	PROPN
iajs-2017	51	19	(	(	PUNCT
iajs-2017	51	20	tk-1	tk-1	NUM
iajs-2017	51	21	)	)	PUNCT
iajs-2017	51	22	was	be	AUX
iajs-2017	51	23	determined	determine	VERB
iajs-2017	51	24	by	by	ADP
iajs-2017	51	25	enzyme	enzyme	NOUN
iajs-2017	51	26	–	–	PUNCT
iajs-2017	51	27	linked	link	VERB
iajs-2017	51	28	immune	immune	ADJ
iajs-2017	51	29	sorbent	sorbent	NOUN
iajs-2017	51	30	assay	assay	NOUN
iajs-2017	51	31	(	(	PUNCT
iajs-2017	51	32	elisa	elisa	NOUN
iajs-2017	51	33	)	)	PUNCT
iajs-2017	51	34	kit	kit	NOUN
iajs-2017	51	35	that	that	PRON
iajs-2017	51	36	supplied	supply	VERB
iajs-2017	51	37	by	by	ADP
iajs-2017	51	38	shanghal	shanghal	NOUN
iajs-2017	51	39	yehuda	yehuda	NOUN
iajs-2017	51	40	biological	biological	ADJ
iajs-2017	51	41	technology	technology	PROPN
iajs-2017	51	42	-	-	PUNCT
iajs-2017	51	43	china	china	PROPN
iajs-2017	51	44	,	,	PUNCT
iajs-2017	51	45	which	which	PRON
iajs-2017	51	46	that	that	SCONJ
iajs-2017	51	47	based	base	VERB
iajs-2017	51	48	on	on	ADP
iajs-2017	51	49	biotin	biotin	NOUN
iajs-2017	51	50	double	double	ADJ
iajs-2017	51	51	antibody	antibody	NOUN
iajs-2017	51	52	sandwich	sandwich	NOUN
iajs-2017	51	53	technology	technology	NOUN
iajs-2017	51	54	.	.	PUNCT
iajs-2017	52	1	assay	assay	PROPN
iajs-2017	52	2	range	range	NOUN
iajs-2017	52	3	:	:	PUNCT
iajs-2017	52	4	0.2ng	0.2ng	NUM
iajs-2017	52	5	/ml20	/ml20	SYM
iajs-2017	53	1	ng	ng	PROPN
iajs-2017	53	2	/	/	SYM
iajs-2017	53	3	ml	ml	PROPN
iajs-2017	53	4	2.4	2.4	NUM
iajs-2017	53	5	estimation	estimation	NOUN
iajs-2017	53	6	of	of	ADP
iajs-2017	53	7	plasma	plasma	NOUN
iajs-2017	53	8	total	total	NOUN
iajs-2017	53	9	antioxidant	antioxidant	NOUN
iajs-2017	53	10	capacity	capacity	NOUN
iajs-2017	53	11	(	(	PUNCT
iajs-2017	53	12	tac	tac	NOUN
iajs-2017	53	13	)	)	PUNCT
iajs-2017	53	14	(	(	PUNCT
iajs-2017	53	15	u	u	NOUN
iajs-2017	53	16	/	/	SYM
iajs-2017	53	17	ml	ml	NOUN
iajs-2017	53	18	)	)	PUNCT
iajs-2017	53	19	total	total	ADJ
iajs-2017	53	20	antioxidant	antioxidant	NOUN
iajs-2017	53	21	capacity	capacity	NOUN
iajs-2017	53	22	uses	use	VERB
iajs-2017	53	23	enzyme	enzyme	NOUN
iajs-2017	53	24	–	–	PUNCT
iajs-2017	53	25	linked	link	VERB
iajs-2017	53	26	immune	immune	ADJ
iajs-2017	53	27	sorbent	sorbent	NOUN
iajs-2017	53	28	assay	assay	NOUN
iajs-2017	53	29	(	(	PUNCT
iajs-2017	53	30	elisa	elisa	NOUN
iajs-2017	53	31	)	)	PUNCT
iajs-2017	53	32	based	base	VERB
iajs-2017	53	33	on	on	ADP
iajs-2017	53	34	biotin	biotin	NOUN
iajs-2017	53	35	double	double	ADJ
iajs-2017	53	36	antibody	antibody	NOUN
iajs-2017	53	37	sandwich	sandwich	NOUN
iajs-2017	53	38	technology	technology	NOUN
iajs-2017	53	39	to	to	PART
iajs-2017	53	40	assay	assay	VERB
iajs-2017	53	41	human	human	ADJ
iajs-2017	53	42	total	total	ADJ
iajs-2017	53	43	antioxidant	antioxidant	NOUN
iajs-2017	53	44	capacity	capacity	NOUN
iajs-2017	53	45	,	,	PUNCT
iajs-2017	53	46	soluble	soluble	ADJ
iajs-2017	53	47	(	(	PUNCT
iajs-2017	53	48	t	t	NOUN
iajs-2017	53	49	-	-	PUNCT
iajs-2017	53	50	aoc	aoc	NOUN
iajs-2017	53	51	)	)	PUNCT
iajs-2017	53	52	.	.	PUNCT
iajs-2017	54	1	add	add	VERB
iajs-2017	54	2	total	total	ADJ
iajs-2017	54	3	antioxidant	antioxidant	ADJ
iajs-2017	54	4	capacity	capacity	NOUN
iajs-2017	54	5	to	to	ADP
iajs-2017	54	6	wells	wells	PROPN
iajs-2017	54	7	that	that	PRON
iajs-2017	54	8	are	be	AUX
iajs-2017	54	9	pre	pre	ADJ
iajs-2017	54	10	-	-	VERB
iajs-2017	54	11	coated	coated	ADJ
iajs-2017	54	12	with	with	ADP
iajs-2017	54	13	total	total	ADJ
iajs-2017	54	14	antioxidant	antioxidant	ADJ
iajs-2017	54	15	capacity	capacity	NOUN
iajs-2017	54	16	monoclonal	monoclonal	NOUN
iajs-2017	54	17	antibody	antibody	NOUN
iajs-2017	54	18	and	and	CCONJ
iajs-2017	54	19	then	then	ADV
iajs-2017	54	20	incubate	incubate	VERB
iajs-2017	54	21	.	.	PUNCT
iajs-2017	55	1	after	after	ADP
iajs-2017	55	2	incubation	incubation	NOUN
iajs-2017	55	3	,	,	PUNCT
iajs-2017	55	4	add	add	VERB
iajs-2017	55	5	anti	anti	ADJ
iajs-2017	55	6	taoc	taoc	NOUN
iajs-2017	55	7	antibodies	antibody	NOUN
iajs-2017	55	8	labeled	label	VERB
iajs-2017	55	9	with	with	ADP
iajs-2017	55	10	biotin	biotin	NOUN
iajs-2017	55	11	to	to	PART
iajs-2017	55	12	unite	unite	VERB
iajs-2017	55	13	with	with	ADP
iajs-2017	55	14	streptavidin	streptavidin	NOUN
iajs-2017	55	15	–	–	PUNCT
iajs-2017	55	16	hrp	hrp	PROPN
iajs-2017	55	17	,	,	PUNCT
iajs-2017	55	18	which	which	PRON
iajs-2017	55	19	forms	form	VERB
iajs-2017	55	20	the	the	DET
iajs-2017	55	21	immune	immune	ADJ
iajs-2017	55	22	complex	complex	NOUN
iajs-2017	55	23	.	.	PUNCT
iajs-2017	56	1	remove	remove	VERB
iajs-2017	56	2	unbound	unbound	NOUN
iajs-2017	56	3	enzymes	enzyme	NOUN
iajs-2017	56	4	after	after	ADP
iajs-2017	56	5	incubation	incubation	NOUN
iajs-2017	56	6	and	and	CCONJ
iajs-2017	56	7	washing	washing	NOUN
iajs-2017	56	8	,	,	PUNCT
iajs-2017	56	9	then	then	ADV
iajs-2017	56	10	add	add	VERB
iajs-2017	56	11	substrate	substrate	NOUN
iajs-2017	56	12	a	a	PRON
iajs-2017	56	13	and	and	CCONJ
iajs-2017	56	14	b.	b.	NOUN
iajs-2017	57	1	the	the	DET
iajs-2017	57	2	solution	solution	NOUN
iajs-2017	57	3	will	will	AUX
iajs-2017	57	4	turn	turn	VERB
iajs-2017	57	5	blue	blue	ADJ
iajs-2017	57	6	and	and	CCONJ
iajs-2017	57	7	change	change	VERB
iajs-2017	57	8	to	to	PART
iajs-2017	57	9	yellow	yellow	VERB
iajs-2017	57	10	with	with	ADP
iajs-2017	57	11	the	the	DET
iajs-2017	57	12	effect	effect	NOUN
iajs-2017	57	13	of	of	ADP
iajs-2017	57	14	acid	acid	NOUN
iajs-2017	57	15	.	.	PUNCT
iajs-2017	58	1	the	the	DET
iajs-2017	58	2	shades	shade	NOUN
iajs-2017	58	3	of	of	ADP
iajs-2017	58	4	solution	solution	NOUN
iajs-2017	58	5	and	and	CCONJ
iajs-2017	58	6	the	the	DET
iajs-2017	58	7	concentration	concentration	NOUN
iajs-2017	58	8	of	of	ADP
iajs-2017	58	9	human	human	ADJ
iajs-2017	58	10	total	total	ADJ
iajs-2017	58	11	antioxidant	antioxidant	NOUN
iajs-2017	58	12	capacity	capacity	NOUN
iajs-2017	58	13	are	be	AUX
iajs-2017	58	14	positively	positively	ADV
iajs-2017	58	15	correlated	correlate	VERB
iajs-2017	58	16	.	.	PUNCT
iajs-2017	59	1	assay	assay	PROPN
iajs-2017	59	2	range	range	NOUN
iajs-2017	59	3	0.3u|ml-90u|ml	0.3u|ml-90u|ml	PROPN
iajs-2017	59	4	2.5	2.5	NUM
iajs-2017	59	5	estimation	estimation	NOUN
iajs-2017	59	6	of	of	ADP
iajs-2017	59	7	prothrombin	prothrombin	ADJ
iajs-2017	59	8	time	time	NOUN
iajs-2017	59	9	(	(	PUNCT
iajs-2017	59	10	pt	pt	NOUN
iajs-2017	59	11	)	)	PUNCT
iajs-2017	59	12	(	(	PUNCT
iajs-2017	59	13	sec	sec	PROPN
iajs-2017	59	14	)	)	PUNCT
iajs-2017	59	15	prothrombin	prothrombin	ADJ
iajs-2017	59	16	time	time	NOUN
iajs-2017	59	17	(	(	PUNCT
iajs-2017	59	18	pt	pt	NOUN
iajs-2017	59	19	)	)	PUNCT
iajs-2017	59	20	was	be	AUX
iajs-2017	59	21	examined	examine	VERB
iajs-2017	59	22	by	by	ADP
iajs-2017	59	23	pack	pack	NOUN
iajs-2017	59	24	from	from	ADP
iajs-2017	59	25	stago	stago	PROPN
iajs-2017	59	26	-	-	PUNCT
iajs-2017	59	27	france	france	PROPN
iajs-2017	59	28	.	.	PUNCT
iajs-2017	60	1	the	the	DET
iajs-2017	60	2	guideline	guideline	NOUN
iajs-2017	60	3	of	of	ADP
iajs-2017	60	4	the	the	DET
iajs-2017	60	5	test	test	NOUN
iajs-2017	60	6	comprises	comprise	NOUN
iajs-2017	60	7	of	of	ADP
iajs-2017	60	8	the	the	DET
iajs-2017	60	9	utilization	utilization	NOUN
iajs-2017	60	10	of	of	ADP
iajs-2017	60	11	calcium	calcium	NOUN
iajs-2017	60	12	thromboplastin	thromboplastin	VERB
iajs-2017	60	13	to	to	PART
iajs-2017	60	14	gauge	gauge	VERB
iajs-2017	60	15	the	the	DET
iajs-2017	60	16	coagulating	coagulating	NOUN
iajs-2017	60	17	time	time	NOUN
iajs-2017	60	18	of	of	ADP
iajs-2017	60	19	the	the	DET
iajs-2017	60	20	patient	patient	NOUN
iajs-2017	60	21	s	s	PART
iajs-2017	60	22	plasma	plasma	NOUN
iajs-2017	60	23	and	and	CCONJ
iajs-2017	60	24	to	to	PART
iajs-2017	60	25	contrast	contrast	VERB
iajs-2017	60	26	it	it	PRON
iajs-2017	60	27	and	and	CCONJ
iajs-2017	60	28	that	that	PRON
iajs-2017	60	29	of	of	ADP
iajs-2017	60	30	a	a	DET
iajs-2017	60	31	typical	typical	ADJ
iajs-2017	60	32	standard	standard	NOUN
iajs-2017	60	33	.	.	PUNCT
iajs-2017	61	1	the	the	DET
iajs-2017	61	2	test	test	NOUN
iajs-2017	61	3	measures	measure	NOUN
iajs-2017	61	4	,	,	PUNCT
iajs-2017	61	5	all	all	PRON
iajs-2017	61	6	in	in	ADV
iajs-2017	61	7	all	all	PRON
iajs-2017	61	8	,	,	PUNCT
iajs-2017	61	9	the	the	DET
iajs-2017	61	10	action	action	NOUN
iajs-2017	61	11	of	of	ADP
iajs-2017	61	12	the	the	DET
iajs-2017	61	13	coagulation	coagulation	NOUN
iajs-2017	61	14	factor	factor	NOUN
iajs-2017	61	15	ll	ll	AUX
iajs-2017	61	16	(	(	PUNCT
iajs-2017	61	17	prothrombin	prothrombin	NOUN
iajs-2017	61	18	)	)	PUNCT
iajs-2017	61	19	,	,	PUNCT
iajs-2017	61	20	factor	factor	NOUN
iajs-2017	61	21	v	v	NOUN
iajs-2017	61	22	(	(	PUNCT
iajs-2017	61	23	proaccelerin	proaccelerin	PROPN
iajs-2017	61	24	)	)	PUNCT
iajs-2017	61	25	,	,	PUNCT
iajs-2017	61	26	factor	factor	NOUN
iajs-2017	61	27	vll	vll	NOUN
iajs-2017	61	28	(	(	PUNCT
iajs-2017	61	29	proconvertin	proconvertin	ADV
iajs-2017	61	30	)	)	PUNCT
iajs-2017	61	31	,	,	PUNCT
iajs-2017	61	32	factor	factor	NOUN
iajs-2017	61	33	x	x	SYM
iajs-2017	61	34	(	(	PUNCT
iajs-2017	61	35	stuart	stuart	PROPN
iajs-2017	61	36	factor	factor	PROPN
iajs-2017	61	37	)	)	PUNCT
iajs-2017	61	38	and	and	CCONJ
iajs-2017	61	39	factor	factor	NOUN
iajs-2017	61	40	l	l	NOUN
iajs-2017	61	41	(	(	PUNCT
iajs-2017	61	42	fibrinogen	fibrinogen	NOUN
iajs-2017	61	43	)	)	PUNCT
iajs-2017	62	1	[	[	X
iajs-2017	62	2	13	13	NUM
iajs-2017	62	3	]	]	PUNCT
iajs-2017	62	4	.	.	PUNCT
iajs-2017	63	1	normal	normal	ADJ
iajs-2017	63	2	value	value	NOUN
iajs-2017	63	3	:	:	PUNCT
iajs-2017	63	4	12	12	NUM
iajs-2017	63	5	-	-	SYM
iajs-2017	63	6	15	15	NUM
iajs-2017	63	7	sec	sec	PROPN
iajs-2017	63	8	.	.	PROPN
iajs-2017	63	9	2.6	2.6	NUM
iajs-2017	63	10	estimation	estimation	NOUN
iajs-2017	63	11	of	of	ADP
iajs-2017	63	12	activated	activate	VERB
iajs-2017	63	13	partial	partial	ADJ
iajs-2017	63	14	thromboplastin	thromboplastin	NOUN
iajs-2017	63	15	time	time	NOUN
iajs-2017	63	16	(	(	PUNCT
iajs-2017	63	17	aptt	aptt	ADV
iajs-2017	63	18	)	)	PUNCT
iajs-2017	63	19	(	(	PUNCT
iajs-2017	63	20	sec	sec	PROPN
iajs-2017	63	21	)	)	PUNCT
iajs-2017	63	22	the	the	DET
iajs-2017	63	23	kaolin	kaolin	NOUN
iajs-2017	63	24	–	–	PUNCT
iajs-2017	63	25	initiated	initiate	VERB
iajs-2017	63	26	halfway	halfway	ADV
iajs-2017	63	27	thromboplastin	thromboplastin	NOUN
iajs-2017	63	28	time	time	NOUN
iajs-2017	63	29	(	(	PUNCT
iajs-2017	63	30	aptt	aptt	ADV
iajs-2017	63	31	)	)	PUNCT
iajs-2017	63	32	was	be	AUX
iajs-2017	63	33	controlled	control	VERB
iajs-2017	63	34	by	by	ADP
iajs-2017	63	35	pack	pack	NOUN
iajs-2017	63	36	from	from	ADP
iajs-2017	63	37	stago	stago	PROPN
iajs-2017	63	38	-	-	PUNCT
iajs-2017	63	39	france	france	PROPN
iajs-2017	63	40	.	.	PUNCT
iajs-2017	64	1	the	the	DET
iajs-2017	64	2	test	test	NOUN
iajs-2017	64	3	includes	include	VERB
iajs-2017	64	4	the	the	DET
iajs-2017	64	5	recalcification	recalcification	NOUN
iajs-2017	64	6	of	of	ADP
iajs-2017	64	7	plasma	plasma	NOUN
iajs-2017	64	8	within	within	ADP
iajs-2017	64	9	the	the	DET
iajs-2017	64	10	sight	sight	NOUN
iajs-2017	64	11	of	of	ADP
iajs-2017	64	12	an	an	DET
iajs-2017	64	13	institutionalized	institutionalize	VERB
iajs-2017	64	14	measure	measure	NOUN
iajs-2017	64	15	of	of	ADP
iajs-2017	64	16	cephalin	cephalin	NOUN
iajs-2017	64	17	(	(	PUNCT
iajs-2017	64	18	platelet	platelet	NOUN
iajs-2017	64	19	substitute	substitute	NOUN
iajs-2017	64	20	)	)	PUNCT
iajs-2017	64	21	,	,	PUNCT
iajs-2017	64	22	and	and	CCONJ
iajs-2017	64	23	the	the	DET
iajs-2017	64	24	factor	factor	NOUN
iajs-2017	64	25	xll	xll	NOUN
iajs-2017	64	26	activator	activator	NOUN
iajs-2017	64	27	(	(	PUNCT
iajs-2017	64	28	kaolin	kaolin	PROPN
iajs-2017	64	29	)	)	PUNCT
iajs-2017	64	30	.	.	PUNCT
iajs-2017	65	1	the	the	DET
iajs-2017	65	2	aptt	aptt	PROPN
iajs-2017	65	3	investigates	investigate	VERB
iajs-2017	65	4	the	the	DET
iajs-2017	65	5	characteristic	characteristic	ADJ
iajs-2017	65	6	coagulation	coagulation	NOUN
iajs-2017	65	7	pathway	pathway	NOUN
iajs-2017	65	8	(	(	PUNCT
iajs-2017	65	9	factors	factor	NOUN
iajs-2017	65	10	xll	xll	VERB
iajs-2017	65	11	,	,	PUNCT
iajs-2017	65	12	xl	xl	PROPN
iajs-2017	65	13	,	,	PUNCT
iajs-2017	65	14	lx	lx	NOUN
iajs-2017	65	15	,	,	PUNCT
iajs-2017	65	16	vlll	vlll	NOUN
iajs-2017	65	17	,	,	PUNCT
iajs-2017	65	18	x	x	NOUN
iajs-2017	65	19	,	,	PUNCT
iajs-2017	65	20	v	v	NOUN
iajs-2017	65	21	,	,	PUNCT
iajs-2017	65	22	ll	ll	NOUN
iajs-2017	65	23	and	and	CCONJ
iajs-2017	65	24	l	l	NOUN
iajs-2017	65	25	)	)	PUNCT
iajs-2017	65	26	aside	aside	ADV
iajs-2017	65	27	from	from	ADP
iajs-2017	65	28	the	the	DET
iajs-2017	65	29	platelets[14	platelets[14	PROPN
iajs-2017	65	30	]	]	X
iajs-2017	65	31	.	.	PUNCT
iajs-2017	66	1	normal	normal	ADJ
iajs-2017	66	2	value	value	NOUN
iajs-2017	66	3	:	:	PUNCT
iajs-2017	66	4	28	28	NUM
iajs-2017	66	5	-	-	SYM
iajs-2017	66	6	40	40	NUM
iajs-2017	66	7	sec	sec	PROPN
iajs-2017	66	8	2.7	2.7	NUM
iajs-2017	66	9	statistical	statistical	ADJ
iajs-2017	66	10	analysis	analysis	NOUN
iajs-2017	66	11	information	information	NOUN
iajs-2017	66	12	were	be	AUX
iajs-2017	66	13	communicated	communicate	VERB
iajs-2017	66	14	as	as	ADP
iajs-2017	66	15	mean	mean	NOUN
iajs-2017	66	16	±	±	NUM
iajs-2017	66	17	sem	sem	NOUN
iajs-2017	66	18	.	.	PUNCT
iajs-2017	67	1	the	the	DET
iajs-2017	67	2	correlation	correlation	NOUN
iajs-2017	67	3	amongst	amongst	ADP
iajs-2017	67	4	patients	patient	NOUN
iajs-2017	67	5	and	and	CCONJ
iajs-2017	67	6	control	control	NOUN
iajs-2017	67	7	bunches	bunche	NOUN
iajs-2017	67	8	was	be	AUX
iajs-2017	67	9	communicated	communicate	VERB
iajs-2017	67	10	by	by	ADP
iajs-2017	67	11	t	t	NOUN
iajs-2017	67	12	-	-	PUNCT
iajs-2017	67	13	test	test	NOUN
iajs-2017	67	14	.	.	PUNCT
iajs-2017	68	1	p	p	X
iajs-2017	68	2	-	-	PUNCT
iajs-2017	68	3	estimation	estimation	NOUN
iajs-2017	68	4	of	of	ADP
iajs-2017	68	5	<	<	X
iajs-2017	68	6	0.005	0.005	NUM
iajs-2017	68	7	and	and	CCONJ
iajs-2017	68	8	<	<	X
iajs-2017	68	9	0	0	NUM
iajs-2017	68	10	.	.	NUM
iajs-2017	68	11	05	05	NUM
iajs-2017	68	12	were	be	AUX
iajs-2017	68	13	considered	consider	VERB
iajs-2017	68	14	profoundly	profoundly	ADV
iajs-2017	68	15	huge	huge	ADJ
iajs-2017	68	16	and	and	CCONJ
iajs-2017	68	17	huge	huge	ADJ
iajs-2017	68	18	,	,	PUNCT
iajs-2017	68	19	individually	individually	ADV
iajs-2017	68	20	.	.	PUNCT
iajs-2017	69	1	pearson	pearson	PROPN
iajs-2017	69	2	's	's	PART
iajs-2017	69	3	connection	connection	NOUN
iajs-2017	69	4	coefficient	coefficient	NOUN
iajs-2017	69	5	(	(	PUNCT
iajs-2017	69	6	r	r	NOUN
iajs-2017	69	7	)	)	PUNCT
iajs-2017	69	8	is	be	AUX
iajs-2017	69	9	utilized	utilize	VERB
iajs-2017	69	10	for	for	ADP
iajs-2017	69	11	portraying	portray	VERB
iajs-2017	69	12	the	the	DET
iajs-2017	69	13	relationship	relationship	NOUN
iajs-2017	69	14	between	between	ADP
iajs-2017	69	15	the	the	DET
iajs-2017	69	16	distinctive	distinctive	ADJ
iajs-2017	69	17	investigation	investigation	NOUN
iajs-2017	69	18	parameters	parameter	NOUN
iajs-2017	69	19	.	.	PUNCT
iajs-2017	69	20	  	  	SPACE
iajs-2017	70	1	3	3	NUM
iajs-2017	70	2	.	.	NOUN
iajs-2017	70	3	results	result	NOUN
iajs-2017	70	4	and	and	CCONJ
iajs-2017	70	5	discussion	discussion	VERB
iajs-2017	70	6	the	the	DET
iajs-2017	70	7	levels	level	NOUN
iajs-2017	70	8	of	of	ADP
iajs-2017	70	9	diagnostic	diagnostic	ADJ
iajs-2017	70	10	parameters	parameter	NOUN
iajs-2017	70	11	in	in	ADP
iajs-2017	70	12	children	child	NOUN
iajs-2017	70	13	patients	patient	NOUN
iajs-2017	70	14	and	and	CCONJ
iajs-2017	70	15	control	control	NOUN
iajs-2017	70	16	groups	group	NOUN
iajs-2017	70	17	are	be	AUX
iajs-2017	70	18	summarizes	summarize	NOUN
iajs-2017	70	19	in	in	ADP
iajs-2017	70	20	table	table	NOUN
iajs-2017	70	21	1	1	NUM
iajs-2017	70	22	.	.	PUNCT
iajs-2017	71	1	the	the	DET
iajs-2017	71	2	results	result	NOUN
iajs-2017	71	3	which	which	PRON
iajs-2017	71	4	expressed	express	VERB
iajs-2017	71	5	as	as	ADP
iajs-2017	71	6	(	(	PUNCT
iajs-2017	71	7	mean±	mean±	PROPN
iajs-2017	71	8	sem	sem	PROPN
iajs-2017	71	9	)	)	PUNCT
iajs-2017	71	10	,	,	PUNCT
iajs-2017	71	11	showed	show	VERB
iajs-2017	71	12	a	a	DET
iajs-2017	71	13	highly	highly	ADV
iajs-2017	71	14	significant	significant	ADJ
iajs-2017	71	15	decrease	decrease	NOUN
iajs-2017	71	16	(	(	PUNCT
iajs-2017	71	17	p	p	X
iajs-2017	71	18	<	<	X
iajs-2017	71	19	0.005	0.005	NUM
iajs-2017	71	20	)	)	PUNCT
iajs-2017	71	21	,	,	PUNCT
iajs-2017	71	22	and	and	CCONJ
iajs-2017	71	23	a	a	DET
iajs-2017	71	24	highly	highly	ADV
iajs-2017	71	25	significant	significant	ADJ
iajs-2017	71	26	increase	increase	NOUN
iajs-2017	71	27	(	(	PUNCT
iajs-2017	71	28	p	p	X
iajs-2017	71	29	<	<	X
iajs-2017	71	30	0.005	0.005	NUM
iajs-2017	71	31	)	)	PUNCT
iajs-2017	71	32	in	in	ADP
iajs-2017	71	33	platelet	platelet	NOUN
iajs-2017	71	34	number	number	NOUN
iajs-2017	71	35	in	in	ADP
iajs-2017	71	36	both	both	DET
iajs-2017	71	37	chemistry	chemistry	NOUN
iajs-2017	71	38	|	|	ADV
iajs-2017	71	39	82	82	NUM
iajs-2017	71	40	ibn	ibn	PROPN
iajs-2017	71	41	al	al	PROPN
iajs-2017	71	42	-	-	PUNCT
iajs-2017	71	43	haitham	haitham	PROPN
iajs-2017	71	44	jour	jour	X
iajs-2017	71	45	.	.	PROPN
iajs-2017	72	1	for	for	ADP
iajs-2017	72	2	pure	pure	ADJ
iajs-2017	72	3	&	&	CCONJ
iajs-2017	72	4	appl	appl	PROPN
iajs-2017	72	5	.	.	PUNCT
iajs-2017	73	1	sci	sci	PROPN
iajs-2017	73	2	.	.	PROPN
iajs-2017	73	3	ihjpas	ihjpas	PROPN
iajs-2017	73	4	https://doi.org/10.30526/31.3.2017	https://doi.org/10.30526/31.3.2017	ADP
iajs-2017	73	5	vol	vol	NOUN
iajs-2017	73	6	.	.	PUNCT
iajs-2017	74	1	31	31	NUM
iajs-2017	75	1	(	(	PUNCT
iajs-2017	75	2	3	3	NUM
iajs-2017	75	3	)	)	SYM
iajs-2017	75	4	2018	2018	NUM
iajs-2017	75	5	idiopathic	idiopathic	ADJ
iajs-2017	75	6	thrombocytopenic	thrombocytopenic	ADJ
iajs-2017	75	7	purpura	purpura	NOUN
iajs-2017	75	8	patients	patient	NOUN
iajs-2017	75	9	(	(	PUNCT
iajs-2017	75	10	g1	g1	PROPN
iajs-2017	75	11	)	)	PUNCT
iajs-2017	75	12	and	and	CCONJ
iajs-2017	75	13	thrombocytosis	thrombocytosis	NOUN
iajs-2017	75	14	caused	cause	VERB
iajs-2017	75	15	by	by	ADP
iajs-2017	75	16	leukemia	leukemia	NOUN
iajs-2017	75	17	patients	patient	NOUN
iajs-2017	75	18	(	(	PUNCT
iajs-2017	75	19	g2	g2	PROPN
iajs-2017	75	20	)	)	PUNCT
iajs-2017	75	21	,	,	PUNCT
iajs-2017	75	22	respectively	respectively	ADV
iajs-2017	75	23	,	,	PUNCT
iajs-2017	75	24	when	when	SCONJ
iajs-2017	75	25	comparing	compare	VERB
iajs-2017	75	26	with	with	ADP
iajs-2017	75	27	control	control	NOUN
iajs-2017	75	28	group	group	NOUN
iajs-2017	75	29	,	,	PUNCT
iajs-2017	75	30	while	while	SCONJ
iajs-2017	75	31	there	there	PRON
iajs-2017	75	32	was	be	VERB
iajs-2017	75	33	a	a	DET
iajs-2017	75	34	highly	highly	ADV
iajs-2017	75	35	significant	significant	ADJ
iajs-2017	75	36	different	different	ADJ
iajs-2017	75	37	(	(	PUNCT
iajs-2017	75	38	p	p	X
iajs-2017	75	39	<	<	X
iajs-2017	75	40	0.005	0.005	NUM
iajs-2017	75	41	)	)	PUNCT
iajs-2017	75	42	in	in	ADP
iajs-2017	75	43	platelet	platelet	NOUN
iajs-2017	75	44	number	number	NOUN
iajs-2017	75	45	between	between	ADP
iajs-2017	75	46	two	two	NUM
iajs-2017	75	47	groups	group	NOUN
iajs-2017	75	48	.	.	PUNCT
iajs-2017	76	1	thrombocytopenia	thrombocytopenia	PROPN
iajs-2017	76	2	is	be	AUX
iajs-2017	76	3	defined	define	VERB
iajs-2017	76	4	as	as	ADP
iajs-2017	76	5	a	a	DET
iajs-2017	76	6	platelet	platelet	NOUN
iajs-2017	76	7	count	count	NOUN
iajs-2017	76	8	of	of	ADP
iajs-2017	76	9	less	less	ADJ
iajs-2017	76	10	than	than	ADP
iajs-2017	76	11	150	150	NUM
iajs-2017	76	12	×	×	NOUN
iajs-2017	76	13	103	103	NUM
iajs-2017	76	14	per	per	ADP
iajs-2017	76	15	µl	µl	NOUN
iajs-2017	76	16	.	.	PUNCT
iajs-2017	77	1	normally	normally	ADV
iajs-2017	77	2	,	,	PUNCT
iajs-2017	77	3	the	the	DET
iajs-2017	77	4	platelet	platelet	NOUN
iajs-2017	77	5	count	count	NOUN
iajs-2017	77	6	in	in	ADP
iajs-2017	77	7	the	the	DET
iajs-2017	77	8	peripheral	peripheral	ADJ
iajs-2017	77	9	blood	blood	NOUN
iajs-2017	77	10	is	be	AUX
iajs-2017	77	11	controlled	control	VERB
iajs-2017	77	12	by	by	ADP
iajs-2017	77	13	complex	complex	NOUN
iajs-2017	77	14	in	in	ADP
iajs-2017	77	15	teractions	teraction	NOUN
iajs-2017	77	16	regulating	regulate	VERB
iajs-2017	77	17	platelet	platelet	NOUN
iajs-2017	77	18	production	production	NOUN
iajs-2017	77	19	in	in	ADP
iajs-2017	77	20	the	the	DET
iajs-2017	77	21	bone	bone	NOUN
iajs-2017	77	22	marrow	marrow	NOUN
iajs-2017	77	23	,	,	PUNCT
iajs-2017	77	24	platelet	platelet	NOUN
iajs-2017	77	25	pooling	pooling	NOUN
iajs-2017	77	26	in	in	ADP
iajs-2017	77	27	the	the	DET
iajs-2017	77	28	liver	liver	NOUN
iajs-2017	77	29	and	and	CCONJ
iajs-2017	77	30	spleen	spleen	NOUN
iajs-2017	77	31	,	,	PUNCT
iajs-2017	77	32	and	and	CCONJ
iajs-2017	77	33	their	their	PRON
iajs-2017	77	34	elimination	elimination	NOUN
iajs-2017	77	35	in	in	ADP
iajs-2017	77	36	the	the	DET
iajs-2017	77	37	reticuloendothelial	reticuloendothelial	ADJ
iajs-2017	77	38	system	system	NOUN
iajs-2017	77	39	,	,	PUNCT
iajs-2017	77	40	which	which	PRON
iajs-2017	77	41	then	then	ADV
iajs-2017	77	42	feeds	feed	VERB
iajs-2017	77	43	back	back	ADV
iajs-2017	77	44	into	into	ADP
iajs-2017	77	45	thrombopoietin	thrombopoietin	ADJ
iajs-2017	77	46	regulation	regulation	NOUN
iajs-2017	77	47	[	[	X
iajs-2017	77	48	15,16	15,16	NUM
iajs-2017	77	49	]	]	PUNCT
iajs-2017	77	50	.	.	PUNCT
iajs-2017	78	1	the	the	DET
iajs-2017	78	2	platelet	platelet	NOUN
iajs-2017	78	3	count	count	NOUN
iajs-2017	78	4	is	be	AUX
iajs-2017	78	5	rather	rather	ADV
iajs-2017	78	6	constant	constant	ADJ
iajs-2017	78	7	in	in	ADP
iajs-2017	78	8	an	an	DET
iajs-2017	78	9	individual	individual	ADJ
iajs-2017	78	10	person	person	NOUN
iajs-2017	78	11	.	.	PUNCT
iajs-2017	79	1	in	in	ADP
iajs-2017	79	2	critically	critically	ADV
iajs-2017	79	3	ill	ill	ADJ
iajs-2017	79	4	patients	patient	NOUN
iajs-2017	79	5	,	,	PUNCT
iajs-2017	79	6	however	however	ADV
iajs-2017	79	7	,	,	PUNCT
iajs-2017	79	8	these	these	DET
iajs-2017	79	9	mechanisms	mechanism	NOUN
iajs-2017	79	10	can	can	AUX
iajs-2017	79	11	fail	fail	VERB
iajs-2017	79	12	,	,	PUNCT
iajs-2017	79	13	which	which	PRON
iajs-2017	79	14	results	result	VERB
iajs-2017	79	15	in	in	ADP
iajs-2017	79	16	a	a	DET
iajs-2017	79	17	disturbance	disturbance	NOUN
iajs-2017	79	18	of	of	ADP
iajs-2017	79	19	the	the	DET
iajs-2017	79	20	balance	balance	NOUN
iajs-2017	79	21	among	among	ADP
iajs-2017	79	22	platelet	platelet	NOUN
iajs-2017	79	23	production	production	NOUN
iajs-2017	79	24	,	,	PUNCT
iajs-2017	79	25	platelet	platelet	NOUN
iajs-2017	79	26	pooling	pooling	NOUN
iajs-2017	79	27	,	,	PUNCT
iajs-2017	79	28	and	and	CCONJ
iajs-2017	79	29	platelet	platelet	NOUN
iajs-2017	79	30	consumption	consumption	NOUN
iajs-2017	79	31	.	.	PUNCT
iajs-2017	80	1	thrombocytopenia	thrombocytopenia	NOUN
iajs-2017	80	2	should	should	AUX
iajs-2017	80	3	be	be	AUX
iajs-2017	80	4	seen	see	VERB
iajs-2017	80	5	as	as	ADP
iajs-2017	80	6	a	a	DET
iajs-2017	80	7	sensitive	sensitive	ADJ
iajs-2017	80	8	marker	marker	NOUN
iajs-2017	80	9	for	for	ADP
iajs-2017	80	10	considerable	considerable	ADJ
iajs-2017	80	11	alteration	alteration	NOUN
iajs-2017	80	12	of	of	ADP
iajs-2017	80	13	normal	normal	ADJ
iajs-2017	80	14	physiology	physiology	NOUN
iajs-2017	80	15	[	[	X
iajs-2017	80	16	17	17	NUM
iajs-2017	80	17	]	]	PUNCT
iajs-2017	80	18	.	.	PUNCT
iajs-2017	81	1	in	in	ADP
iajs-2017	81	2	kids	kid	NOUN
iajs-2017	81	3	in	in	ADP
iajs-2017	81	4	relatively	relatively	ADV
iajs-2017	81	5	every	every	DET
iajs-2017	81	6	case	case	NOUN
iajs-2017	81	7	the	the	DET
iajs-2017	81	8	hoisted	hoisted	ADJ
iajs-2017	81	9	platelet	platelet	NOUN
iajs-2017	81	10	check	check	NOUN
iajs-2017	81	11	is	be	AUX
iajs-2017	81	12	because	because	SCONJ
iajs-2017	81	13	of	of	ADP
iajs-2017	81	14	another	another	DET
iajs-2017	81	15	medicinal	medicinal	ADJ
iajs-2017	81	16	condition	condition	NOUN
iajs-2017	81	17	,	,	PUNCT
iajs-2017	81	18	for	for	ADP
iajs-2017	81	19	example	example	NOUN
iajs-2017	81	20	,	,	PUNCT
iajs-2017	81	21	intense	intense	ADJ
iajs-2017	81	22	contamination	contamination	NOUN
iajs-2017	81	23	,	,	PUNCT
iajs-2017	81	24	incessant	incessant	ADJ
iajs-2017	81	25	aggravation	aggravation	NOUN
iajs-2017	81	26	,	,	PUNCT
iajs-2017	81	27	collagen	collagen	NOUN
iajs-2017	81	28	vascular	vascular	NOUN
iajs-2017	81	29	and	and	CCONJ
iajs-2017	81	30	renal	renal	ADJ
iajs-2017	81	31	maladies	malady	NOUN
iajs-2017	81	32	,	,	PUNCT
iajs-2017	81	33	langerhan	langerhan	NOUN
iajs-2017	81	34	's	's	PART
iajs-2017	81	35	cell	cell	NOUN
iajs-2017	81	36	histiocytosis	histiocytosis	NOUN
iajs-2017	81	37	,	,	PUNCT
iajs-2017	81	38	press	press	NOUN
iajs-2017	81	39	lack	lack	NOUN
iajs-2017	81	40	,	,	PUNCT
iajs-2017	81	41	hemolytic	hemolytic	ADJ
iajs-2017	81	42	pallor	pallor	NOUN
iajs-2017	81	43	,	,	PUNCT
iajs-2017	81	44	and	and	CCONJ
iajs-2017	81	45	kawasaki	kawasaki	PROPN
iajs-2017	81	46	disease	disease	NOUN
iajs-2017	81	47	[	[	X
iajs-2017	81	48	18	18	NUM
iajs-2017	81	49	]	]	PUNCT
iajs-2017	81	50	.	.	PUNCT
iajs-2017	82	1	in	in	ADP
iajs-2017	82	2	endless	endless	ADJ
iajs-2017	82	3	myelogenous	myelogenous	ADJ
iajs-2017	82	4	leukemia	leukemia	NOUN
iajs-2017	82	5	,	,	PUNCT
iajs-2017	82	6	there	there	PRON
iajs-2017	82	7	are	be	VERB
iajs-2017	82	8	diminished	diminish	VERB
iajs-2017	82	9	levels	level	NOUN
iajs-2017	82	10	of	of	ADP
iajs-2017	82	11	serum	serum	NOUN
iajs-2017	82	12	erythropoietin	erythropoietin	NOUN
iajs-2017	82	13	in	in	ADP
iajs-2017	82	14	polycythemia	polycythemia	NOUN
iajs-2017	82	15	vera	vera	NOUN
iajs-2017	82	16	and	and	CCONJ
iajs-2017	82	17	diminished	diminished	ADJ
iajs-2017	82	18	levels	level	NOUN
iajs-2017	82	19	of	of	ADP
iajs-2017	82	20	granulocyte	granulocyte	ADJ
iajs-2017	82	21	province	province	NOUN
iajs-2017	82	22	fortifying	fortifying	NOUN
iajs-2017	82	23	element	element	NOUN
iajs-2017	82	24	.	.	PUNCT
iajs-2017	83	1	in	in	ADP
iajs-2017	83	2	myeloproliferative	myeloproliferative	ADJ
iajs-2017	83	3	scatters	scatter	NOUN
iajs-2017	83	4	,	,	PUNCT
iajs-2017	83	5	there	there	PRON
iajs-2017	83	6	is	be	VERB
iajs-2017	83	7	diminished	diminish	VERB
iajs-2017	83	8	official	official	NOUN
iajs-2017	83	9	of	of	ADP
iajs-2017	83	10	thrombopoietin	thrombopoietin	PROPN
iajs-2017	83	11	to	to	ADP
iajs-2017	83	12	megakaryocytes	megakaryocyte	NOUN
iajs-2017	83	13	due	due	ADP
iajs-2017	83	14	to	to	ADP
iajs-2017	83	15	the	the	DET
iajs-2017	83	16	diminished	diminished	ADJ
iajs-2017	83	17	number	number	NOUN
iajs-2017	83	18	and	and	CCONJ
iajs-2017	83	19	capacity	capacity	NOUN
iajs-2017	83	20	of	of	ADP
iajs-2017	83	21	thrombopoietin	thrombopoietin	ADJ
iajs-2017	83	22	receptors	receptor	NOUN
iajs-2017	83	23	,	,	PUNCT
iajs-2017	83	24	yet	yet	CCONJ
iajs-2017	83	25	in	in	ADP
iajs-2017	83	26	fundamental	fundamental	ADJ
iajs-2017	83	27	thrombocythemia	thrombocythemia	NOUN
iajs-2017	83	28	,	,	PUNCT
iajs-2017	83	29	these	these	DET
iajs-2017	83	30	ancestors	ancestor	NOUN
iajs-2017	83	31	are	be	AUX
iajs-2017	83	32	additionally	additionally	ADV
iajs-2017	83	33	uniquely	uniquely	ADV
iajs-2017	83	34	touchy	touchy	ADJ
iajs-2017	83	35	to	to	ADP
iajs-2017	83	36	the	the	DET
iajs-2017	83	37	activity	activity	NOUN
iajs-2017	83	38	of	of	ADP
iajs-2017	83	39	the	the	DET
iajs-2017	83	40	hormone	hormone	NOUN
iajs-2017	83	41	.	.	PUNCT
iajs-2017	84	1	this	this	PRON
iajs-2017	84	2	prompts	prompt	VERB
iajs-2017	84	3	the	the	DET
iajs-2017	84	4	expanded	expand	VERB
iajs-2017	84	5	megakaryocyte	megakaryocyte	NOUN
iajs-2017	84	6	multiplication	multiplication	NOUN
iajs-2017	84	7	and	and	CCONJ
iajs-2017	84	8	platelet	platelet	NOUN
iajs-2017	84	9	generation	generation	NOUN
iajs-2017	84	10	found	find	VERB
iajs-2017	84	11	in	in	ADP
iajs-2017	84	12	fundamental	fundamental	ADJ
iajs-2017	84	13	thrombocythemia	thrombocythemia	NOUN
iajs-2017	84	14	[	[	X
iajs-2017	84	15	19	19	NUM
iajs-2017	84	16	]	]	PUNCT
iajs-2017	84	17	.	.	PUNCT
iajs-2017	85	1	despite	despite	SCONJ
iajs-2017	85	2	the	the	DET
iajs-2017	85	3	fact	fact	NOUN
iajs-2017	85	4	that	that	SCONJ
iajs-2017	85	5	thrombocytopenia	thrombocytopenia	PROPN
iajs-2017	85	6	is	be	AUX
iajs-2017	85	7	a	a	DET
iajs-2017	85	8	sign	sign	NOUN
iajs-2017	85	9	of	of	ADP
iajs-2017	85	10	intense	intense	ADJ
iajs-2017	85	11	lymphoblastic	lymphoblastic	ADJ
iajs-2017	85	12	leukemia	leukemia	NOUN
iajs-2017	85	13	(	(	PUNCT
iajs-2017	85	14	all	all	ADV
iajs-2017	85	15	)	)	PUNCT
iajs-2017	85	16	,	,	PUNCT
iajs-2017	85	17	in	in	ADP
iajs-2017	85	18	a	a	DET
iajs-2017	85	19	few	few	ADJ
iajs-2017	85	20	arrangement	arrangement	NOUN
iajs-2017	85	21	upwards	upwards	ADV
iajs-2017	85	22	of	of	ADP
iajs-2017	85	23	25	25	NUM
iajs-2017	85	24	%	%	NOUN
iajs-2017	85	25	of	of	ADP
iajs-2017	85	26	youngsters	youngster	NOUN
iajs-2017	85	27	have	have	AUX
iajs-2017	85	28	been	be	AUX
iajs-2017	85	29	found	find	VERB
iajs-2017	85	30	to	to	PART
iajs-2017	85	31	have	have	VERB
iajs-2017	85	32	platelet	platelet	NOUN
iajs-2017	85	33	tallies	tally	NOUN
iajs-2017	85	34	surpassing	surpass	VERB
iajs-2017	85	35	100,000	100,000	NUM
iajs-2017	85	36	/	/	SYM
iajs-2017	85	37	mm3	mm3	NOUN
iajs-2017	85	38	at	at	ADP
iajs-2017	85	39	conclusion	conclusion	NOUN
iajs-2017	85	40	.	.	PUNCT
iajs-2017	86	1	in	in	ADP
iajs-2017	86	2	any	any	DET
iajs-2017	86	3	case	case	NOUN
iajs-2017	86	4	,	,	PUNCT
iajs-2017	86	5	thrombocytosis	thrombocytosis	NOUN
iajs-2017	86	6	is	be	AUX
iajs-2017	86	7	n't	not	PART
iajs-2017	86	8	normally	normally	ADV
iajs-2017	86	9	perceived	perceive	VERB
iajs-2017	86	10	as	as	ADP
iajs-2017	86	11	an	an	DET
iajs-2017	86	12	introducing	introduce	VERB
iajs-2017	86	13	highlight	highlight	NOUN
iajs-2017	86	14	of	of	ADP
iajs-2017	86	15	all	all	PRON
iajs-2017	86	16	.	.	PUNCT
iajs-2017	87	1	we	we	PRON
iajs-2017	87	2	as	as	ADP
iajs-2017	87	3	of	of	ADP
iajs-2017	87	4	late	late	ADV
iajs-2017	87	5	observed	observe	VERB
iajs-2017	87	6	a	a	DET
iajs-2017	87	7	patient	patient	NOUN
iajs-2017	87	8	with	with	ADP
iajs-2017	87	9	an	an	DET
iajs-2017	87	10	underlying	underlying	ADJ
iajs-2017	87	11	platelet	platelet	NOUN
iajs-2017	87	12	check	check	NOUN
iajs-2017	87	13	of	of	ADP
iajs-2017	87	14	more	more	ADJ
iajs-2017	87	15	than	than	ADP
iajs-2017	87	16	500,000	500,000	NUM
iajs-2017	87	17	/	/	SYM
iajs-2017	87	18	mm3	mm3	PROPN
iajs-2017	87	19	,	,	PUNCT
iajs-2017	87	20	a	a	DET
iajs-2017	87	21	discovering	discovering	NOUN
iajs-2017	87	22	which	which	PRON
iajs-2017	87	23	had	have	AUX
iajs-2017	87	24	postponed	postpone	VERB
iajs-2017	87	25	doubt	doubt	NOUN
iajs-2017	87	26	of	of	ADP
iajs-2017	87	27	hematologic	hematologic	NOUN
iajs-2017	87	28	danger	danger	NOUN
iajs-2017	87	29	.	.	PUNCT
iajs-2017	88	1	in	in	ADP
iajs-2017	88	2	this	this	DET
iajs-2017	88	3	way	way	NOUN
iajs-2017	88	4	,	,	PUNCT
iajs-2017	88	5	it	it	PRON
iajs-2017	88	6	appears	appear	VERB
iajs-2017	88	7	to	to	PART
iajs-2017	88	8	be	be	AUX
iajs-2017	88	9	likely	likely	ADJ
iajs-2017	88	10	that	that	SCONJ
iajs-2017	88	11	the	the	DET
iajs-2017	88	12	platelet	platelet	NOUN
iajs-2017	88	13	include	include	VERB
iajs-2017	88	14	heights	height	NOUN
iajs-2017	88	15	were	be	AUX
iajs-2017	88	16	some	some	DET
iajs-2017	88	17	path	path	NOUN
iajs-2017	88	18	due	due	ADP
iajs-2017	88	19	to	to	ADP
iajs-2017	88	20	the	the	DET
iajs-2017	88	21	leukemic	leukemic	ADJ
iajs-2017	88	22	procedure	procedure	NOUN
iajs-2017	88	23	[	[	X
iajs-2017	88	24	20	20	NUM
iajs-2017	88	25	]	]	PUNCT
iajs-2017	88	26	.	.	PUNCT
iajs-2017	89	1	the	the	DET
iajs-2017	89	2	present	present	ADJ
iajs-2017	89	3	study	study	NOUN
iajs-2017	89	4	showed	show	VERB
iajs-2017	89	5	a	a	DET
iajs-2017	89	6	significant	significant	ADJ
iajs-2017	89	7	elevation	elevation	NOUN
iajs-2017	89	8	(	(	PUNCT
iajs-2017	89	9	p	p	X
iajs-2017	89	10	<	<	X
iajs-2017	89	11	0.05	0.05	NUM
iajs-2017	89	12	)	)	PUNCT
iajs-2017	89	13	in	in	ADP
iajs-2017	89	14	pt	pt	NOUN
iajs-2017	89	15	levels	level	NOUN
iajs-2017	89	16	in	in	ADP
iajs-2017	89	17	g1	g1	PROPN
iajs-2017	89	18	and	and	CCONJ
iajs-2017	89	19	g2	g2	PROPN
iajs-2017	89	20	patients	patient	NOUN
iajs-2017	89	21	when	when	SCONJ
iajs-2017	89	22	compared	compare	VERB
iajs-2017	89	23	with	with	ADP
iajs-2017	89	24	control	control	NOUN
iajs-2017	89	25	,	,	PUNCT
iajs-2017	89	26	and	and	CCONJ
iajs-2017	89	27	there	there	PRON
iajs-2017	89	28	was	be	VERB
iajs-2017	89	29	no	no	DET
iajs-2017	89	30	significant	significant	ADJ
iajs-2017	89	31	different	different	ADJ
iajs-2017	89	32	in	in	ADP
iajs-2017	89	33	pt	pt	NOUN
iajs-2017	89	34	levels	level	NOUN
iajs-2017	89	35	between	between	ADP
iajs-2017	89	36	two	two	NUM
iajs-2017	89	37	groups	group	NOUN
iajs-2017	89	38	.	.	PUNCT
iajs-2017	90	1	also	also	ADV
iajs-2017	90	2	there	there	PRON
iajs-2017	90	3	was	be	VERB
iajs-2017	90	4	a	a	DET
iajs-2017	90	5	highly	highly	ADV
iajs-2017	90	6	significant	significant	ADJ
iajs-2017	90	7	increase	increase	NOUN
iajs-2017	90	8	in	in	ADP
iajs-2017	90	9	ptt	ptt	NOUN
iajs-2017	90	10	level	level	NOUN
iajs-2017	90	11	(	(	PUNCT
iajs-2017	90	12	p	p	X
iajs-2017	90	13	<	<	X
iajs-2017	90	14	0.005	0.005	NUM
iajs-2017	90	15	)	)	PUNCT
iajs-2017	90	16	in	in	ADP
iajs-2017	90	17	g1	g1	PROPN
iajs-2017	90	18	,	,	PUNCT
iajs-2017	90	19	and	and	CCONJ
iajs-2017	90	20	no	no	DET
iajs-2017	90	21	significant	significant	ADJ
iajs-2017	90	22	different	different	ADJ
iajs-2017	90	23	in	in	ADP
iajs-2017	90	24	ptt	ptt	NOUN
iajs-2017	90	25	level	level	NOUN
iajs-2017	90	26	in	in	ADP
iajs-2017	90	27	g2	g2	PROPN
iajs-2017	90	28	when	when	SCONJ
iajs-2017	90	29	compared	compare	VERB
iajs-2017	90	30	with	with	ADP
iajs-2017	90	31	control	control	NOUN
iajs-2017	90	32	,	,	PUNCT
iajs-2017	90	33	in	in	ADP
iajs-2017	90	34	addition	addition	NOUN
iajs-2017	90	35	to	to	ADP
iajs-2017	90	36	a	a	DET
iajs-2017	90	37	highly	highly	ADV
iajs-2017	90	38	significant	significant	ADJ
iajs-2017	90	39	different	different	ADJ
iajs-2017	90	40	in	in	ADP
iajs-2017	90	41	ptt	ptt	NOUN
iajs-2017	90	42	level	level	NOUN
iajs-2017	90	43	between	between	ADP
iajs-2017	90	44	two	two	NUM
iajs-2017	90	45	groups	group	NOUN
iajs-2017	90	46	.	.	PUNCT
iajs-2017	91	1	unlike	unlike	ADP
iajs-2017	91	2	factors	factor	NOUN
iajs-2017	91	3	viii	viii	ADJ
iajs-2017	91	4	and	and	CCONJ
iajs-2017	91	5	ix	ix	INTJ
iajs-2017	91	6	,	,	PUNCT
iajs-2017	91	7	the	the	DET
iajs-2017	91	8	platelet	platelet	NOUN
iajs-2017	91	9	clotting	clot	VERB
iajs-2017	91	10	factor	factor	NOUN
iajs-2017	91	11	is	be	AUX
iajs-2017	91	12	not	not	PART
iajs-2017	91	13	available	available	ADJ
iajs-2017	91	14	until	until	SCONJ
iajs-2017	91	15	platelets	platelet	NOUN
iajs-2017	91	16	are	be	AUX
iajs-2017	91	17	acted	act	VERB
iajs-2017	91	18	upon	upon	SCONJ
iajs-2017	91	19	by	by	ADP
iajs-2017	91	20	thrombin	thrombin	NOUN
iajs-2017	91	21	.	.	PUNCT
iajs-2017	92	1	in	in	ADP
iajs-2017	92	2	thrombocytopenia	thrombocytopenia	PROPN
iajs-2017	92	3	,	,	PUNCT
iajs-2017	92	4	the	the	DET
iajs-2017	92	5	flawed	flawed	ADJ
iajs-2017	92	6	prothrombin	prothrombin	ADJ
iajs-2017	92	7	utilization	utilization	NOUN
iajs-2017	92	8	is	be	AUX
iajs-2017	92	9	clear	clear	ADJ
iajs-2017	92	10	yet	yet	ADV
iajs-2017	92	11	the	the	DET
iajs-2017	92	12	absence	absence	NOUN
iajs-2017	92	13	of	of	ADP
iajs-2017	92	14	platelets	platelet	NOUN
iajs-2017	92	15	is	be	AUX
iajs-2017	92	16	frequently	frequently	ADV
iajs-2017	92	17	muddled	muddle	VERB
iajs-2017	92	18	by	by	ADP
iajs-2017	92	19	a	a	DET
iajs-2017	92	20	subjective	subjective	ADJ
iajs-2017	92	21	absence	absence	NOUN
iajs-2017	92	22	of	of	ADP
iajs-2017	92	23	their	their	PRON
iajs-2017	92	24	thickening	thickening	NOUN
iajs-2017	92	25	component	component	NOUN
iajs-2017	92	26	.	.	PUNCT
iajs-2017	93	1	the	the	DET
iajs-2017	93	2	prothrombin	prothrombin	ADJ
iajs-2017	93	3	utilization	utilization	NOUN
iajs-2017	93	4	time	time	NOUN
iajs-2017	93	5	yields	yield	VERB
iajs-2017	93	6	more	more	ADV
iajs-2017	93	7	noteworthy	noteworthy	ADJ
iajs-2017	93	8	data	datum	NOUN
iajs-2017	93	9	,	,	PUNCT
iajs-2017	93	10	in	in	ADP
iajs-2017	93	11	this	this	DET
iajs-2017	93	12	way	way	NOUN
iajs-2017	93	13	,	,	PUNCT
iajs-2017	93	14	than	than	SCONJ
iajs-2017	93	15	does	do	VERB
iajs-2017	93	16	the	the	DET
iajs-2017	93	17	platelet	platelet	NOUN
iajs-2017	93	18	check	check	NOUN
iajs-2017	93	19	[	[	X
iajs-2017	93	20	21	21	NUM
iajs-2017	93	21	]	]	PUNCT
iajs-2017	93	22	.	.	PUNCT
iajs-2017	94	1	the	the	DET
iajs-2017	94	2	thickening	thickening	NOUN
iajs-2017	94	3	time	time	NOUN
iajs-2017	94	4	is	be	AUX
iajs-2017	94	5	n't	not	PART
iajs-2017	94	6	uncovering	uncover	VERB
iajs-2017	94	7	since	since	SCONJ
iajs-2017	94	8	it	it	PRON
iajs-2017	94	9	is	be	AUX
iajs-2017	94	10	ordinary	ordinary	ADJ
iajs-2017	94	11	in	in	ADP
iajs-2017	94	12	thrombocytopenia	thrombocytopenia	PROPN
iajs-2017	94	13	and	and	CCONJ
iajs-2017	94	14	factor	factor	NOUN
iajs-2017	94	15	vii	vii	PROPN
iajs-2017	94	16	inadequacy	inadequacy	NOUN
iajs-2017	94	17	yet	yet	ADV
iajs-2017	94	18	notably	notably	ADV
iajs-2017	94	19	drawn	draw	VERB
iajs-2017	94	20	out	out	ADP
iajs-2017	94	21	in	in	ADP
iajs-2017	94	22	the	the	DET
iajs-2017	94	23	hageman	hageman	NOUN
iajs-2017	94	24	attribute	attribute	NOUN
iajs-2017	94	25	,	,	PUNCT
iajs-2017	94	26	in	in	ADP
iajs-2017	94	27	which	which	PRON
iajs-2017	94	28	hemostasis	hemostasis	NOUN
iajs-2017	94	29	once	once	ADV
iajs-2017	94	30	in	in	ADP
iajs-2017	94	31	a	a	DET
iajs-2017	94	32	while	while	NOUN
iajs-2017	94	33	is	be	AUX
iajs-2017	94	34	by	by	ADP
iajs-2017	94	35	all	all	DET
iajs-2017	94	36	accounts	account	NOUN
iajs-2017	94	37	traded	trade	VERB
iajs-2017	94	38	off	off	ADP
iajs-2017	94	39	.	.	PUNCT
iajs-2017	95	1	the	the	DET
iajs-2017	95	2	one	one	NUM
iajs-2017	95	3	-	-	PUNCT
iajs-2017	95	4	arrange	arrange	NOUN
iajs-2017	95	5	prothrombin	prothrombin	NOUN
iajs-2017	95	6	time	time	NOUN
iajs-2017	95	7	is	be	AUX
iajs-2017	95	8	ordinary	ordinary	ADJ
iajs-2017	95	9	in	in	ADP
iajs-2017	95	10	thrombopathy	thrombopathy	ADJ
iajs-2017	95	11	and	and	CCONJ
iajs-2017	95	12	hemophilias	hemophilia	NOUN
iajs-2017	95	13	an	an	PRON
iajs-2017	95	14	and	and	CCONJ
iajs-2017	95	15	b	b	NOUN
iajs-2017	95	16	,	,	PUNCT
iajs-2017	95	17	while	while	SCONJ
iajs-2017	95	18	the	the	DET
iajs-2017	95	19	iowa	iowa	PROPN
iajs-2017	95	20	twoorganize	twoorganize	PROPN
iajs-2017	95	21	prothrombin	prothrombin	NOUN
iajs-2017	95	22	test	test	NOUN
iajs-2017	95	23	is	be	AUX
iajs-2017	95	24	typical	typical	ADJ
iajs-2017	95	25	in	in	ADP
iajs-2017	95	26	thrombocytopenia	thrombocytopenia	PROPN
iajs-2017	95	27	and	and	CCONJ
iajs-2017	95	28	in	in	ADP
iajs-2017	95	29	factor	factor	NOUN
iajs-2017	95	30	vii	vii	PROPN
iajs-2017	95	31	inadequacy	inadequacy	NOUN
iajs-2017	96	1	[	[	X
iajs-2017	96	2	22	22	NUM
iajs-2017	96	3	]	]	PUNCT
iajs-2017	96	4	.	.	PUNCT
iajs-2017	97	1	the	the	DET
iajs-2017	97	2	thrombocytopenia	thrombocytopenia	NOUN
iajs-2017	97	3	was	be	AUX
iajs-2017	97	4	convoluted	convolute	VERB
iajs-2017	97	5	by	by	ADP
iajs-2017	97	6	thrombopathy	thrombopathy	ADJ
iajs-2017	97	7	,	,	PUNCT
iajs-2017	97	8	since	since	SCONJ
iajs-2017	97	9	the	the	DET
iajs-2017	97	10	platelets	platelet	NOUN
iajs-2017	97	11	were	be	AUX
iajs-2017	97	12	notably	notably	ADV
iajs-2017	97	13	lacking	lack	VERB
iajs-2017	97	14	in	in	ADP
iajs-2017	97	15	the	the	DET
iajs-2017	97	16	platelet	platelet	NOUN
iajs-2017	97	17	thickening	thickening	NOUN
iajs-2017	97	18	element	element	NOUN
iajs-2017	97	19	(	(	PUNCT
iajs-2017	97	20	pcf	pcf	PROPN
iajs-2017	97	21	)	)	PUNCT
iajs-2017	98	1	[	[	X
iajs-2017	98	2	23	23	NUM
iajs-2017	98	3	]	]	PUNCT
iajs-2017	98	4	.	.	PUNCT
iajs-2017	99	1	the	the	DET
iajs-2017	99	2	coagulation	coagulation	NOUN
iajs-2017	99	3	anomalies	anomaly	NOUN
iajs-2017	99	4	specifically	specifically	ADV
iajs-2017	99	5	owing	owe	VERB
iajs-2017	99	6	to	to	ADP
iajs-2017	99	7	intense	intense	ADJ
iajs-2017	99	8	leukemia	leukemia	NOUN
iajs-2017	99	9	and	and	CCONJ
iajs-2017	99	10	its	its	PRON
iajs-2017	99	11	treatment	treatment	NOUN
iajs-2017	99	12	are	be	AUX
iajs-2017	99	13	in	in	ADP
iajs-2017	99	14	this	this	DET
iajs-2017	99	15	manner	manner	NOUN
iajs-2017	99	16	multifactorial	multifactorial	ADJ
iajs-2017	99	17	.	.	PUNCT
iajs-2017	100	1	potential	potential	ADJ
iajs-2017	100	2	reasons	reason	NOUN
iajs-2017	100	3	for	for	ADP
iajs-2017	100	4	drain	drain	NOUN
iajs-2017	100	5	rely	rely	VERB
iajs-2017	100	6	upon	upon	SCONJ
iajs-2017	100	7	pretreatment	pretreatment	NOUN
iajs-2017	100	8	factors	factor	NOUN
iajs-2017	100	9	,	,	PUNCT
iajs-2017	100	10	for	for	ADP
iajs-2017	100	11	example	example	NOUN
iajs-2017	100	12	,	,	PUNCT
iajs-2017	100	13	kind	kind	ADV
iajs-2017	100	14	of	of	ADP
iajs-2017	100	15	intense	intense	ADJ
iajs-2017	100	16	leukemia	leukemia	NOUN
iajs-2017	100	17	,	,	PUNCT
iajs-2017	100	18	chemistry	chemistry	NOUN
iajs-2017	100	19	|	|	ADV
iajs-2017	100	20	83	83	NUM
iajs-2017	100	21	ibn	ibn	PROPN
iajs-2017	100	22	al	al	PROPN
iajs-2017	100	23	-	-	PUNCT
iajs-2017	100	24	haitham	haitham	PROPN
iajs-2017	100	25	jour	jour	X
iajs-2017	100	26	.	.	PROPN
iajs-2017	101	1	for	for	ADP
iajs-2017	101	2	pure	pure	ADJ
iajs-2017	101	3	&	&	CCONJ
iajs-2017	101	4	appl	appl	PROPN
iajs-2017	101	5	.	.	PUNCT
iajs-2017	102	1	sci	sci	PROPN
iajs-2017	102	2	.	.	PROPN
iajs-2017	102	3	ihjpas	ihjpas	PROPN
iajs-2017	102	4	https://doi.org/10.30526/31.3.2017	https://doi.org/10.30526/31.3.2017	ADP
iajs-2017	102	5	vol	vol	NOUN
iajs-2017	102	6	.	.	PUNCT
iajs-2017	103	1	31	31	NUM
iajs-2017	104	1	(	(	PUNCT
iajs-2017	104	2	3	3	NUM
iajs-2017	104	3	)	)	PUNCT
iajs-2017	104	4	2018	2018	NUM
iajs-2017	104	5	introducing	introduce	VERB
iajs-2017	104	6	impact	impact	NOUN
iajs-2017	104	7	cell	cell	NOUN
iajs-2017	104	8	check	check	NOUN
iajs-2017	104	9	,	,	PUNCT
iajs-2017	104	10	and	and	CCONJ
iajs-2017	104	11	seriousness	seriousness	NOUN
iajs-2017	104	12	of	of	ADP
iajs-2017	104	13	thrombocytopenia	thrombocytopenia	PROPN
iajs-2017	104	14	.	.	PUNCT
iajs-2017	105	1	the	the	DET
iajs-2017	105	2	one	one	NUM
iajs-2017	105	3	-	-	PUNCT
iajs-2017	105	4	organize	organize	VERB
iajs-2017	105	5	prothrombin	prothrombin	NOUN
iajs-2017	105	6	time	time	NOUN
iajs-2017	105	7	(	(	PUNCT
iajs-2017	105	8	pt	pt	NOUN
iajs-2017	105	9	)	)	PUNCT
iajs-2017	105	10	and	and	CCONJ
iajs-2017	105	11	initiated	initiate	VERB
iajs-2017	105	12	incomplete	incomplete	ADJ
iajs-2017	105	13	thromboplastin	thromboplastin	NOUN
iajs-2017	105	14	time	time	NOUN
iajs-2017	105	15	(	(	PUNCT
iajs-2017	105	16	ptt	ptt	NOUN
iajs-2017	105	17	)	)	PUNCT
iajs-2017	105	18	are	be	AUX
iajs-2017	105	19	perpetually	perpetually	ADV
iajs-2017	105	20	drawn	draw	VERB
iajs-2017	105	21	out	out	ADP
iajs-2017	105	22	in	in	ADP
iajs-2017	105	23	these	these	DET
iajs-2017	105	24	disorders	disorder	NOUN
iajs-2017	105	25	[	[	X
iajs-2017	105	26	24	24	NUM
iajs-2017	105	27	]	]	PUNCT
iajs-2017	105	28	.	.	PUNCT
iajs-2017	106	1	the	the	DET
iajs-2017	106	2	outcomes	outcome	NOUN
iajs-2017	106	3	in	in	ADP
iajs-2017	106	4	table	table	NOUN
iajs-2017	106	5	2	2	NUM
iajs-2017	106	6	.	.	PUNCT
iajs-2017	106	7	demonstrated	demonstrate	VERB
iajs-2017	106	8	an	an	DET
iajs-2017	106	9	exceedingly	exceedingly	ADV
iajs-2017	106	10	critical	critical	ADJ
iajs-2017	106	11	increment	increment	NOUN
iajs-2017	106	12	(	(	PUNCT
iajs-2017	106	13	p	p	X
iajs-2017	106	14	<	<	X
iajs-2017	106	15	0.005	0.005	NUM
iajs-2017	106	16	)	)	PUNCT
iajs-2017	106	17	in	in	ADP
iajs-2017	106	18	plasma	plasma	NOUN
iajs-2017	106	19	thymidine	thymidine	ADJ
iajs-2017	106	20	kinase-1(tk-1	kinase-1(tk-1	PROPN
iajs-2017	106	21	)	)	PUNCT
iajs-2017	106	22	levels	level	NOUN
iajs-2017	106	23	in	in	ADP
iajs-2017	106	24	both	both	DET
iajs-2017	106	25	idiopathic	idiopathic	ADJ
iajs-2017	106	26	thrombocytopenic	thrombocytopenic	ADJ
iajs-2017	106	27	purpura	purpura	NOUN
iajs-2017	106	28	patients	patient	NOUN
iajs-2017	106	29	(	(	PUNCT
iajs-2017	106	30	g1	g1	PROPN
iajs-2017	106	31	)	)	PUNCT
iajs-2017	106	32	and	and	CCONJ
iajs-2017	106	33	thrombocytosis	thrombocytosis	NOUN
iajs-2017	106	34	caused	cause	VERB
iajs-2017	106	35	by	by	ADP
iajs-2017	106	36	leukemia	leukemia	NOUN
iajs-2017	106	37	patients	patient	NOUN
iajs-2017	106	38	(	(	PUNCT
iajs-2017	106	39	g2	g2	PROPN
iajs-2017	106	40	)	)	PUNCT
iajs-2017	106	41	,	,	PUNCT
iajs-2017	106	42	separately	separately	ADV
iajs-2017	106	43	,	,	PUNCT
iajs-2017	106	44	when	when	SCONJ
iajs-2017	106	45	contrasting	contrasting	NOUN
iajs-2017	106	46	and	and	CCONJ
iajs-2017	106	47	control	control	NOUN
iajs-2017	106	48	group	group	NOUN
iajs-2017	106	49	,	,	PUNCT
iajs-2017	106	50	while	while	SCONJ
iajs-2017	106	51	there	there	PRON
iajs-2017	106	52	was	be	VERB
iajs-2017	106	53	no	no	DET
iajs-2017	106	54	noteworthy	noteworthy	ADJ
iajs-2017	106	55	distinctive	distinctive	ADJ
iajs-2017	106	56	in	in	ADP
iajs-2017	106	57	tk-1	tk-1	ADP
iajs-2017	106	58	between	between	ADP
iajs-2017	106	59	two	two	NUM
iajs-2017	106	60	gatherings	gathering	NOUN
iajs-2017	106	61	.	.	PUNCT
iajs-2017	107	1	in	in	ADP
iajs-2017	107	2	the	the	DET
iajs-2017	107	3	flow	flow	NOUN
iajs-2017	107	4	contemplate	contemplate	NOUN
iajs-2017	107	5	,	,	PUNCT
iajs-2017	107	6	the	the	DET
iajs-2017	107	7	level	level	NOUN
iajs-2017	107	8	of	of	ADP
iajs-2017	107	9	tk-1	tk-1	ADP
iajs-2017	107	10	in	in	ADP
iajs-2017	107	11	youngsters	youngster	NOUN
iajs-2017	107	12	patients	patient	NOUN
iajs-2017	107	13	with	with	ADP
iajs-2017	107	14	thrombocytosis	thrombocytosis	NOUN
iajs-2017	107	15	that	that	PRON
iajs-2017	107	16	caused	cause	VERB
iajs-2017	107	17	by	by	ADP
iajs-2017	107	18	leukemia	leukemia	NOUN
iajs-2017	107	19	(	(	PUNCT
iajs-2017	107	20	g2	g2	PROPN
iajs-2017	107	21	)	)	PUNCT
iajs-2017	107	22	was	be	AUX
iajs-2017	107	23	higher	high	ADJ
iajs-2017	107	24	than	than	ADP
iajs-2017	107	25	that	that	PRON
iajs-2017	107	26	in	in	ADP
iajs-2017	107	27	kids	kid	NOUN
iajs-2017	107	28	patients	patient	NOUN
iajs-2017	107	29	with	with	ADP
iajs-2017	107	30	idiopathic	idiopathic	ADJ
iajs-2017	107	31	thrombocytopenia	thrombocytopenia	NOUN
iajs-2017	107	32	(	(	PUNCT
iajs-2017	107	33	g1	g1	PROPN
iajs-2017	107	34	)	)	PUNCT
iajs-2017	107	35	;	;	PUNCT
iajs-2017	107	36	in	in	ADP
iajs-2017	107	37	this	this	DET
iajs-2017	107	38	manner	manner	NOUN
iajs-2017	107	39	kids	kid	NOUN
iajs-2017	107	40	patients	patient	NOUN
iajs-2017	107	41	with	with	ADP
iajs-2017	107	42	thrombocytosis	thrombocytosis	NOUN
iajs-2017	107	43	that	that	PRON
iajs-2017	107	44	caused	cause	VERB
iajs-2017	107	45	by	by	ADP
iajs-2017	107	46	leukemia	leukemia	NOUN
iajs-2017	107	47	might	might	AUX
iajs-2017	107	48	be	be	AUX
iajs-2017	107	49	more	more	ADV
iajs-2017	107	50	inclined	inclined	ADJ
iajs-2017	107	51	to	to	ADP
iajs-2017	107	52	malignancy	malignancy	NOUN
iajs-2017	107	53	infections	infection	NOUN
iajs-2017	107	54	than	than	ADP
iajs-2017	107	55	that	that	PRON
iajs-2017	107	56	in	in	ADP
iajs-2017	107	57	kids	kid	NOUN
iajs-2017	107	58	patients	patient	NOUN
iajs-2017	107	59	with	with	ADP
iajs-2017	107	60	idiopathic	idiopathic	ADJ
iajs-2017	107	61	thrombocytopenia	thrombocytopenia	NOUN
iajs-2017	107	62	,	,	PUNCT
iajs-2017	107	63	in	in	ADP
iajs-2017	107	64	light	light	NOUN
iajs-2017	107	65	of	of	ADP
iajs-2017	107	66	the	the	DET
iajs-2017	107	67	fact	fact	NOUN
iajs-2017	107	68	that	that	SCONJ
iajs-2017	107	69	thymidine	thymidine	PROPN
iajs-2017	107	70	kinase	kinase	PROPN
iajs-2017	107	71	(	(	PUNCT
iajs-2017	107	72	tk	tk	PROPN
iajs-2017	107	73	)	)	PUNCT
iajs-2017	107	74	action	action	NOUN
iajs-2017	107	75	in	in	ADP
iajs-2017	107	76	plasma	plasma	NOUN
iajs-2017	107	77	is	be	AUX
iajs-2017	107	78	a	a	DET
iajs-2017	107	79	tumor	tumor	NOUN
iajs-2017	107	80	development	development	NOUN
iajs-2017	107	81	related	relate	VERB
iajs-2017	107	82	marker	marker	NOUN
iajs-2017	107	83	which	which	PRON
iajs-2017	107	84	has	have	AUX
iajs-2017	107	85	been	be	AUX
iajs-2017	107	86	utilized	utilize	VERB
iajs-2017	107	87	for	for	ADP
iajs-2017	107	88	forecast	forecast	NOUN
iajs-2017	107	89	and	and	CCONJ
iajs-2017	107	90	observing	observe	VERB
iajs-2017	107	91	of	of	ADP
iajs-2017	107	92	treatment	treatment	NOUN
iajs-2017	107	93	of	of	ADP
iajs-2017	107	94	lymphoma	lymphoma	NOUN
iajs-2017	107	95	and	and	CCONJ
iajs-2017	107	96	leukemia	leukemia	NOUN
iajs-2017	107	97	[	[	X
iajs-2017	107	98	25	25	NUM
iajs-2017	107	99	]	]	PUNCT
iajs-2017	107	100	.	.	PUNCT
iajs-2017	108	1	tk1	tk1	PROPN
iajs-2017	108	2	is	be	AUX
iajs-2017	108	3	synthesized	synthesize	VERB
iajs-2017	108	4	by	by	ADP
iajs-2017	108	5	the	the	DET
iajs-2017	108	6	cell	cell	NOUN
iajs-2017	108	7	during	during	ADP
iajs-2017	108	8	the	the	DET
iajs-2017	108	9	s	s	NOUN
iajs-2017	108	10	phase	phase	NOUN
iajs-2017	108	11	of	of	ADP
iajs-2017	108	12	cell	cell	NOUN
iajs-2017	108	13	division	division	NOUN
iajs-2017	108	14	.	.	PUNCT
iajs-2017	109	1	after	after	SCONJ
iajs-2017	109	2	cell	cell	NOUN
iajs-2017	109	3	division	division	NOUN
iajs-2017	109	4	is	be	AUX
iajs-2017	109	5	finished	finish	VERB
iajs-2017	109	6	,	,	PUNCT
iajs-2017	109	7	tk1	tk1	PROPN
iajs-2017	109	8	is	be	AUX
iajs-2017	109	9	debased	debase	VERB
iajs-2017	109	10	intracellularly	intracellularly	ADV
iajs-2017	109	11	and	and	CCONJ
iajs-2017	109	12	does	do	AUX
iajs-2017	109	13	not	not	PART
iajs-2017	109	14	go	go	VERB
iajs-2017	109	15	to	to	ADP
iajs-2017	109	16	body	body	NOUN
iajs-2017	109	17	liquids	liquid	NOUN
iajs-2017	109	18	after	after	ADP
iajs-2017	109	19	ordinary	ordinary	ADJ
iajs-2017	109	20	cell	cell	NOUN
iajs-2017	109	21	division	division	NOUN
iajs-2017	110	1	[	[	X
iajs-2017	110	2	26	26	NUM
iajs-2017	110	3	]	]	PUNCT
iajs-2017	110	4	.	.	PUNCT
iajs-2017	111	1	investigation	investigation	NOUN
iajs-2017	111	2	of	of	ADP
iajs-2017	111	3	aufderklamm	aufderklamm	PROPN
iajs-2017	111	4	and	and	CCONJ
iajs-2017	111	5	et	et	PROPN
iajs-2017	111	6	al	al	PROPN
iajs-2017	111	7	.	.	PUNCT
iajs-2017	112	1	[	[	X
iajs-2017	112	2	27	27	NUM
iajs-2017	112	3	]	]	PUNCT
iajs-2017	112	4	shows	show	VERB
iajs-2017	112	5	that	that	SCONJ
iajs-2017	112	6	tk1	tk1	PROPN
iajs-2017	112	7	has	have	VERB
iajs-2017	112	8	all	all	DET
iajs-2017	112	9	the	the	DET
iajs-2017	112	10	earmarks	earmark	NOUN
iajs-2017	112	11	of	of	ADP
iajs-2017	112	12	being	be	AUX
iajs-2017	112	13	a	a	DET
iajs-2017	112	14	decent	decent	ADJ
iajs-2017	112	15	all	all	DET
iajs-2017	112	16	inclusive	inclusive	ADJ
iajs-2017	112	17	marker	marker	NOUN
iajs-2017	112	18	for	for	ADP
iajs-2017	112	19	growth	growth	NOUN
iajs-2017	112	20	among	among	ADP
iajs-2017	112	21	both	both	CCONJ
iajs-2017	112	22	strong	strong	ADJ
iajs-2017	112	23	and	and	CCONJ
iajs-2017	112	24	hematological	hematological	ADJ
iajs-2017	112	25	malignancies	malignancy	NOUN
iajs-2017	112	26	.	.	PUNCT
iajs-2017	113	1	earlier	early	ADJ
iajs-2017	113	2	examines	examine	NOUN
iajs-2017	113	3	on	on	ADP
iajs-2017	113	4	stk1	stk1	PROPN
iajs-2017	113	5	,	,	PUNCT
iajs-2017	113	6	affirm	affirm	NOUN
iajs-2017	113	7	that	that	PRON
iajs-2017	113	8	tk1	tk1	PROPN
iajs-2017	113	9	in	in	ADP
iajs-2017	113	10	serum	serum	NOUN
iajs-2017	113	11	is	be	AUX
iajs-2017	113	12	n't	not	PART
iajs-2017	113	13	helpful	helpful	ADJ
iajs-2017	113	14	for	for	ADP
iajs-2017	113	15	assessment	assessment	NOUN
iajs-2017	113	16	of	of	ADP
iajs-2017	113	17	tumor	tumor	NOUN
iajs-2017	113	18	movement	movement	NOUN
iajs-2017	113	19	but	but	CCONJ
iajs-2017	113	20	at	at	ADP
iajs-2017	113	21	the	the	DET
iajs-2017	113	22	same	same	ADJ
iajs-2017	113	23	time	time	NOUN
iajs-2017	113	24	is	be	AUX
iajs-2017	113	25	a	a	DET
iajs-2017	113	26	valuable	valuable	ADJ
iajs-2017	113	27	instrument	instrument	NOUN
iajs-2017	113	28	for	for	ADP
iajs-2017	113	29	assessment	assessment	NOUN
iajs-2017	113	30	of	of	ADP
iajs-2017	113	31	the	the	DET
iajs-2017	113	32	impact	impact	NOUN
iajs-2017	113	33	of	of	ADP
iajs-2017	113	34	tumor	tumor	NOUN
iajs-2017	113	35	therapy	therapy	NOUN
iajs-2017	114	1	[	[	X
iajs-2017	114	2	28	28	NUM
iajs-2017	114	3	]	]	PUNCT
iajs-2017	114	4	.	.	PUNCT
iajs-2017	114	5	  	  	SPACE
iajs-2017	115	1	to	to	ADP
iajs-2017	115	2	the	the	DET
iajs-2017	115	3	extent	extent	NOUN
iajs-2017	115	4	as	as	ADV
iajs-2017	115	5	far	far	ADV
iajs-2017	115	6	as	as	SCONJ
iajs-2017	115	7	anyone	anyone	PRON
iajs-2017	115	8	is	be	AUX
iajs-2017	115	9	concerned	concern	VERB
iajs-2017	115	10	,	,	PUNCT
iajs-2017	115	11	there	there	PRON
iajs-2017	115	12	is	be	VERB
iajs-2017	115	13	no	no	DET
iajs-2017	115	14	information	information	NOUN
iajs-2017	115	15	in	in	ADP
iajs-2017	115	16	the	the	DET
iajs-2017	115	17	writing	writing	NOUN
iajs-2017	115	18	concerning	concern	VERB
iajs-2017	115	19	the	the	DET
iajs-2017	115	20	plasma	plasma	NOUN
iajs-2017	115	21	level	level	NOUN
iajs-2017	115	22	of	of	ADP
iajs-2017	115	23	thymidine	thymidine	ADJ
iajs-2017	115	24	kinase-1	kinase-1	PROPN
iajs-2017	115	25	chemical	chemical	NOUN
iajs-2017	115	26	in	in	ADP
iajs-2017	115	27	youngster	youngster	NOUN
iajs-2017	115	28	’s	’s	PART
iajs-2017	115	29	patients	patient	NOUN
iajs-2017	115	30	with	with	ADP
iajs-2017	115	31	idiopathic	idiopathic	ADJ
iajs-2017	115	32	thrombocytopenic	thrombocytopenic	ADJ
iajs-2017	115	33	purpura	purpura	NOUN
iajs-2017	115	34	and	and	CCONJ
iajs-2017	115	35	with	with	ADP
iajs-2017	115	36	thrombocytosis	thrombocytosis	NOUN
iajs-2017	115	37	that	that	PRON
iajs-2017	115	38	caused	cause	VERB
iajs-2017	115	39	by	by	ADP
iajs-2017	115	40	leukemia	leukemia	NOUN
iajs-2017	115	41	.	.	PUNCT
iajs-2017	116	1	accordingly	accordingly	ADV
iajs-2017	116	2	,	,	PUNCT
iajs-2017	116	3	the	the	DET
iajs-2017	116	4	present	present	ADJ
iajs-2017	116	5	investigation	investigation	NOUN
iajs-2017	116	6	was	be	AUX
iajs-2017	116	7	the	the	DET
iajs-2017	116	8	primary	primary	NOUN
iajs-2017	116	9	that	that	PRON
iajs-2017	116	10	planned	plan	VERB
iajs-2017	116	11	to	to	PART
iajs-2017	116	12	reveal	reveal	VERB
iajs-2017	116	13	an	an	DET
iajs-2017	116	14	insight	insight	NOUN
iajs-2017	116	15	into	into	ADP
iajs-2017	116	16	the	the	DET
iajs-2017	116	17	part	part	NOUN
iajs-2017	116	18	and	and	CCONJ
iajs-2017	116	19	level	level	NOUN
iajs-2017	116	20	of	of	ADP
iajs-2017	116	21	tk-1	tk-1	PUNCT
iajs-2017	116	22	and	and	CCONJ
iajs-2017	116	23	its	its	PRON
iajs-2017	116	24	association	association	NOUN
iajs-2017	116	25	with	with	ADP
iajs-2017	116	26	tac	tac	PROPN
iajs-2017	116	27	in	in	ADP
iajs-2017	116	28	such	such	ADJ
iajs-2017	116	29	patients	patient	NOUN
iajs-2017	116	30	,	,	PUNCT
iajs-2017	116	31	which	which	PRON
iajs-2017	116	32	could	could	AUX
iajs-2017	116	33	investigate	investigate	VERB
iajs-2017	116	34	at	at	ADP
iajs-2017	116	35	any	any	DET
iajs-2017	116	36	rate	rate	NOUN
iajs-2017	116	37	partially	partially	ADV
iajs-2017	116	38	the	the	DET
iajs-2017	116	39	commitment	commitment	NOUN
iajs-2017	116	40	of	of	ADP
iajs-2017	116	41	this	this	DET
iajs-2017	116	42	catalyst	catalyst	NOUN
iajs-2017	116	43	to	to	ADP
iajs-2017	116	44	the	the	DET
iajs-2017	116	45	pathogenesis	pathogenesis	NOUN
iajs-2017	116	46	of	of	ADP
iajs-2017	116	47	the	the	DET
iajs-2017	116	48	illness	illness	NOUN
iajs-2017	116	49	.	.	PUNCT
iajs-2017	117	1	the	the	DET
iajs-2017	117	2	outcomes	outcome	NOUN
iajs-2017	117	3	in	in	ADP
iajs-2017	117	4	table	table	NOUN
iajs-2017	117	5	2	2	NUM
iajs-2017	117	6	.	.	PUNCT
iajs-2017	117	7	uncovered	uncover	VERB
iajs-2017	117	8	no	no	DET
iajs-2017	117	9	noteworthy	noteworthy	ADJ
iajs-2017	117	10	height	height	NOUN
iajs-2017	117	11	in	in	ADP
iajs-2017	117	12	plasma	plasma	NOUN
iajs-2017	117	13	add	add	VERB
iajs-2017	117	14	up	up	ADP
iajs-2017	117	15	to	to	ADP
iajs-2017	117	16	cell	cell	NOUN
iajs-2017	117	17	reinforcement	reinforcement	NOUN
iajs-2017	117	18	limit	limit	NOUN
iajs-2017	117	19	(	(	PUNCT
iajs-2017	117	20	tac	tac	NOUN
iajs-2017	117	21	)	)	PUNCT
iajs-2017	117	22	levels	level	NOUN
iajs-2017	117	23	in	in	ADP
iajs-2017	117	24	youngster	youngster	NOUN
iajs-2017	117	25	’s	’s	PART
iajs-2017	117	26	patients	patient	NOUN
iajs-2017	117	27	with	with	ADP
iajs-2017	117	28	idiopathic	idiopathic	ADJ
iajs-2017	117	29	thrombocytopenic	thrombocytopenic	ADJ
iajs-2017	117	30	purpura	purpura	NOUN
iajs-2017	117	31	patients	patient	NOUN
iajs-2017	117	32	(	(	PUNCT
iajs-2017	117	33	g1	g1	PROPN
iajs-2017	117	34	)	)	PUNCT
iajs-2017	117	35	and	and	CCONJ
iajs-2017	117	36	an	an	DET
iajs-2017	117	37	exceptionally	exceptionally	ADV
iajs-2017	117	38	huge	huge	ADJ
iajs-2017	117	39	rise	rise	NOUN
iajs-2017	117	40	in	in	ADP
iajs-2017	117	41	kids	kid	NOUN
iajs-2017	117	42	’	’	PART
iajs-2017	117	43	patients	patient	NOUN
iajs-2017	117	44	with	with	ADP
iajs-2017	117	45	thrombocytosis	thrombocytosis	NOUN
iajs-2017	117	46	caused	cause	VERB
iajs-2017	117	47	by	by	ADP
iajs-2017	117	48	leukemia	leukemia	NOUN
iajs-2017	117	49	patients	patient	NOUN
iajs-2017	117	50	(	(	PUNCT
iajs-2017	117	51	g2	g2	PROPN
iajs-2017	117	52	)	)	PUNCT
iajs-2017	117	53	,	,	PUNCT
iajs-2017	117	54	individually	individually	ADV
iajs-2017	117	55	,	,	PUNCT
iajs-2017	117	56	when	when	SCONJ
iajs-2017	117	57	contrasting	contrast	VERB
iajs-2017	117	58	and	and	CCONJ
iajs-2017	117	59	control	control	NOUN
iajs-2017	117	60	gathering	gathering	NOUN
iajs-2017	117	61	,	,	PUNCT
iajs-2017	117	62	while	while	SCONJ
iajs-2017	117	63	there	there	PRON
iajs-2017	117	64	was	be	VERB
iajs-2017	117	65	a	a	DET
iajs-2017	117	66	critical	critical	ADJ
iajs-2017	117	67	diverse	diverse	NOUN
iajs-2017	117	68	in	in	ADP
iajs-2017	117	69	tac	tac	PROPN
iajs-2017	117	70	levels	level	NOUN
iajs-2017	117	71	between	between	ADP
iajs-2017	117	72	two	two	NUM
iajs-2017	117	73	gatherings	gathering	NOUN
iajs-2017	117	74	.	.	PUNCT
iajs-2017	118	1	as	as	ADP
iajs-2017	118	2	of	of	ADP
iajs-2017	118	3	late	late	ADJ
iajs-2017	118	4	,	,	PUNCT
iajs-2017	118	5	a	a	DET
iajs-2017	118	6	few	few	ADJ
iajs-2017	118	7	confirmations	confirmation	NOUN
iajs-2017	118	8	have	have	AUX
iajs-2017	118	9	recommended	recommend	VERB
iajs-2017	118	10	that	that	PRON
iajs-2017	118	11	oxidative	oxidative	ADJ
iajs-2017	118	12	pressure	pressure	NOUN
iajs-2017	118	13	assumes	assume	VERB
iajs-2017	118	14	a	a	DET
iajs-2017	118	15	vital	vital	ADJ
iajs-2017	118	16	part	part	NOUN
iajs-2017	118	17	in	in	ADP
iajs-2017	118	18	the	the	DET
iajs-2017	118	19	pathogenesis	pathogenesis	NOUN
iajs-2017	118	20	of	of	ADP
iajs-2017	118	21	immune	immune	ADJ
iajs-2017	118	22	system	system	NOUN
iajs-2017	118	23	maladies	maladie	VERB
iajs-2017	118	24	,	,	PUNCT
iajs-2017	118	25	and	and	CCONJ
iajs-2017	118	26	it	it	PRON
iajs-2017	118	27	is	be	AUX
iajs-2017	118	28	likewise	likewise	ADV
iajs-2017	118	29	associated	associate	VERB
iajs-2017	118	30	with	with	ADP
iajs-2017	118	31	the	the	DET
iajs-2017	118	32	improvement	improvement	NOUN
iajs-2017	118	33	of	of	ADP
iajs-2017	118	34	itp	itp	PROPN
iajs-2017	118	35	.	.	PUNCT
iajs-2017	119	1	these	these	DET
iajs-2017	119	2	findings	finding	NOUN
iajs-2017	119	3	might	might	AUX
iajs-2017	119	4	provide	provide	VERB
iajs-2017	119	5	a	a	DET
iajs-2017	119	6	new	new	ADJ
iajs-2017	119	7	hypothesis	hypothesis	NOUN
iajs-2017	119	8	for	for	ADP
iajs-2017	119	9	the	the	DET
iajs-2017	119	10	initiation	initiation	NOUN
iajs-2017	119	11	of	of	ADP
iajs-2017	119	12	abnormal	abnormal	ADJ
iajs-2017	119	13	autoimmunity	autoimmunity	NOUN
iajs-2017	119	14	and	and	CCONJ
iajs-2017	119	15	a	a	DET
iajs-2017	119	16	possible	possible	ADJ
iajs-2017	119	17	novel	novel	ADJ
iajs-2017	119	18	therapeutic	therapeutic	ADJ
iajs-2017	119	19	approach	approach	NOUN
iajs-2017	119	20	[	[	X
iajs-2017	119	21	29	29	NUM
iajs-2017	119	22	]	]	PUNCT
iajs-2017	119	23	.	.	PUNCT
iajs-2017	120	1	sinan	sinan	PROPN
iajs-2017	120	2	akgun	akgun	PROPN
iajs-2017	120	3	and	and	CCONJ
iajs-2017	120	4	et	et	NOUN
iajs-2017	120	5	al	al	PROPN
iajs-2017	120	6	.	.	PROPN
iajs-2017	121	1	in	in	ADP
iajs-2017	121	2	their	their	PRON
iajs-2017	121	3	investigation	investigation	NOUN
iajs-2017	121	4	,	,	PUNCT
iajs-2017	121	5	they	they	PRON
iajs-2017	121	6	reason	reason	VERB
iajs-2017	121	7	that	that	SCONJ
iajs-2017	121	8	an	an	DET
iajs-2017	121	9	addition	addition	NOUN
iajs-2017	121	10	in	in	ADP
iajs-2017	121	11	serum	serum	PROPN
iajs-2017	121	12	mda	mda	PROPN
iajs-2017	121	13	,	,	PUNCT
iajs-2017	121	14	tos	tos	PROPN
iajs-2017	121	15	,	,	PUNCT
iajs-2017	121	16	and	and	CCONJ
iajs-2017	121	17	osi	osi	PROPN
iajs-2017	121	18	levels	level	NOUN
iajs-2017	121	19	,	,	PUNCT
iajs-2017	121	20	and	and	CCONJ
iajs-2017	121	21	a	a	DET
iajs-2017	121	22	decrement	decrement	NOUN
iajs-2017	121	23	in	in	ADP
iajs-2017	121	24	tac	tac	PROPN
iajs-2017	121	25	levels	level	NOUN
iajs-2017	121	26	were	be	AUX
iajs-2017	121	27	found	find	VERB
iajs-2017	121	28	in	in	ADP
iajs-2017	121	29	patients	patient	NOUN
iajs-2017	121	30	with	with	ADP
iajs-2017	121	31	intense	intense	ADJ
iajs-2017	121	32	and	and	CCONJ
iajs-2017	121	33	unending	unending	ADJ
iajs-2017	121	34	itp	itp	PROPN
iajs-2017	121	35	.	.	PROPN
iajs-2017	122	1	based	base	VERB
iajs-2017	122	2	on	on	ADP
iajs-2017	122	3	these	these	DET
iajs-2017	122	4	discoveries	discovery	NOUN
iajs-2017	122	5	,	,	PUNCT
iajs-2017	122	6	they	they	PRON
iajs-2017	122	7	recommend	recommend	VERB
iajs-2017	122	8	that	that	SCONJ
iajs-2017	122	9	free	free	ADJ
iajs-2017	122	10	oxygen	oxygen	NOUN
iajs-2017	122	11	radicals	radical	NOUN
iajs-2017	122	12	may	may	AUX
iajs-2017	122	13	affect	affect	VERB
iajs-2017	122	14	the	the	DET
iajs-2017	122	15	basic	basic	ADJ
iajs-2017	122	16	and	and	CCONJ
iajs-2017	122	17	utilitarian	utilitarian	ADJ
iajs-2017	122	18	harm	harm	NOUN
iajs-2017	122	19	of	of	ADP
iajs-2017	122	20	platelets	platelet	NOUN
iajs-2017	122	21	,	,	PUNCT
iajs-2017	122	22	and	and	CCONJ
iajs-2017	122	23	on	on	ADP
iajs-2017	122	24	the	the	DET
iajs-2017	122	25	system	system	NOUN
iajs-2017	122	26	of	of	ADP
iajs-2017	122	27	thrombocytopenia	thrombocytopenia	NOUN
iajs-2017	122	28	in	in	ADP
iajs-2017	122	29	both	both	CCONJ
iajs-2017	122	30	intense	intense	ADJ
iajs-2017	122	31	and	and	CCONJ
iajs-2017	122	32	unending	unending	ADJ
iajs-2017	122	33	itp	itp	NOUN
iajs-2017	122	34	,	,	PUNCT
iajs-2017	122	35	notwithstanding	notwithstanding	ADP
iajs-2017	122	36	a	a	DET
iajs-2017	122	37	positive	positive	ADJ
iajs-2017	122	38	relationship	relationship	NOUN
iajs-2017	122	39	between	between	ADP
iajs-2017	122	40	's	's	PART
iajs-2017	122	41	thrombocyte	thrombocyte	NOUN
iajs-2017	122	42	check	check	NOUN
iajs-2017	122	43	and	and	CCONJ
iajs-2017	122	44	tac	tac	NOUN
iajs-2017	122	45	,	,	PUNCT
iajs-2017	122	46	in	in	ADP
iajs-2017	122	47	patients	patient	NOUN
iajs-2017	122	48	with	with	ADP
iajs-2017	122	49	intense	intense	ADJ
iajs-2017	122	50	and	and	CCONJ
iajs-2017	122	51	ceaseless	ceaseless	NOUN
iajs-2017	122	52	itp	itp	NOUN
iajs-2017	123	1	[	[	X
iajs-2017	123	2	30	30	NUM
iajs-2017	123	3	]	]	PUNCT
iajs-2017	123	4	.	.	PUNCT
iajs-2017	124	1	the	the	DET
iajs-2017	124	2	platelet	platelet	NOUN
iajs-2017	124	3	obliteration	obliteration	NOUN
iajs-2017	124	4	and	and	CCONJ
iajs-2017	124	5	draining	drain	VERB
iajs-2017	124	6	may	may	AUX
iajs-2017	124	7	assume	assume	VERB
iajs-2017	124	8	significant	significant	ADJ
iajs-2017	124	9	part	part	NOUN
iajs-2017	124	10	on	on	ADP
iajs-2017	124	11	rise	rise	NOUN
iajs-2017	124	12	of	of	ADP
iajs-2017	124	13	lipid	lipid	NOUN
iajs-2017	124	14	peroxidation	peroxidation	NOUN
iajs-2017	124	15	and	and	CCONJ
iajs-2017	124	16	diminishment	diminishment	NOUN
iajs-2017	124	17	in	in	ADP
iajs-2017	124	18	cancer	cancer	NOUN
iajs-2017	124	19	prevention	prevention	NOUN
iajs-2017	124	20	agent	agent	NOUN
iajs-2017	124	21	limit	limit	NOUN
iajs-2017	124	22	in	in	ADP
iajs-2017	124	23	patients	patient	NOUN
iajs-2017	124	24	with	with	ADP
iajs-2017	124	25	itp	itp	PROPN
iajs-2017	124	26	,	,	PUNCT
iajs-2017	124	27	additionally	additionally	ADV
iajs-2017	124	28	examines	examine	VERB
iajs-2017	124	29	on	on	ADP
iajs-2017	124	30	oxidant	oxidant	NOUN
iajs-2017	124	31	and	and	CCONJ
iajs-2017	124	32	cell	cell	NOUN
iajs-2017	124	33	reinforcement	reinforcement	NOUN
iajs-2017	124	34	status	status	NOUN
iajs-2017	124	35	of	of	ADP
iajs-2017	124	36	itp	itp	PROPN
iajs-2017	124	37	are	be	AUX
iajs-2017	124	38	likewise	likewise	ADV
iajs-2017	124	39	expected	expect	VERB
iajs-2017	124	40	to	to	PART
iajs-2017	124	41	confirm	confirm	VERB
iajs-2017	124	42	these	these	DET
iajs-2017	124	43	outcomes	outcome	NOUN
iajs-2017	124	44	[	[	X
iajs-2017	124	45	31	31	NUM
iajs-2017	124	46	]	]	PUNCT
iajs-2017	124	47	.	.	PUNCT
iajs-2017	125	1	chemistry	chemistry	NOUN
iajs-2017	126	1	|	|	ADV
iajs-2017	126	2	84	84	NUM
iajs-2017	126	3	ibn	ibn	PROPN
iajs-2017	126	4	al	al	PROPN
iajs-2017	126	5	-	-	PUNCT
iajs-2017	126	6	haitham	haitham	PROPN
iajs-2017	126	7	jour	jour	X
iajs-2017	126	8	.	.	PROPN
iajs-2017	126	9	for	for	ADP
iajs-2017	126	10	pure	pure	ADJ
iajs-2017	126	11	&	&	CCONJ
iajs-2017	126	12	appl	appl	PROPN
iajs-2017	126	13	.	.	PUNCT
iajs-2017	127	1	sci	sci	PROPN
iajs-2017	127	2	.	.	PROPN
iajs-2017	127	3	ihjpas	ihjpas	PROPN
iajs-2017	127	4	https://doi.org/10.30526/31.3.2017	https://doi.org/10.30526/31.3.2017	ADP
iajs-2017	127	5	vol	vol	NOUN
iajs-2017	127	6	.	.	PUNCT
iajs-2017	128	1	31	31	NUM
iajs-2017	129	1	(	(	PUNCT
iajs-2017	129	2	3	3	NUM
iajs-2017	129	3	)	)	PUNCT
iajs-2017	129	4	2018	2018	NUM
iajs-2017	129	5	the	the	DET
iajs-2017	129	6	findings	finding	NOUN
iajs-2017	129	7	of	of	ADP
iajs-2017	129	8	(	(	PUNCT
iajs-2017	129	9	c.	c.	PROPN
iajs-2017	129	10	q.	q.	PROPN
iajs-2017	129	11	jin	jin	PROPN
iajs-2017	129	12	and	and	CCONJ
iajs-2017	129	13	et	et	PROPN
iajs-2017	129	14	al	al	PROPN
iajs-2017	129	15	.	.	PUNCT
iajs-2017	129	16	)	)	PUNCT
iajs-2017	130	1	[	[	X
iajs-2017	130	2	32	32	NUM
iajs-2017	130	3	]	]	PUNCT
iajs-2017	130	4	think	think	VERB
iajs-2017	130	5	about	about	ADP
iajs-2017	130	6	is	be	AUX
iajs-2017	130	7	proposes	propose	VERB
iajs-2017	130	8	that	that	PRON
iajs-2017	130	9	oxidative	oxidative	ADJ
iajs-2017	130	10	pressure	pressure	NOUN
iajs-2017	130	11	may	may	AUX
iajs-2017	130	12	affect	affect	VERB
iajs-2017	130	13	the	the	DET
iajs-2017	130	14	auxiliary	auxiliary	ADJ
iajs-2017	130	15	and	and	CCONJ
iajs-2017	130	16	practical	practical	ADJ
iajs-2017	130	17	harm	harm	NOUN
iajs-2017	130	18	of	of	ADP
iajs-2017	130	19	platelets	platelet	NOUN
iajs-2017	130	20	and	and	CCONJ
iajs-2017	130	21	on	on	ADP
iajs-2017	130	22	the	the	DET
iajs-2017	130	23	system	system	NOUN
iajs-2017	130	24	of	of	ADP
iajs-2017	130	25	thrombocytopenia	thrombocytopenia	NOUN
iajs-2017	130	26	in	in	ADP
iajs-2017	130	27	unending	unende	VERB
iajs-2017	130	28	itp	itp	PROPN
iajs-2017	130	29	.	.	PUNCT
iajs-2017	131	1	thusly	thusly	ADV
iajs-2017	131	2	,	,	PUNCT
iajs-2017	131	3	oxidative	oxidative	ADJ
iajs-2017	131	4	pressure	pressure	NOUN
iajs-2017	131	5	is	be	AUX
iajs-2017	131	6	thought	think	VERB
iajs-2017	131	7	to	to	PART
iajs-2017	131	8	assume	assume	VERB
iajs-2017	131	9	a	a	DET
iajs-2017	131	10	part	part	NOUN
iajs-2017	131	11	in	in	ADP
iajs-2017	131	12	thrombocyte	thrombocyte	NOUN
iajs-2017	131	13	harm	harm	NOUN
iajs-2017	131	14	[	[	X
iajs-2017	131	15	32	32	NUM
iajs-2017	131	16	]	]	PUNCT
iajs-2017	131	17	.	.	PUNCT
iajs-2017	132	1	the	the	DET
iajs-2017	132	2	expanded	expand	VERB
iajs-2017	132	3	aggregate	aggregate	ADJ
iajs-2017	132	4	cell	cell	NOUN
iajs-2017	132	5	reinforcement	reinforcement	NOUN
iajs-2017	132	6	limit	limit	NOUN
iajs-2017	132	7	may	may	AUX
iajs-2017	132	8	avert	avert	VERB
iajs-2017	132	9	oxidative	oxidative	ADJ
iajs-2017	132	10	damage	damage	NOUN
iajs-2017	132	11	prompted	prompt	VERB
iajs-2017	132	12	by	by	ADP
iajs-2017	132	13	exercise	exercise	NOUN
iajs-2017	132	14	and	and	CCONJ
iajs-2017	132	15	change	change	NOUN
iajs-2017	132	16	in	in	ADP
iajs-2017	132	17	platelet	platelet	NOUN
iajs-2017	132	18	reactions	reaction	NOUN
iajs-2017	132	19	to	to	ADP
iajs-2017	132	20	preparing	prepare	VERB
iajs-2017	132	21	might	might	AUX
iajs-2017	132	22	be	be	AUX
iajs-2017	132	23	identified	identify	VERB
iajs-2017	132	24	with	with	ADP
iajs-2017	132	25	enhanced	enhanced	ADJ
iajs-2017	132	26	cancer	cancer	NOUN
iajs-2017	132	27	prevention	prevention	NOUN
iajs-2017	132	28	agent	agent	NOUN
iajs-2017	132	29	status	status	NOUN
iajs-2017	132	30	[	[	X
iajs-2017	132	31	33	33	NUM
iajs-2017	132	32	]	]	PUNCT
iajs-2017	132	33	.	.	PUNCT
iajs-2017	133	1	in	in	ADP
iajs-2017	133	2	this	this	DET
iajs-2017	133	3	study	study	NOUN
iajs-2017	133	4	,	,	PUNCT
iajs-2017	133	5	figures	figure	NOUN
iajs-2017	133	6	1	1	NUM
iajs-2017	133	7	.	.	PUNCT
iajs-2017	134	1	and	and	CCONJ
iajs-2017	134	2	2	2	X
iajs-2017	134	3	.	.	NUM
iajs-2017	134	4	were	be	AUX
iajs-2017	134	5	showed	show	VERB
iajs-2017	134	6	a	a	DET
iajs-2017	134	7	highly	highly	ADV
iajs-2017	134	8	significant	significant	ADJ
iajs-2017	134	9	positive	positive	ADJ
iajs-2017	134	10	correlation	correlation	NOUN
iajs-2017	134	11	between	between	ADP
iajs-2017	134	12	thymidine	thymidine	PROPN
iajs-2017	134	13	kinase	kinase	PROPN
iajs-2017	134	14	-1	-1	PROPN
iajs-2017	134	15	and	and	CCONJ
iajs-2017	134	16	total	total	ADJ
iajs-2017	134	17	antioxidant	antioxidant	ADJ
iajs-2017	134	18	capacity	capacity	NOUN
iajs-2017	134	19	levels	level	NOUN
iajs-2017	134	20	in	in	ADP
iajs-2017	134	21	both	both	DET
iajs-2017	134	22	g1	g1	NOUN
iajs-2017	134	23	(	(	PUNCT
iajs-2017	134	24	r	r	NOUN
iajs-2017	134	25	=	=	NOUN
iajs-2017	134	26	0.675	0.675	NUM
iajs-2017	134	27	)	)	PUNCT
iajs-2017	134	28	and	and	CCONJ
iajs-2017	134	29	g2	g2	PROPN
iajs-2017	134	30	(	(	PUNCT
iajs-2017	134	31	r	r	NOUN
iajs-2017	134	32	=	=	NOUN
iajs-2017	134	33	0.820	0.820	NUM
iajs-2017	134	34	)	)	PUNCT
iajs-2017	134	35	.	.	PUNCT
iajs-2017	135	1	table	table	NOUN
iajs-2017	135	2	1	1	NUM
iajs-2017	135	3	.	.	PUNCT
iajs-2017	136	1	levels	level	NOUN
iajs-2017	136	2	of	of	ADP
iajs-2017	136	3	diagnostic	diagnostic	ADJ
iajs-2017	136	4	parameters	parameter	NOUN
iajs-2017	136	5	in	in	ADP
iajs-2017	136	6	control	control	NOUN
iajs-2017	136	7	,	,	PUNCT
iajs-2017	136	8	children	child	NOUN
iajs-2017	136	9	patients	patient	NOUN
iajs-2017	136	10	with	with	ADP
iajs-2017	136	11	idiopathic	idiopathic	ADJ
iajs-2017	136	12	thrombocytopenia	thrombocytopenia	PROPN
iajs-2017	136	13	purpura	purpura	NOUN
iajs-2017	136	14	(	(	PUNCT
iajs-2017	136	15	g1	g1	PROPN
iajs-2017	136	16	)	)	PUNCT
iajs-2017	136	17	,	,	PUNCT
iajs-2017	136	18	and	and	CCONJ
iajs-2017	136	19	with	with	ADP
iajs-2017	136	20	thrombocytosis	thrombocytosis	NOUN
iajs-2017	136	21	caused	cause	VERB
iajs-2017	136	22	by	by	ADP
iajs-2017	136	23	leukemia	leukemia	NOUN
iajs-2017	136	24	(	(	PUNCT
iajs-2017	136	25	g2	g2	PROPN
iajs-2017	136	26	)	)	PUNCT
iajs-2017	136	27	groups	group	NOUN
iajs-2017	136	28	.	.	PUNCT
iajs-2017	137	1	groups	group	NOUN
iajs-2017	137	2	parameters	parameter	NOUN
iajs-2017	137	3	control	control	PROPN
iajs-2017	137	4	no.(30	no.(30	PROPN
iajs-2017	137	5	)	)	PUNCT
iajs-2017	137	6	g1	g1	PROPN
iajs-2017	137	7	no	no	ADV
iajs-2017	137	8	.	.	PUNCT
iajs-2017	138	1	(	(	PUNCT
iajs-2017	138	2	30	30	NUM
iajs-2017	138	3	)	)	PUNCT
iajs-2017	138	4	g2	g2	PROPN
iajs-2017	138	5	no.(30	no.(30	NOUN
iajs-2017	138	6	)	)	PUNCT
iajs-2017	139	1	p	p	NOUN
iajs-2017	139	2	-	-	PUNCT
iajs-2017	139	3	value	value	NOUN
iajs-2017	139	4	(	(	PUNCT
iajs-2017	139	5	c	c	PROPN
iajs-2017	139	6	&	&	CCONJ
iajs-2017	139	7	g1	g1	PROPN
iajs-2017	139	8	)	)	PUNCT
iajs-2017	139	9	p	p	NOUN
iajs-2017	139	10	-	-	PUNCT
iajs-2017	139	11	value	value	NOUN
iajs-2017	139	12	(	(	PUNCT
iajs-2017	139	13	c	c	PROPN
iajs-2017	139	14	&	&	CCONJ
iajs-2017	139	15	g2	g2	PROPN
iajs-2017	139	16	)	)	PUNCT
iajs-2017	140	1	p	p	NOUN
iajs-2017	140	2	-	-	PUNCT
iajs-2017	140	3	value	value	NOUN
iajs-2017	140	4	(	(	PUNCT
iajs-2017	140	5	g1&g2	g1&g2	ADJ
iajs-2017	140	6	)	)	PUNCT
iajs-2017	140	7	platelet	platelet	NOUN
iajs-2017	140	8	(	(	PUNCT
iajs-2017	140	9	103	103	NUM
iajs-2017	140	10	/	/	SYM
iajs-2017	140	11	μl	μl	NOUN
iajs-2017	140	12	)	)	PUNCT
iajs-2017	140	13	290	290	NUM
iajs-2017	140	14	±	±	NUM
iajs-2017	140	15	53.55	53.55	NUM
iajs-2017	140	16	23.67	23.67	NUM
iajs-2017	140	17	±4.43	±4.43	PROPN
iajs-2017	140	18	778.60	778.60	NUM
iajs-2017	140	19	±142.20	±142.20	NOUN
iajs-2017	140	20	hs	hs	PROPN
iajs-2017	140	21	hs	hs	PROPN
iajs-2017	140	22	hs	hs	PROPN
iajs-2017	140	23	pt	pt	PROPN
iajs-2017	140	24	(	(	PUNCT
iajs-2017	140	25	sec	sec	PROPN
iajs-2017	140	26	)	)	PUNCT
iajs-2017	140	27	11.73±2.14	11.73±2.14	NUM
iajs-2017	140	28	15.52±2.83	15.52±2.83	NUM
iajs-2017	140	29	12.58	12.58	NUM
iajs-2017	140	30	±	±	NUM
iajs-2017	140	31	2.29	2.29	NUM
iajs-2017	140	32	s	s	NOUN
iajs-2017	140	33	s	s	PART
iajs-2017	140	34	ns	ns	NUM
iajs-2017	140	35	aptt	aptt	ADJ
iajs-2017	140	36	(	(	PUNCT
iajs-2017	140	37	sec	sec	PROPN
iajs-2017	140	38	)	)	PUNCT
iajs-2017	140	39	32.36±5.90	32.36±5.90	NUM
iajs-2017	140	40	41.45±7.56	41.45±7.56	NUM
iajs-2017	140	41	32.60	32.60	NUM
iajs-2017	140	42	±	±	NUM
iajs-2017	140	43	5.95	5.95	NUM
iajs-2017	140	44	hs	hs	PROPN
iajs-2017	140	45	ns	ns	NUM
iajs-2017	140	46	hs	hs	PROPN
iajs-2017	140	47	table	table	NOUN
iajs-2017	140	48	2	2	NUM
iajs-2017	140	49	.	.	PUNCT
iajs-2017	140	50	levels	level	NOUN
iajs-2017	140	51	of	of	ADP
iajs-2017	140	52	thymidine	thymidine	ADJ
iajs-2017	140	53	kinase	kinase	PROPN
iajs-2017	140	54	-1(tk-1	-1(tk-1	PROPN
iajs-2017	140	55	)	)	PUNCT
iajs-2017	140	56	and	and	CCONJ
iajs-2017	140	57	total	total	ADJ
iajs-2017	140	58	antioxidant	antioxidant	ADJ
iajs-2017	140	59	capacity	capacity	NOUN
iajs-2017	140	60	(	(	PUNCT
iajs-2017	140	61	tac	tac	NOUN
iajs-2017	140	62	)	)	PUNCT
iajs-2017	140	63	in	in	ADP
iajs-2017	140	64	control	control	NOUN
iajs-2017	140	65	,	,	PUNCT
iajs-2017	140	66	children	child	NOUN
iajs-2017	140	67	patients	patient	NOUN
iajs-2017	140	68	with	with	ADP
iajs-2017	140	69	idiopathic	idiopathic	ADJ
iajs-2017	140	70	thrombocytopenia	thrombocytopenia	PROPN
iajs-2017	140	71	purpura	purpura	NOUN
iajs-2017	140	72	(	(	PUNCT
iajs-2017	140	73	g1	g1	PROPN
iajs-2017	140	74	)	)	PUNCT
iajs-2017	140	75	,	,	PUNCT
iajs-2017	140	76	and	and	CCONJ
iajs-2017	140	77	with	with	ADP
iajs-2017	140	78	thrombocytosis	thrombocytosis	NOUN
iajs-2017	140	79	caused	cause	VERB
iajs-2017	140	80	by	by	ADP
iajs-2017	140	81	leukemia	leukemia	NOUN
iajs-2017	140	82	(	(	PUNCT
iajs-2017	140	83	g2	g2	PROPN
iajs-2017	140	84	)	)	PUNCT
iajs-2017	140	85	groups	group	NOUN
iajs-2017	140	86	.	.	PUNCT
iajs-2017	141	1	p	p	X
iajs-2017	141	2	-	-	PUNCT
iajs-2017	141	3	value	value	NOUN
iajs-2017	141	4	(	(	PUNCT
iajs-2017	141	5	g1	g1	PROPN
iajs-2017	141	6	&	&	CCONJ
iajs-2017	141	7	g2	g2	PROPN
iajs-2017	141	8	)	)	PUNCT
iajs-2017	142	1	p	p	NOUN
iajs-2017	142	2	-	-	PUNCT
iajs-2017	142	3	value	value	NOUN
iajs-2017	142	4	(	(	PUNCT
iajs-2017	142	5	c	c	PROPN
iajs-2017	142	6	&	&	CCONJ
iajs-2017	142	7	g2	g2	PROPN
iajs-2017	142	8	)	)	PUNCT
iajs-2017	143	1	p	p	NOUN
iajs-2017	143	2	-	-	PUNCT
iajs-2017	143	3	value	value	NOUN
iajs-2017	143	4	(	(	PUNCT
iajs-2017	143	5	c	c	PROPN
iajs-2017	143	6	&	&	CCONJ
iajs-2017	143	7	g1	g1	PROPN
iajs-2017	143	8	)	)	PUNCT
iajs-2017	143	9	g2	g2	PROPN
iajs-2017	143	10	no.(30	no.(30	NOUN
iajs-2017	143	11	)	)	PUNCT
iajs-2017	143	12	g1	g1	PROPN
iajs-2017	143	13	no.(30	no.(30	NOUN
iajs-2017	143	14	)	)	PUNCT
iajs-2017	143	15	control	control	PROPN
iajs-2017	143	16	no.(30	no.(30	NOUN
iajs-2017	143	17	)	)	PUNCT
iajs-2017	143	18	groups	group	NOUN
iajs-2017	143	19	parameters	parameter	NOUN
iajs-2017	143	20	ns	ns	INTJ
iajs-2017	143	21	hs	hs	PROPN
iajs-2017	143	22	hs	hs	PROPN
iajs-2017	143	23	7.42	7.42	NUM
iajs-2017	143	24	±	±	NUM
iajs-2017	143	25	1.35	1.35	NUM
iajs-2017	143	26	6.81	6.81	NUM
iajs-2017	143	27	±	±	NUM
iajs-2017	143	28	1.24	1.24	NUM
iajs-2017	143	29	2.99	2.99	NUM
iajs-2017	143	30	±	±	NUM
iajs-2017	143	31	0.54	0.54	NUM
iajs-2017	143	32	tk-1	tk-1	ADP
iajs-2017	143	33	(	(	PUNCT
iajs-2017	143	34	ng/	ng/	ADJ
iajs-2017	143	35	ml	ml	NOUN
iajs-2017	143	36	)	)	PUNCT
iajs-2017	143	37	s	s	VERB
iajs-2017	143	38	hs	hs	PROPN
iajs-2017	143	39	ns	ns	NUM
iajs-2017	143	40	40.70±	40.70±	NUM
iajs-2017	143	41	7.43	7.43	NUM
iajs-2017	143	42	27.08	27.08	NUM
iajs-2017	143	43	±	±	NUM
iajs-2017	143	44	4.60	4.60	NUM
iajs-2017	143	45	20.49	20.49	NUM
iajs-2017	143	46	±	±	NUM
iajs-2017	143	47	3.74	3.74	NUM
iajs-2017	143	48	tac	tac	NOUN
iajs-2017	143	49	(	(	PUNCT
iajs-2017	143	50	u	u	NOUN
iajs-2017	143	51	/	/	SYM
iajs-2017	143	52	ml	ml	NOUN
iajs-2017	143	53	)	)	PUNCT
iajs-2017	143	54	chemistry	chemistry	NOUN
iajs-2017	143	55	|	|	ADV
iajs-2017	143	56	85	85	NUM
iajs-2017	143	57	ibn	ibn	PROPN
iajs-2017	143	58	al	al	PROPN
iajs-2017	143	59	-	-	PUNCT
iajs-2017	143	60	haitham	haitham	PROPN
iajs-2017	143	61	jour	jour	X
iajs-2017	143	62	.	.	PROPN
iajs-2017	144	1	for	for	ADP
iajs-2017	144	2	pure	pure	ADJ
iajs-2017	144	3	&	&	CCONJ
iajs-2017	144	4	appl	appl	PROPN
iajs-2017	144	5	.	.	PUNCT
iajs-2017	145	1	sci	sci	PROPN
iajs-2017	145	2	.	.	PROPN
iajs-2017	145	3	ihjpas	ihjpas	PROPN
iajs-2017	145	4	https://doi.org/10.30526/31.3.2017	https://doi.org/10.30526/31.3.2017	ADP
iajs-2017	145	5	vol	vol	NOUN
iajs-2017	145	6	.	.	PUNCT
iajs-2017	146	1	31	31	NUM
iajs-2017	147	1	(	(	PUNCT
iajs-2017	147	2	3	3	NUM
iajs-2017	147	3	)	)	SYM
iajs-2017	147	4	2018	2018	NUM
iajs-2017	147	5	figure	figure	NOUN
iajs-2017	147	6	1	1	NUM
iajs-2017	147	7	.	.	PUNCT
iajs-2017	147	8	correlation	correlation	NOUN
iajs-2017	147	9	between	between	ADP
iajs-2017	147	10	tk-1	tk-1	PUNCT
iajs-2017	147	11	and	and	CCONJ
iajs-2017	147	12	figure	figure	VERB
iajs-2017	147	13	2	2	NUM
iajs-2017	147	14	.	.	PUNCT
iajs-2017	147	15	correlation	correlation	NOUN
iajs-2017	147	16	between	between	ADP
iajs-2017	147	17	tk-1	tk-1	ADP
iajs-2017	147	18	and	and	CCONJ
iajs-2017	147	19	tac	tac	PROPN
iajs-2017	147	20	tac	tac	PROPN
iajs-2017	147	21	in	in	ADP
iajs-2017	147	22	children	child	NOUN
iajs-2017	147	23	patients	patient	NOUN
iajs-2017	147	24	with	with	ADP
iajs-2017	147	25	itp	itp	PROPN
iajs-2017	147	26	.	.	PUNCT
iajs-2017	148	1	in	in	ADP
iajs-2017	148	2	children	child	NOUN
iajs-2017	148	3	patients	patient	NOUN
iajs-2017	148	4	with	with	ADP
iajs-2017	148	5	thrombocytosis	thrombocytosis	NOUN
iajs-2017	148	6	.	.	PUNCT
iajs-2017	149	1	4	4	X
iajs-2017	149	2	.	.	X
iajs-2017	149	3	conclusions	conclusion	NOUN
iajs-2017	149	4	this	this	DET
iajs-2017	149	5	study	study	NOUN
iajs-2017	149	6	was	be	AUX
iajs-2017	149	7	the	the	DET
iajs-2017	149	8	first	first	ADJ
iajs-2017	149	9	in	in	ADP
iajs-2017	149	10	the	the	DET
iajs-2017	149	11	determination	determination	NOUN
iajs-2017	149	12	of	of	ADP
iajs-2017	149	13	plasma	plasma	NOUN
iajs-2017	149	14	thymidine	thymidine	NOUN
iajs-2017	149	15	kinase	kinase	PROPN
iajs-2017	149	16	-1	-1	PROPN
iajs-2017	149	17	(	(	PUNCT
iajs-2017	149	18	tk-1	tk-1	ADP
iajs-2017	149	19	)	)	PUNCT
iajs-2017	149	20	level	level	NOUN
iajs-2017	149	21	as	as	ADP
iajs-2017	149	22	tumor	tumor	NOUN
iajs-2017	149	23	marker	marker	NOUN
iajs-2017	149	24	in	in	ADP
iajs-2017	149	25	the	the	DET
iajs-2017	149	26	children	child	NOUN
iajs-2017	149	27	patients	patient	NOUN
iajs-2017	149	28	with	with	ADP
iajs-2017	149	29	thrombocytopenia	thrombocytopenia	NOUN
iajs-2017	149	30	and	and	CCONJ
iajs-2017	149	31	with	with	ADP
iajs-2017	149	32	thrombocytosis	thrombocytosis	NOUN
iajs-2017	149	33	.	.	PUNCT
iajs-2017	150	1	current	current	ADJ
iajs-2017	150	2	study	study	NOUN
iajs-2017	150	3	proved	prove	VERB
iajs-2017	150	4	a	a	DET
iajs-2017	150	5	highly	highly	ADV
iajs-2017	150	6	significant	significant	ADJ
iajs-2017	150	7	elevation	elevation	NOUN
iajs-2017	150	8	in	in	ADP
iajs-2017	150	9	tk-1	tk-1	ADP
iajs-2017	150	10	levels	level	NOUN
iajs-2017	150	11	in	in	ADP
iajs-2017	150	12	the	the	DET
iajs-2017	150	13	iraqi	iraqi	ADJ
iajs-2017	150	14	children	child	NOUN
iajs-2017	150	15	patients	patient	NOUN
iajs-2017	150	16	with	with	ADP
iajs-2017	150	17	platelet	platelet	NOUN
iajs-2017	150	18	count	count	NOUN
iajs-2017	150	19	disorder	disorder	NOUN
iajs-2017	150	20	;	;	PUNCT
iajs-2017	150	21	therefore	therefore	ADV
iajs-2017	150	22	,	,	PUNCT
iajs-2017	150	23	tk-1	tk-1	ADP
iajs-2017	150	24	may	may	AUX
iajs-2017	150	25	be	be	AUX
iajs-2017	150	26	a	a	DET
iajs-2017	150	27	novel	novel	ADJ
iajs-2017	150	28	biomarker	biomarker	NOUN
iajs-2017	150	29	for	for	ADP
iajs-2017	150	30	this	this	DET
iajs-2017	150	31	disease	disease	NOUN
iajs-2017	150	32	and	and	CCONJ
iajs-2017	150	33	there	there	PRON
iajs-2017	150	34	was	be	VERB
iajs-2017	150	35	a	a	DET
iajs-2017	150	36	probability	probability	NOUN
iajs-2017	150	37	of	of	ADP
iajs-2017	150	38	expose	expose	VERB
iajs-2017	150	39	these	these	DET
iajs-2017	150	40	patients	patient	NOUN
iajs-2017	150	41	for	for	ADP
iajs-2017	150	42	tumor	tumor	NOUN
iajs-2017	150	43	diseases	disease	NOUN
iajs-2017	150	44	.	.	PUNCT
iajs-2017	151	1	plasma	plasma	NOUN
iajs-2017	151	2	total	total	ADJ
iajs-2017	151	3	antioxidant	antioxidant	NOUN
iajs-2017	151	4	capacity	capacity	NOUN
iajs-2017	151	5	(	(	PUNCT
iajs-2017	151	6	tac	tac	NOUN
iajs-2017	151	7	)	)	PUNCT
iajs-2017	151	8	levels	level	NOUN
iajs-2017	151	9	were	be	AUX
iajs-2017	151	10	increase	increase	NOUN
iajs-2017	151	11	in	in	ADP
iajs-2017	151	12	iraqi	iraqi	ADJ
iajs-2017	151	13	children	child	NOUN
iajs-2017	151	14	patients	patient	NOUN
iajs-2017	151	15	with	with	ADP
iajs-2017	151	16	platelet	platelet	NOUN
iajs-2017	151	17	count	count	NOUN
iajs-2017	151	18	disorder	disorder	NOUN
iajs-2017	151	19	,	,	PUNCT
iajs-2017	151	20	while	while	SCONJ
iajs-2017	151	21	there	there	PRON
iajs-2017	151	22	was	be	VERB
iajs-2017	151	23	a	a	DET
iajs-2017	151	24	significant	significant	ADJ
iajs-2017	151	25	different	different	ADJ
iajs-2017	151	26	in	in	ADP
iajs-2017	151	27	tac	tac	PROPN
iajs-2017	151	28	level	level	NOUN
iajs-2017	151	29	in	in	ADP
iajs-2017	151	30	two	two	NUM
iajs-2017	151	31	patient	patient	NOUN
iajs-2017	151	32	’s	’s	PART
iajs-2017	151	33	groups	group	NOUN
iajs-2017	151	34	.	.	PUNCT
iajs-2017	152	1	there	there	PRON
iajs-2017	152	2	was	be	VERB
iajs-2017	152	3	a	a	DET
iajs-2017	152	4	highly	highly	ADV
iajs-2017	152	5	significant	significant	ADJ
iajs-2017	152	6	positive	positive	ADJ
iajs-2017	152	7	correlation	correlation	NOUN
iajs-2017	152	8	between	between	ADP
iajs-2017	152	9	tk-1	tk-1	ADP
iajs-2017	152	10	and	and	CCONJ
iajs-2017	152	11	tac	tac	PROPN
iajs-2017	152	12	levels	level	NOUN
iajs-2017	152	13	in	in	ADP
iajs-2017	152	14	both	both	CCONJ
iajs-2017	152	15	iraqi	iraqi	ADJ
iajs-2017	152	16	children	child	NOUN
iajs-2017	152	17	patients	patient	NOUN
iajs-2017	152	18	with	with	ADP
iajs-2017	152	19	thrombocytopenia	thrombocytopenia	NOUN
iajs-2017	152	20	and	and	CCONJ
iajs-2017	152	21	with	with	ADP
iajs-2017	152	22	thrombocytosis	thrombocytosis	NOUN
iajs-2017	152	23	.	.	PUNCT
iajs-2017	153	1	references	reference	NOUN
iajs-2017	153	2	1	1	NUM
iajs-2017	153	3	.	.	PUNCT
iajs-2017	154	1	kaplan	kaplan	PROPN
iajs-2017	154	2	.	.	PUNCT
iajs-2017	155	1	z.s	z.s	PROPN
iajs-2017	155	2	.	.	PROPN
iajs-2017	155	3	;	;	PUNCT
iajs-2017	156	1	jackson	jackson	PROPN
iajs-2017	156	2	.	.	PUNCT
iajs-2017	157	1	s.p	s.p	PROPN
iajs-2017	157	2	.	.	PUNCT
iajs-2017	158	1	the	the	DET
iajs-2017	158	2	role	role	NOUN
iajs-2017	158	3	of	of	ADP
iajs-2017	158	4	platelets	platelet	NOUN
iajs-2017	158	5	in	in	ADP
iajs-2017	158	6	atherothrombosis	atherothrombosis	NOUN
iajs-2017	158	7	.	.	PUNCT
iajs-2017	159	1	ash	ash	NOUN
iajs-2017	159	2	education	education	NOUN
iajs-2017	159	3	program	program	NOUN
iajs-2017	159	4	book	book	NOUN
iajs-2017	159	5	.	.	PUNCT
iajs-2017	160	1	2011	2011	NUM
iajs-2017	160	2	,	,	PUNCT
iajs-2017	160	3	201	201	NUM
iajs-2017	160	4	,	,	PUNCT
iajs-2017	160	5	11	11	NUM
iajs-2017	160	6	,	,	PUNCT
iajs-2017	160	7	51	51	NUM
iajs-2017	160	8	-	-	SYM
iajs-2017	160	9	61	61	NUM
iajs-2017	160	10	.	.	X
iajs-2017	161	1	2	2	X
iajs-2017	161	2	.	.	X
iajs-2017	161	3	hitchcock	hitchcock	PROPN
iajs-2017	161	4	.	.	PUNCT
iajs-2017	162	1	i.s	i.s	PROPN
iajs-2017	162	2	.	.	PROPN
iajs-2017	162	3	;	;	PUNCT
iajs-2017	162	4	kaushansky	kaushansky	PROPN
iajs-2017	162	5	.	.	PUNCT
iajs-2017	163	1	k.	k.	PROPN
iajs-2017	163	2	thrombopoietin	thrombopoietin	PROPN
iajs-2017	164	1	from	from	ADP
iajs-2017	164	2	beginning	begin	VERB
iajs-2017	164	3	to	to	ADP
iajs-2017	164	4	end	end	NOUN
iajs-2017	164	5	.	.	PUNCT
iajs-2017	165	1	br	br	X
iajs-2017	165	2	j	j	PROPN
iajs-2017	165	3	haematol.2014,165	haematol.2014,165	PROPN
iajs-2017	165	4	,	,	PUNCT
iajs-2017	165	5	2	2	NUM
iajs-2017	165	6	,	,	PUNCT
iajs-2017	165	7	259	259	NUM
iajs-2017	165	8	-	-	SYM
iajs-2017	165	9	268	268	NUM
iajs-2017	165	10	.	.	PUNCT
iajs-2017	166	1	3	3	X
iajs-2017	166	2	.	.	X
iajs-2017	166	3	tefferi	tefferi	ADJ
iajs-2017	166	4	.	.	PUNCT
iajs-2017	167	1	a.	a.	NOUN
iajs-2017	167	2	;	;	PUNCT
iajs-2017	167	3	hanson	hanson	PROPN
iajs-2017	167	4	.	.	PUNCT
iajs-2017	168	1	c.a	c.a	PROPN
iajs-2017	168	2	.	.	PROPN
iajs-2017	168	3	;	;	PUNCT
iajs-2017	168	4	inwards	inward	NOUN
iajs-2017	168	5	.	.	PUNCT
iajs-2017	169	1	dj	dj	X
iajs-2017	169	2	.	.	PUNCT
iajs-2017	170	1	how	how	SCONJ
iajs-2017	170	2	to	to	PART
iajs-2017	170	3	interpret	interpret	VERB
iajs-2017	170	4	and	and	CCONJ
iajs-2017	170	5	pursue	pursue	VERB
iajs-2017	170	6	an	an	DET
iajs-2017	170	7	abnormal	abnormal	ADJ
iajs-2017	170	8	complete	complete	ADJ
iajs-2017	170	9	blood	blood	NOUN
iajs-2017	170	10	cell	cell	NOUN
iajs-2017	170	11	count	count	NOUN
iajs-2017	170	12	in	in	ADP
iajs-2017	170	13	adults	adult	NOUN
iajs-2017	170	14	.	.	PUNCT
iajs-2017	171	1	mayo	mayo	PROPN
iajs-2017	171	2	clin	clin	PROPN
iajs-2017	171	3	proc.2005	proc.2005	PROPN
iajs-2017	171	4	,	,	PUNCT
iajs-2017	171	5	80	80	NUM
iajs-2017	171	6	,	,	PUNCT
iajs-2017	171	7	7	7	NUM
iajs-2017	171	8	,	,	PUNCT
iajs-2017	171	9	923	923	NUM
iajs-2017	171	10	-	-	SYM
iajs-2017	171	11	936	936	NUM
iajs-2017	171	12	.	.	NOUN
iajs-2017	172	1	4	4	NUM
iajs-2017	172	2	.	.	NOUN
iajs-2017	172	3	labarque	labarque	ADJ
iajs-2017	172	4	.	.	PUNCT
iajs-2017	173	1	v.	v.	ADV
iajs-2017	173	2	;	;	PUNCT
iajs-2017	173	3	van	van	PROPN
iajs-2017	173	4	geet	geet	NOUN
iajs-2017	173	5	.	.	PUNCT
iajs-2017	174	1	c.	c.	NOUN
iajs-2017	174	2	clinical	clinical	ADJ
iajs-2017	174	3	practice	practice	NOUN
iajs-2017	174	4	:	:	PUNCT
iajs-2017	174	5	immune	immune	ADJ
iajs-2017	174	6	thrombocytopenia	thrombocytopenia	NOUN
iajs-2017	174	7	in	in	ADP
iajs-2017	174	8	paediatrics	paediatric	NOUN
iajs-2017	174	9	.	.	PUNCT
iajs-2017	175	1	eur	eur	PROPN
iajs-2017	175	2	j	j	PROPN
iajs-2017	175	3	pediatr	pediatr	PROPN
iajs-2017	175	4	.	.	PUNCT
iajs-2017	175	5	2014	2014	NUM
iajs-2017	175	6	,	,	PUNCT
iajs-2017	175	7	173	173	NUM
iajs-2017	175	8	,	,	PUNCT
iajs-2017	175	9	2	2	NUM
iajs-2017	175	10	,	,	PUNCT
iajs-2017	175	11	163	163	NUM
iajs-2017	175	12	-	-	SYM
iajs-2017	175	13	72	72	NUM
iajs-2017	175	14	.	.	PUNCT
iajs-2017	176	1	5	5	NUM
iajs-2017	176	2	.	.	PUNCT
iajs-2017	177	1	kühne.t	kühne.t	PROPN
iajs-2017	177	2	.	.	PUNCT
iajs-2017	177	3	;	;	PUNCT
iajs-2017	177	4	imbach	imbach	NOUN
iajs-2017	177	5	.	.	PUNCT
iajs-2017	178	1	p.	p.	NOUN
iajs-2017	178	2	management	management	NOUN
iajs-2017	178	3	of	of	ADP
iajs-2017	178	4	children	child	NOUN
iajs-2017	178	5	and	and	CCONJ
iajs-2017	178	6	adolescents	adolescent	NOUN
iajs-2017	178	7	with	with	ADP
iajs-2017	178	8	primary	primary	ADJ
iajs-2017	178	9	immune	immune	ADJ
iajs-2017	178	10	thrombocytopenia	thrombocytopenia	PROPN
iajs-2017	178	11	:	:	PUNCT
iajs-2017	178	12	controversies	controversy	NOUN
iajs-2017	178	13	and	and	CCONJ
iajs-2017	178	14	solutions	solution	NOUN
iajs-2017	178	15	.	.	PUNCT
iajs-2017	179	1	vox	vox	AUX
iajs-2017	179	2	.	.	PUNCT
iajs-2017	179	3	sang	sing	VERB
iajs-2017	179	4	.	.	PUNCT
iajs-2017	180	1	2013	2013	NUM
iajs-2017	180	2	,	,	PUNCT
iajs-2017	180	3	104	104	NUM
iajs-2017	180	4	,	,	PUNCT
iajs-2017	180	5	1	1	NUM
iajs-2017	180	6	,	,	PUNCT
iajs-2017	180	7	55	55	NUM
iajs-2017	180	8	-	-	SYM
iajs-2017	180	9	66	66	NUM
iajs-2017	180	10	.	.	PUNCT
iajs-2017	181	1	6	6	NUM
iajs-2017	181	2	.	.	NUM
iajs-2017	181	3	mantadakis.e	mantadakis.e	NOUN
iajs-2017	181	4	.	.	PUNCT
iajs-2017	182	1	;	;	PUNCT
iajs-2017	182	2	tsalkidis	tsalkidi	NOUN
iajs-2017	182	3	.	.	PUNCT
iajs-2017	183	1	a.	a.	NOUN
iajs-2017	183	2	;	;	PUNCT
iajs-2017	184	1	chatzimichael	chatzimichael	PROPN
iajs-2017	184	2	.	.	PUNCT
iajs-2017	185	1	a.	a.	NOUN
iajs-2017	185	2	thrombocytosis	thrombocytosis	NOUN
iajs-2017	185	3	in	in	ADP
iajs-2017	185	4	childhood	childhood	NOUN
iajs-2017	185	5	.	.	PUNCT
iajs-2017	186	1	indian	indian	ADJ
iajs-2017	186	2	pediatr	pediatr	NOUN
iajs-2017	186	3	.	.	PUNCT
iajs-2017	186	4	2008	2008	NUM
iajs-2017	186	5	,	,	PUNCT
iajs-2017	186	6	45	45	NUM
iajs-2017	186	7	,	,	PUNCT
iajs-2017	186	8	8	8	NUM
iajs-2017	186	9	,	,	PUNCT
iajs-2017	186	10	669–677	669–677	NUM
iajs-2017	186	11	.	.	PUNCT
iajs-2017	187	1	7	7	X
iajs-2017	187	2	.	.	X
iajs-2017	187	3	alegre	alegre	PROPN
iajs-2017	187	4	.	.	PUNCT
iajs-2017	188	1	m.m	m.m	PROPN
iajs-2017	188	2	.	.	PROPN
iajs-2017	188	3	;	;	PUNCT
iajs-2017	188	4	robison	robison	PROPN
iajs-2017	188	5	.	.	PUNCT
iajs-2017	189	1	r.a	r.a	PROPN
iajs-2017	189	2	.	.	PROPN
iajs-2017	189	3	;	;	PUNCT
iajs-2017	189	4	o'neill	o'neill	PROPN
iajs-2017	189	5	.	.	PUNCT
iajs-2017	190	1	k.l	k.l	PROPN
iajs-2017	190	2	.	.	PROPN
iajs-2017	190	3	thymidine	thymidine	PROPN
iajs-2017	190	4	kinase	kinase	PROPN
iajs-2017	190	5	1	1	NUM
iajs-2017	190	6	:	:	PUNCT
iajs-2017	190	7	a	a	DET
iajs-2017	190	8	universal	universal	ADJ
iajs-2017	190	9	marker	marker	NOUN
iajs-2017	190	10	for	for	ADP
iajs-2017	190	11	cancer	cancer	NOUN
iajs-2017	190	12	.	.	PUNCT
iajs-2017	191	1	cancer	cancer	NOUN
iajs-2017	191	2	and	and	CCONJ
iajs-2017	191	3	clinical	clinical	ADJ
iajs-2017	191	4	oncology	oncology	NOUN
iajs-2017	191	5	.	.	PUNCT
iajs-2017	192	1	2013	2013	NUM
iajs-2017	192	2	,	,	PUNCT
iajs-2017	192	3	2	2	NUM
iajs-2017	192	4	,	,	PUNCT
iajs-2017	192	5	1	1	NUM
iajs-2017	192	6	,	,	PUNCT
iajs-2017	192	7	159	159	NUM
iajs-2017	192	8	-	-	SYM
iajs-2017	192	9	167	167	NUM
iajs-2017	192	10	.	.	PUNCT
iajs-2017	193	1	8	8	NUM
iajs-2017	193	2	.	.	X
iajs-2017	193	3	ondrej	ondrej	PROPN
iajs-2017	193	4	.	.	PUNCT
iajs-2017	194	1	t.	t.	NOUN
iajs-2017	194	2	;	;	PUNCT
iajs-2017	194	3	lubos	lubos	PROPN
iajs-2017	194	4	.	.	PUNCT
iajs-2017	195	1	h.	h.	PROPN
iajs-2017	196	1	the	the	DET
iajs-2017	196	2	role	role	NOUN
iajs-2017	196	3	of	of	ADP
iajs-2017	196	4	thymidine	thymidine	ADJ
iajs-2017	196	5	kinase	kinase	PROPN
iajs-2017	196	6	in	in	ADP
iajs-2017	196	7	cancer	cancer	NOUN
iajs-2017	196	8	diseases	disease	NOUN
iajs-2017	196	9	.	.	PUNCT
iajs-2017	197	1	expert	expert	NOUN
iajs-2017	197	2	.	.	PUNCT
iajs-2017	198	1	opin	opin	NOUN
iajs-2017	198	2	.	.	PUNCT
iajs-2017	199	1	med	med	PROPN
iajs-2017	199	2	.	.	PROPN
iajs-2017	199	3	diagn	diagn	PROPN
iajs-2017	199	4	.	.	PUNCT
iajs-2017	200	1	2008	2008	NUM
iajs-2017	200	2	,	,	PUNCT
iajs-2017	200	3	2	2	NUM
iajs-2017	200	4	,	,	PUNCT
iajs-2017	200	5	2	2	NUM
iajs-2017	200	6	,	,	PUNCT
iajs-2017	200	7	129	129	NUM
iajs-2017	200	8	-	-	SYM
iajs-2017	200	9	141	141	NUM
iajs-2017	200	10	.	.	PUNCT
iajs-2017	201	1	9	9	NUM
iajs-2017	201	2	.	.	X
iajs-2017	201	3	öhrvik	öhrvik	NOUN
iajs-2017	201	4	.	.	PUNCT
iajs-2017	202	1	a.	a.	NOUN
iajs-2017	202	2	;	;	PUNCT
iajs-2017	202	3	lindh	lindh	NOUN
iajs-2017	202	4	.	.	PUNCT
iajs-2017	203	1	m.	m.	NOUN
iajs-2017	203	2	;	;	PUNCT
iajs-2017	203	3	einarsson	einarsson	NOUN
iajs-2017	203	4	.	.	PUNCT
iajs-2017	204	1	r.	r.	PROPN
iajs-2017	204	2	sensitive	sensitive	ADJ
iajs-2017	204	3	5nonradiometric	5nonradiometric	PROPN
iajs-2017	204	4	method	method	NOUN
iajs-2017	204	5	for	for	ADP
iajs-2017	204	6	determining	determine	VERB
iajs-2017	204	7	thymidine	thymidine	ADJ
iajs-2017	204	8	kinase	kinase	PROPN
iajs-2017	204	9	1	1	NUM
iajs-2017	204	10	activity	activity	NOUN
iajs-2017	204	11	.	.	PUNCT
iajs-2017	205	1	clin	clin	PROPN
iajs-2017	205	2	.	.	PUNCT
iajs-2017	205	3	chem	chem	PROPN
iajs-2017	205	4	.	.	PUNCT
iajs-2017	206	1	2004	2004	NUM
iajs-2017	206	2	,	,	PUNCT
iajs-2017	206	3	50	50	NUM
iajs-2017	206	4	,	,	PUNCT
iajs-2017	206	5	9	9	NUM
iajs-2017	206	6	,	,	PUNCT
iajs-2017	206	7	1597	1597	NUM
iajs-2017	206	8	1606	1606	NUM
iajs-2017	206	9	.	.	PUNCT
iajs-2017	207	1	chemistry	chemistry	NOUN
iajs-2017	208	1	|	|	ADV
iajs-2017	208	2	86	86	NUM
iajs-2017	208	3	ibn	ibn	PROPN
iajs-2017	208	4	al	al	PROPN
iajs-2017	208	5	-	-	PUNCT
iajs-2017	208	6	haitham	haitham	PROPN
iajs-2017	208	7	jour	jour	X
iajs-2017	208	8	.	.	PROPN
iajs-2017	209	1	for	for	ADP
iajs-2017	209	2	pure	pure	ADJ
iajs-2017	209	3	&	&	CCONJ
iajs-2017	209	4	appl	appl	PROPN
iajs-2017	209	5	.	.	PUNCT
iajs-2017	210	1	sci	sci	PROPN
iajs-2017	210	2	.	.	PROPN
iajs-2017	210	3	ihjpas	ihjpas	PROPN
iajs-2017	210	4	https://doi.org/10.30526/31.3.2017	https://doi.org/10.30526/31.3.2017	ADP
iajs-2017	210	5	vol	vol	NOUN
iajs-2017	210	6	.	.	PUNCT
iajs-2017	211	1	31	31	NUM
iajs-2017	212	1	(	(	PUNCT
iajs-2017	212	2	3	3	NUM
iajs-2017	212	3	)	)	PUNCT
iajs-2017	212	4	2018	2018	NUM
iajs-2017	212	5	10	10	NUM
iajs-2017	212	6	.	.	PUNCT
iajs-2017	213	1	tozzi	tozzi	NOUN
iajs-2017	213	2	-	-	PUNCT
iajs-2017	213	3	ciancareeli	ciancareeli	NOUN
iajs-2017	213	4	.	.	PUNCT
iajs-2017	214	1	m.g	m.g	PROPN
iajs-2017	214	2	.	.	PROPN
iajs-2017	214	3	;	;	PUNCT
iajs-2017	215	1	penco	penco	PROPN
iajs-2017	215	2	.	.	PUNCT
iajs-2017	216	1	m.	m.	NOUN
iajs-2017	216	2	;	;	PUNCT
iajs-2017	216	3	d.i	d.i	PROPN
iajs-2017	216	4	massimo	massimo	PROPN
iajs-2017	216	5	.	.	PUNCT
iajs-2017	217	1	c.	c.	PROPN
iajs-2017	217	2	influence	influence	PROPN
iajs-2017	217	3	of	of	ADP
iajs-2017	217	4	acute	acute	ADJ
iajs-2017	217	5	exercise	exercise	NOUN
iajs-2017	217	6	on	on	ADP
iajs-2017	217	7	human	human	ADJ
iajs-2017	217	8	platelet	platelet	NOUN
iajs-2017	217	9	responsiveness	responsiveness	NOUN
iajs-2017	217	10	:	:	PUNCT
iajs-2017	217	11	possible	possible	ADJ
iajs-2017	217	12	involvement	involvement	NOUN
iajs-2017	217	13	of	of	ADP
iajs-2017	217	14	exercise	exercise	NOUN
iajs-2017	217	15	-	-	PUNCT
iajs-2017	217	16	induced	induce	VERB
iajs-2017	217	17	oxidative	oxidative	ADJ
iajs-2017	217	18	stress	stress	NOUN
iajs-2017	217	19	.	.	PUNCT
iajs-2017	218	1	eur	eur	PROPN
iajs-2017	218	2	j	j	PROPN
iajs-2017	218	3	appl	appl	PROPN
iajs-2017	218	4	physiol	physiol	PROPN
iajs-2017	218	5	.	.	PUNCT
iajs-2017	219	1	2002,86	2002,86	NUM
iajs-2017	219	2	,	,	PUNCT
iajs-2017	219	3	3	3	NUM
iajs-2017	219	4	,	,	PUNCT
iajs-2017	219	5	266	266	NUM
iajs-2017	219	6	-	-	SYM
iajs-2017	219	7	272	272	NUM
iajs-2017	219	8	.	.	PUNCT
iajs-2017	219	9	11	11	NUM
iajs-2017	219	10	.	.	X
iajs-2017	219	11	di	di	PROPN
iajs-2017	219	12	massimo.c	massimo.c	PROPN
iajs-2017	219	13	.	.	PUNCT
iajs-2017	219	14	;	;	PUNCT
iajs-2017	219	15	scarpelli	scarpelli	PROPN
iajs-2017	219	16	.	.	PUNCT
iajs-2017	220	1	p.	p.	NOUN
iajs-2017	220	2	;	;	PUNCT
iajs-2017	221	1	penco	penco	PROPN
iajs-2017	221	2	.	.	PUNCT
iajs-2017	222	1	m.	m.	NOUN
iajs-2017	222	2	;	;	PUNCT
iajs-2017	222	3	tozzi	tozzi	NOUN
iajs-2017	222	4	-	-	PUNCT
iajs-2017	222	5	ciancarelli	ciancarelli	NOUN
iajs-2017	222	6	.	.	PUNCT
iajs-2017	223	1	m.g	m.g	PROPN
iajs-2017	223	2	.	.	PROPN
iajs-2017	223	3	possible	possible	ADJ
iajs-2017	223	4	involvement	involvement	NOUN
iajs-2017	223	5	of	of	ADP
iajs-2017	223	6	plasma	plasma	NOUN
iajs-2017	223	7	antioxidant	antioxidant	NOUN
iajs-2017	223	8	defences	defence	NOUN
iajs-2017	223	9	in	in	ADP
iajs-2017	223	10	training	training	NOUN
iajs-2017	223	11	-	-	PUNCT
iajs-2017	223	12	associated	associate	VERB
iajs-2017	223	13	decrease	decrease	NOUN
iajs-2017	223	14	of	of	ADP
iajs-2017	223	15	platelet	platelet	NOUN
iajs-2017	223	16	responsiveness	responsiveness	NOUN
iajs-2017	223	17	in	in	ADP
iajs-2017	223	18	humans	human	NOUN
iajs-2017	223	19	.	.	PUNCT
iajs-2017	224	1	eur	eur	PROPN
iajs-2017	224	2	j	j	PROPN
iajs-2017	224	3	appl	appl	PROPN
iajs-2017	224	4	physiol	physiol	PROPN
iajs-2017	224	5	.	.	PUNCT
iajs-2017	225	1	2004	2004	NUM
iajs-2017	225	2	,	,	PUNCT
iajs-2017	225	3	91	91	NUM
iajs-2017	225	4	,	,	PUNCT
iajs-2017	225	5	4	4	NUM
iajs-2017	225	6	,	,	PUNCT
iajs-2017	225	7	406	406	NUM
iajs-2017	225	8	-	-	SYM
iajs-2017	225	9	412	412	NUM
iajs-2017	225	10	.	.	NOUN
iajs-2017	225	11	12	12	NUM
iajs-2017	225	12	.	.	PUNCT
iajs-2017	226	1	carlos	carlos	PROPN
iajs-2017	226	2	.	.	PUNCT
iajs-2017	227	1	k.	k.	PROPN
iajs-2017	227	2	;	;	PUNCT
iajs-2017	227	3	bucalen	bucalen	PROPN
iajs-2017	227	4	.	.	PUNCT
iajs-2017	228	1	f.	f.	PROPN
iajs-2017	228	2	total	total	PROPN
iajs-2017	228	3	antioxidant	antioxidant	ADJ
iajs-2017	228	4	capacity	capacity	NOUN
iajs-2017	228	5	:	:	PUNCT
iajs-2017	228	6	a	a	DET
iajs-2017	228	7	biomarker	biomarker	NOUN
iajs-2017	228	8	in	in	ADP
iajs-2017	228	9	biomedical	biomedical	ADJ
iajs-2017	228	10	and	and	CCONJ
iajs-2017	228	11	nutritional	nutritional	ADJ
iajs-2017	228	12	studies	study	NOUN
iajs-2017	228	13	.	.	PUNCT
iajs-2017	229	1	j	j	PROPN
iajs-2017	229	2	cell	cell	NOUN
iajs-2017	229	3	mol	mol	ADP
iajs-2017	229	4	biol.2008	biol.2008	PROPN
iajs-2017	229	5	,	,	PUNCT
iajs-2017	229	6	7	7	NUM
iajs-2017	229	7	,	,	PUNCT
iajs-2017	229	8	1	1	NUM
iajs-2017	229	9	,	,	PUNCT
iajs-2017	229	10	1	1	NUM
iajs-2017	229	11	-	-	SYM
iajs-2017	229	12	15	15	NUM
iajs-2017	229	13	.	.	NOUN
iajs-2017	229	14	13	13	NUM
iajs-2017	229	15	.	.	PUNCT
iajs-2017	230	1	caen	caen	PROPN
iajs-2017	230	2	.	.	PUNCT
iajs-2017	231	1	j.	j.	PROPN
iajs-2017	231	2	;	;	PUNCT
iajs-2017	231	3	larrieu	larrieu	PROPN
iajs-2017	231	4	.	.	PUNCT
iajs-2017	232	1	m.	m.	PROPN
iajs-2017	232	2	j.	j.	PROPN
iajs-2017	232	3	;	;	PUNCT
iajs-2017	232	4	samama	samama	PROPN
iajs-2017	232	5	.	.	PUNCT
iajs-2017	233	1	m.l	m.l	PROPN
iajs-2017	233	2	.	.	PROPN
iajs-2017	233	3	hemostase	hemostase	PROPN
iajs-2017	233	4	.	.	PUNCT
iajs-2017	234	1	methods	method	NOUN
iajs-2017	234	2	exploration	exploration	VERB
iajs-2017	234	3	diagnostic	diagnostic	ADJ
iajs-2017	234	4	pratique	pratique	NOUN
iajs-2017	234	5	.	.	PUNCT
iajs-2017	235	1	paris	paris	PROPN
iajs-2017	235	2	:	:	PUNCT
iajs-2017	235	3	l	l	NOUN
iajs-2017	235	4	expansion	expansion	NOUN
iajs-2017	235	5	scientifique	scientifique	NOUN
iajs-2017	235	6	.	.	PUNCT
iajs-2017	236	1	1975	1975	NUM
iajs-2017	236	2	,	,	PUNCT
iajs-2017	236	3	24	24	NUM
iajs-2017	236	4	,	,	PUNCT
iajs-2017	236	5	344	344	NUM
iajs-2017	236	6	-	-	SYM
iajs-2017	236	7	347	347	NUM
iajs-2017	236	8	.	.	PUNCT
iajs-2017	237	1	14	14	NUM
iajs-2017	237	2	.	.	PUNCT
iajs-2017	237	3	langdell	langdell	PROPN
iajs-2017	237	4	.	.	PUNCT
iajs-2017	238	1	r.d	r.d	PROPN
iajs-2017	238	2	.	.	PROPN
iajs-2017	238	3	;	;	PUNCT
iajs-2017	238	4	wagner.r.h	wagner.r.h	PROPN
iajs-2017	238	5	.	.	PUNCT
iajs-2017	238	6	;	;	PUNCT
iajs-2017	239	1	brinkhous	brinkhous	ADJ
iajs-2017	239	2	.	.	PUNCT
iajs-2017	240	1	k.m	k.m	PROPN
iajs-2017	240	2	.	.	PROPN
iajs-2017	240	3	effect	effect	NOUN
iajs-2017	240	4	of	of	ADP
iajs-2017	240	5	antihemophilic	antihemophilic	ADJ
iajs-2017	240	6	factor	factor	NOUN
iajs-2017	240	7	on	on	ADP
iajs-2017	240	8	one	one	NUM
iajs-2017	240	9	-	-	PUNCT
iajs-2017	240	10	stage	stage	NOUN
iajs-2017	240	11	clotting	clotting	NOUN
iajs-2017	240	12	tests	test	NOUN
iajs-2017	240	13	.	.	PUNCT
iajs-2017	241	1	j	j	PROPN
iajs-2017	241	2	lab	lab	PROPN
iajs-2017	241	3	clin	clin	PROPN
iajs-2017	241	4	med	med	PROPN
iajs-2017	241	5	.	.	PUNCT
iajs-2017	242	1	1953	1953	NUM
iajs-2017	242	2	,	,	PUNCT
iajs-2017	242	3	41	41	NUM
iajs-2017	242	4	,	,	PUNCT
iajs-2017	242	5	637	637	NUM
iajs-2017	242	6	-	-	SYM
iajs-2017	242	7	647	647	NUM
iajs-2017	242	8	.	.	PUNCT
iajs-2017	243	1	15	15	NUM
iajs-2017	243	2	.	.	X
iajs-2017	244	1	josefsson	josefsson	PROPN
iajs-2017	244	2	,	,	PUNCT
iajs-2017	244	3	e.c	e.c	PROPN
iajs-2017	244	4	.	.	PROPN
iajs-2017	244	5	;	;	PUNCT
iajs-2017	244	6	dowling	dowle	VERB
iajs-2017	244	7	,	,	PUNCT
iajs-2017	244	8	m.r	m.r	PROPN
iajs-2017	244	9	.	.	PROPN
iajs-2017	244	10	;	;	PUNCT
iajs-2017	244	11	lebois	lebois	NOUN
iajs-2017	244	12	,	,	PUNCT
iajs-2017	244	13	m.	m.	NOUN
iajs-2017	244	14	;	;	PUNCT
iajs-2017	244	15	kile	kile	PROPN
iajs-2017	244	16	,	,	PUNCT
iajs-2017	244	17	b.t	b.t	PROPN
iajs-2017	244	18	.	.	PUNCT
iajs-2017	245	1	the	the	DET
iajs-2017	245	2	regulation	regulation	NOUN
iajs-2017	245	3	of	of	ADP
iajs-2017	245	4	platelet	platelet	NOUN
iajs-2017	245	5	life	life	NOUN
iajs-2017	245	6	span	span	NOUN
iajs-2017	245	7	.	.	PUNCT
iajs-2017	246	1	in	in	ADP
iajs-2017	246	2	:	:	PUNCT
iajs-2017	246	3	michelson	michelson	PROPN
iajs-2017	246	4	ad	ad	NOUN
iajs-2017	246	5	;	;	PUNCT
iajs-2017	246	6	3ed	3ed	PROPN
iajs-2017	246	7	.	.	PUNCT
iajs-2017	246	8	;	;	PUNCT
iajs-2017	246	9	elsevier	elsevier	PROPN
iajs-2017	246	10	inc	inc	PROPN
iajs-2017	246	11	:	:	PUNCT
iajs-2017	246	12	london	london	PROPN
iajs-2017	246	13	,	,	PUNCT
iajs-2017	246	14	2013	2013	NUM
iajs-2017	246	15	,	,	PUNCT
iajs-2017	246	16	p.51	p.51	PROPN
iajs-2017	246	17	-	-	PUNCT
iajs-2017	246	18	66	66	NUM
iajs-2017	246	19	.	.	PUNCT
iajs-2017	247	1	16	16	NUM
iajs-2017	247	2	.	.	PUNCT
iajs-2017	248	1	grozovsky	grozovsky	NOUN
iajs-2017	248	2	.	.	PUNCT
iajs-2017	249	1	r.	r.	PROPN
iajs-2017	249	2	;	;	PUNCT
iajs-2017	249	3	begonja	begonja	PROPN
iajs-2017	249	4	.	.	PUNCT
iajs-2017	250	1	a.j	a.j	PROPN
iajs-2017	250	2	.	.	PROPN
iajs-2017	250	3	;	;	PUNCT
iajs-2017	251	1	liu	liu	PROPN
iajs-2017	251	2	.	.	PUNCT
iajs-2017	252	1	k.	k.	PROPN
iajs-2017	253	1	the	the	DET
iajs-2017	253	2	ashwell	ashwell	PROPN
iajs-2017	253	3	-	-	PUNCT
iajs-2017	253	4	morell	morell	PROPN
iajs-2017	253	5	receptor	receptor	NOUN
iajs-2017	253	6	regulates	regulate	VERB
iajs-2017	253	7	hepatic	hepatic	ADJ
iajs-2017	253	8	thrombopoietin	thrombopoietin	ADJ
iajs-2017	253	9	production	production	NOUN
iajs-2017	253	10	via	via	ADP
iajs-2017	253	11	jak2	jak2	PROPN
iajs-2017	253	12	-	-	PUNCT
iajs-2017	253	13	stat3	stat3	NOUN
iajs-2017	253	14	signaling	signaling	NOUN
iajs-2017	253	15	.	.	PUNCT
iajs-2017	254	1	nat	nat	PROPN
iajs-2017	254	2	med	me	VERB
iajs-2017	254	3	.	.	PROPN
iajs-2017	254	4	2015	2015	NUM
iajs-2017	254	5	,	,	PUNCT
iajs-2017	254	6	21	21	NUM
iajs-2017	254	7	,	,	PUNCT
iajs-2017	254	8	1	1	NUM
iajs-2017	254	9	,	,	PUNCT
iajs-2017	254	10	47	47	NUM
iajs-2017	254	11	-	-	SYM
iajs-2017	254	12	54	54	NUM
iajs-2017	254	13	.	.	PUNCT
iajs-2017	255	1	17	17	NUM
iajs-2017	255	2	.	.	PUNCT
iajs-2017	256	1	segal	segal	PROPN
iajs-2017	256	2	.	.	PUNCT
iajs-2017	257	1	j.b	j.b	PROPN
iajs-2017	257	2	.	.	PUNCT
iajs-2017	257	3	;	;	PUNCT
iajs-2017	257	4	moliterno.a.r	moliterno.a.r	PROPN
iajs-2017	257	5	.	.	PUNCT
iajs-2017	258	1	platelet	platelet	NOUN
iajs-2017	258	2	counts	count	NOUN
iajs-2017	258	3	differ	differ	VERB
iajs-2017	258	4	by	by	ADP
iajs-2017	258	5	sex	sex	NOUN
iajs-2017	258	6	,	,	PUNCT
iajs-2017	258	7	ethnicity	ethnicity	NOUN
iajs-2017	258	8	,	,	PUNCT
iajs-2017	258	9	and	and	CCONJ
iajs-2017	258	10	age	age	NOUN
iajs-2017	258	11	in	in	ADP
iajs-2017	258	12	the	the	DET
iajs-2017	258	13	united	united	PROPN
iajs-2017	258	14	states	states	PROPN
iajs-2017	258	15	.	.	PUNCT
iajs-2017	259	1	ann	ann	PROPN
iajs-2017	259	2	epidemiol	epidemiol	PROPN
iajs-2017	259	3	.	.	PUNCT
iajs-2017	260	1	2006	2006	NUM
iajs-2017	260	2	,	,	PUNCT
iajs-2017	260	3	16	16	NUM
iajs-2017	260	4	,	,	PUNCT
iajs-2017	260	5	2	2	NUM
iajs-2017	260	6	,	,	PUNCT
iajs-2017	260	7	123	123	NUM
iajs-2017	260	8	-	-	SYM
iajs-2017	260	9	130	130	NUM
iajs-2017	260	10	.	.	PUNCT
iajs-2017	261	1	18	18	NUM
iajs-2017	261	2	.	.	X
iajs-2017	261	3	dame	dame	NOUN
iajs-2017	261	4	.	.	PUNCT
iajs-2017	262	1	c.	c.	PROPN
iajs-2017	262	2	;	;	PUNCT
iajs-2017	262	3	sutor	sutor	NOUN
iajs-2017	262	4	.	.	PUNCT
iajs-2017	263	1	a.h	a.h	PROPN
iajs-2017	263	2	.	.	PROPN
iajs-2017	263	3	primary	primary	ADJ
iajs-2017	263	4	and	and	CCONJ
iajs-2017	263	5	secondary	secondary	ADJ
iajs-2017	263	6	thrombocytosis	thrombocytosis	NOUN
iajs-2017	263	7	in	in	ADP
iajs-2017	263	8	childhood	childhood	NOUN
iajs-2017	263	9	.	.	PUNCT
iajs-2017	264	1	br	br	PROPN
iajs-2017	264	2	j	j	PROPN
iajs-2017	264	3	haematol	haematol	NOUN
iajs-2017	264	4	.	.	PUNCT
iajs-2017	265	1	2005	2005	NUM
iajs-2017	265	2	,	,	PUNCT
iajs-2017	265	3	129,165	129,165	NUM
iajs-2017	265	4	-	-	SYM
iajs-2017	265	5	177	177	NUM
iajs-2017	265	6	.	.	PUNCT
iajs-2017	266	1	19	19	NUM
iajs-2017	266	2	.	.	PUNCT
iajs-2017	266	3	axelrad	axelrad	PROPN
iajs-2017	266	4	.	.	PUNCT
iajs-2017	267	1	a.a	a.a	PROPN
iajs-2017	267	2	.	.	PROPN
iajs-2017	267	3	;	;	PUNCT
iajs-2017	267	4	eskinazi	eskinazi	PROPN
iajs-2017	267	5	.	.	PUNCT
iajs-2017	268	1	d.	d.	PROPN
iajs-2017	268	2	;	;	PUNCT
iajs-2017	268	3	correa	correa	PROPN
iajs-2017	268	4	.	.	PUNCT
iajs-2017	269	1	p.n	p.n	PROPN
iajs-2017	269	2	.	.	PROPN
iajs-2017	269	3	;	;	PUNCT
iajs-2017	270	1	amato	amato	PROPN
iajs-2017	270	2	.	.	PROPN
iajs-2017	270	3	d.	d.	PROPN
iajs-2017	270	4	hypersensitivity	hypersensitivity	NOUN
iajs-2017	270	5	of	of	ADP
iajs-2017	270	6	circulating	circulate	VERB
iajs-2017	270	7	progenitor	progenitor	NOUN
iajs-2017	270	8	cells	cell	NOUN
iajs-2017	270	9	to	to	ADP
iajs-2017	270	10	megakaryocyte	megakaryocyte	NOUN
iajs-2017	270	11	growth	growth	NOUN
iajs-2017	270	12	and	and	CCONJ
iajs-2017	270	13	development	development	NOUN
iajs-2017	270	14	factor	factor	NOUN
iajs-2017	270	15	(	(	PUNCT
iajs-2017	270	16	peg	peg	NOUN
iajs-2017	270	17	-	-	PUNCT
iajs-2017	270	18	rhu	rhu	PROPN
iajs-2017	270	19	mgdf	mgdf	PROPN
iajs-2017	270	20	)	)	PUNCT
iajs-2017	270	21	in	in	ADP
iajs-2017	270	22	essential	essential	ADJ
iajs-2017	270	23	thrombocythemia	thrombocythemia	NOUN
iajs-2017	270	24	.	.	PUNCT
iajs-2017	271	1	blood	blood	NOUN
iajs-2017	271	2	.	.	PUNCT
iajs-2017	272	1	2000	2000	NUM
iajs-2017	272	2	,	,	PUNCT
iajs-2017	272	3	96	96	NUM
iajs-2017	272	4	,	,	PUNCT
iajs-2017	272	5	3310	3310	NUM
iajs-2017	272	6	-	-	SYM
iajs-2017	272	7	3321	3321	NUM
iajs-2017	272	8	.	.	PUNCT
iajs-2017	273	1	20	20	NUM
iajs-2017	273	2	.	.	PUNCT
iajs-2017	274	1	julie	julie	PROPN
iajs-2017	274	2	.	.	PROPN
iajs-2017	274	3	b.	b.	PROPN
iajs-2017	274	4	;	;	PUNCT
iajs-2017	274	5	lila	lila	PROPN
iajs-2017	274	6	.	.	PUNCT
iajs-2017	275	1	p.	p.	NOUN
iajs-2017	275	2	;	;	PUNCT
iajs-2017	276	1	marianna	marianna	PROPN
iajs-2017	276	2	.	.	PUNCT
iajs-2017	276	3	h.	h.	PROPN
iajs-2017	276	4	thrombocytosis	thrombocytosis	PROPN
iajs-2017	276	5	as	as	ADP
iajs-2017	276	6	a	a	DET
iajs-2017	276	7	presenting	present	VERB
iajs-2017	276	8	feature	feature	NOUN
iajs-2017	276	9	of	of	ADP
iajs-2017	276	10	acute	acute	ADJ
iajs-2017	276	11	lymphoblastic	lymphoblastic	ADJ
iajs-2017	276	12	leukemia	leukemia	NOUN
iajs-2017	276	13	in	in	ADP
iajs-2017	276	14	childhood	childhood	NOUN
iajs-2017	276	15	,	,	PUNCT
iajs-2017	276	16	am	be	AUX
iajs-2017	276	17	j	j	PROPN
iajs-2017	276	18	hematol	hematol	NOUN
iajs-2017	276	19	.	.	PUNCT
iajs-2017	277	1	1989	1989	NUM
iajs-2017	277	2	,	,	PUNCT
iajs-2017	277	3	31	31	NUM
iajs-2017	277	4	,	,	PUNCT
iajs-2017	277	5	46	46	NUM
iajs-2017	277	6	-	-	SYM
iajs-2017	277	7	49	49	NUM
iajs-2017	277	8	.	.	PUNCT
iajs-2017	278	1	21	21	NUM
iajs-2017	278	2	.	.	PUNCT
iajs-2017	279	1	quick	quick	ADJ
iajs-2017	279	2	a.	a.	NOUN
iajs-2017	279	3	j.	j.	PROPN
iajs-2017	279	4	the	the	DET
iajs-2017	279	5	prothrombin	prothrombin	ADJ
iajs-2017	279	6	consumption	consumption	NOUN
iajs-2017	279	7	time	time	NOUN
iajs-2017	279	8	as	as	ADP
iajs-2017	279	9	a	a	DET
iajs-2017	279	10	determinant	determinant	NOUN
iajs-2017	279	11	of	of	ADP
iajs-2017	279	12	platelet	platelet	NOUN
iajs-2017	279	13	function	function	NOUN
iajs-2017	279	14	,	,	PUNCT
iajs-2017	279	15	am	be	AUX
iajs-2017	279	16	j	j	PROPN
iajs-2017	279	17	clin	clin	PROPN
iajs-2017	279	18	path	path	NOUN
iajs-2017	279	19	.	.	PUNCT
iajs-2017	280	1	1974	1974	NUM
iajs-2017	280	2	,	,	PUNCT
iajs-2017	280	3	61	61	NUM
iajs-2017	280	4	,	,	PUNCT
iajs-2017	280	5	4	4	NUM
iajs-2017	280	6	,	,	PUNCT
iajs-2017	280	7	449–457	449–457	NUM
iajs-2017	280	8	.	.	PUNCT
iajs-2017	281	1	22	22	NUM
iajs-2017	281	2	.	.	PUNCT
iajs-2017	282	1	burrows	burrow	NOUN
iajs-2017	282	2	.	.	PUNCT
iajs-2017	283	1	r.f	r.f	PROPN
iajs-2017	283	2	.	.	PROPN
iajs-2017	283	3	;	;	PUNCT
iajs-2017	284	1	kelton	kelton	PROPN
iajs-2017	284	2	.	.	PUNCT
iajs-2017	285	1	j.g	j.g	PROPN
iajs-2017	285	2	.	.	PROPN
iajs-2017	285	3	perinatal	perinatal	ADJ
iajs-2017	285	4	thrombocytopenia	thrombocytopenia	PROPN
iajs-2017	285	5	.	.	PUNCT
iajs-2017	286	1	clin	clin	PROPN
iajs-2017	286	2	perinatal	perinatal	PROPN
iajs-2017	286	3	.	.	PUNCT
iajs-2017	287	1	1995	1995	NUM
iajs-2017	287	2	,	,	PUNCT
iajs-2017	287	3	22	22	NUM
iajs-2017	287	4	,	,	PUNCT
iajs-2017	287	5	779	779	NUM
iajs-2017	287	6	–	–	PUNCT
iajs-2017	287	7	801	801	NUM
iajs-2017	287	8	.	.	X
iajs-2017	288	1	23	23	NUM
iajs-2017	288	2	.	.	PUNCT
iajs-2017	289	1	duane	duane	PROPN
iajs-2017	289	2	.	.	PUNCT
iajs-2017	290	1	k.	k.	PROPN
iajs-2017	290	2	;	;	PUNCT
iajs-2017	291	1	hasegawa	hasegawa	PROPN
iajs-2017	291	2	.	.	PUNCT
iajs-2017	292	1	m.d	m.d	PROPN
iajs-2017	292	2	.	.	PROPN
iajs-2017	292	3	coagulation	coagulation	NOUN
iajs-2017	292	4	abnormalities	abnormality	NOUN
iajs-2017	292	5	in	in	ADP
iajs-2017	292	6	acute	acute	ADJ
iajs-2017	292	7	leukemia	leukemia	NOUN
iajs-2017	292	8	.	.	PUNCT
iajs-2017	293	1	lab	lab	NOUN
iajs-2017	293	2	medicine	medicine	NOUN
iajs-2017	293	3	.	.	PUNCT
iajs-2017	294	1	1986	1986	NUM
iajs-2017	294	2	,	,	PUNCT
iajs-2017	294	3	17	17	NUM
iajs-2017	294	4	,	,	PUNCT
iajs-2017	294	5	7	7	NUM
iajs-2017	294	6	,	,	PUNCT
iajs-2017	294	7	388	388	NUM
iajs-2017	294	8	-	-	SYM
iajs-2017	294	9	394	394	NUM
iajs-2017	294	10	.	.	NOUN
iajs-2017	295	1	24	24	NUM
iajs-2017	295	2	.	.	PUNCT
iajs-2017	296	1	hirsh	hirsh	PROPN
iajs-2017	296	2	.	.	PUNCT
iajs-2017	297	1	j.	j.	PROPN
iajs-2017	297	2	blood	blood	NOUN
iajs-2017	297	3	tests	test	VERB
iajs-2017	297	4	for	for	ADP
iajs-2017	297	5	the	the	DET
iajs-2017	297	6	diagnosis	diagnosis	NOUN
iajs-2017	297	7	of	of	ADP
iajs-2017	297	8	venous	venous	ADJ
iajs-2017	297	9	and	and	CCONJ
iajs-2017	297	10	arterial	arterial	ADJ
iajs-2017	297	11	thrombosis	thrombosis	NOUN
iajs-2017	297	12	.	.	PUNCT
iajs-2017	298	1	blood	blood	NOUN
iajs-2017	298	2	.	.	PUNCT
iajs-2017	299	1	1981	1981	NUM
iajs-2017	299	2	,	,	PUNCT
iajs-2017	299	3	57	57	NUM
iajs-2017	299	4	,	,	PUNCT
iajs-2017	299	5	1	1	NUM
iajs-2017	299	6	,	,	PUNCT
iajs-2017	299	7	18	18	NUM
iajs-2017	299	8	.	.	NOUN
iajs-2017	299	9	25	25	NUM
iajs-2017	299	10	.	.	PUNCT
iajs-2017	299	11	topolcan	topolcan	PROPN
iajs-2017	299	12	.	.	PUNCT
iajs-2017	300	1	o.	o.	PROPN
iajs-2017	300	2	;	;	PUNCT
iajs-2017	300	3	holubec	holubec	PROPN
iajs-2017	300	4	.	.	PUNCT
iajs-2017	301	1	l.jr	l.jr	PROPN
iajs-2017	301	2	.	.	PUNCT
iajs-2017	302	1	the	the	DET
iajs-2017	302	2	role	role	NOUN
iajs-2017	302	3	of	of	ADP
iajs-2017	302	4	thymidine	thymidine	ADJ
iajs-2017	302	5	kinase	kinase	PROPN
iajs-2017	302	6	in	in	ADP
iajs-2017	302	7	cancer	cancer	NOUN
iajs-2017	302	8	diseases	disease	NOUN
iajs-2017	302	9	.	.	PUNCT
iajs-2017	303	1	expert	expert	NOUN
iajs-2017	303	2	opin	opin	NOUN
iajs-2017	303	3	.	.	PUNCT
iajs-2017	304	1	med	med	PROPN
iajs-2017	304	2	.	.	PROPN
iajs-2017	304	3	diagn	diagn	PROPN
iajs-2017	304	4	.	.	PUNCT
iajs-2017	305	1	2008	2008	NUM
iajs-2017	305	2	,	,	PUNCT
iajs-2017	305	3	2	2	NUM
iajs-2017	305	4	,	,	PUNCT
iajs-2017	305	5	2	2	NUM
iajs-2017	305	6	,	,	PUNCT
iajs-2017	305	7	129–141	129–141	NUM
iajs-2017	305	8	.	.	NOUN
iajs-2017	305	9	26	26	NUM
iajs-2017	305	10	.	.	PUNCT
iajs-2017	306	1	zhu	zhu	PROPN
iajs-2017	306	2	.	.	PUNCT
iajs-2017	307	1	c.	c.	PROPN
iajs-2017	307	2	;	;	PUNCT
iajs-2017	307	3	harlow	harlow	PROPN
iajs-2017	307	4	.	.	PUNCT
iajs-2017	308	1	l.s	l.s	AUX
iajs-2017	308	2	.	.	PROPN
iajs-2017	308	3	;	;	PUNCT
iajs-2017	308	4	berenstein	berenstein	PROPN
iajs-2017	308	5	.	.	PUNCT
iajs-2017	309	1	d.	d.	PROPN
iajs-2017	309	2	;	;	PUNCT
iajs-2017	309	3	munch	munch	PROPN
iajs-2017	309	4	-	-	PUNCT
iajs-2017	309	5	petersen.s	petersen.s	PROPN
iajs-2017	309	6	.	.	PUNCT
iajs-2017	309	7	;	;	PUNCT
iajs-2017	309	8	munch	munch	PROPN
iajs-2017	309	9	-	-	PUNCT
iajs-2017	309	10	petersen	petersen	PROPN
iajs-2017	309	11	.	.	PUNCT
iajs-2017	310	1	b.	b.	PROPN
iajs-2017	310	2	effect	effect	NOUN
iajs-2017	310	3	of	of	ADP
iajs-2017	310	4	c	c	NOUN
iajs-2017	310	5	-	-	PUNCT
iajs-2017	310	6	terminal	terminal	NOUN
iajs-2017	310	7	of	of	ADP
iajs-2017	310	8	human	human	ADJ
iajs-2017	310	9	cytosolic	cytosolic	ADJ
iajs-2017	310	10	thymidine	thymidine	PROPN
iajs-2017	310	11	kinase	kinase	PROPN
iajs-2017	310	12	(	(	PUNCT
iajs-2017	310	13	tk1	tk1	PROPN
iajs-2017	310	14	)	)	PUNCT
iajs-2017	310	15	on	on	ADP
iajs-2017	310	16	in	in	ADP
iajs-2017	310	17	vitro	vitro	X
iajs-2017	310	18	stability	stability	NOUN
iajs-2017	310	19	and	and	CCONJ
iajs-2017	310	20	enzymatic	enzymatic	ADJ
iajs-2017	310	21	properties	property	NOUN
iajs-2017	310	22	.	.	PUNCT
iajs-2017	311	1	nucleos	nucleos	PROPN
iajs-2017	311	2	nucleot	nucleot	VERB
iajs-2017	311	3	nucl	nucl	PROPN
iajs-2017	311	4	.2006	.2006	PROPN
iajs-2017	311	5	,	,	PUNCT
iajs-2017	311	6	25	25	NUM
iajs-2017	311	7	,	,	PUNCT
iajs-2017	311	8	(	(	PUNCT
iajs-2017	311	9	9	9	NUM
iajs-2017	311	10	-	-	PUNCT
iajs-2017	311	11	11),1185–1188	11),1185–1188	NUM
iajs-2017	311	12	.	.	PUNCT
iajs-2017	312	1	27	27	NUM
iajs-2017	312	2	.	.	PUNCT
iajs-2017	313	1	aufderklamm	aufderklamm	PROPN
iajs-2017	313	2	.	.	PUNCT
iajs-2017	314	1	s.	s.	PROPN
iajs-2017	314	2	;	;	PUNCT
iajs-2017	314	3	todenhofer	todenhofer	VERB
iajs-2017	314	4	.	.	PUNCT
iajs-2017	315	1	t.	t.	NOUN
iajs-2017	315	2	;	;	PUNCT
iajs-2017	315	3	gakis	gakis	PROPN
iajs-2017	315	4	.	.	PUNCT
iajs-2017	316	1	g.	g.	NOUN
iajs-2017	316	2	;	;	PUNCT
iajs-2017	316	3	kruck	kruck	VERB
iajs-2017	316	4	.	.	PUNCT
iajs-2017	317	1	s.	s.	PROPN
iajs-2017	317	2	;	;	PUNCT
iajs-2017	317	3	hennenlotter	hennenlotter	PROPN
iajs-2017	317	4	.	.	PUNCT
iajs-2017	318	1	j.	j.	PROPN
iajs-2017	318	2	;	;	PUNCT
iajs-2017	318	3	stenzl	stenzl	PROPN
iajs-2017	318	4	.	.	PUNCT
iajs-2017	319	1	a.	a.	NOUN
iajs-2017	319	2	;	;	PUNCT
iajs-2017	319	3	schwentner	schwentner	NOUN
iajs-2017	319	4	.	.	PUNCT
iajs-2017	320	1	c.	c.	PROPN
iajs-2017	320	2	thymidine	thymidine	PROPN
iajs-2017	320	3	kinase	kinase	PROPN
iajs-2017	320	4	and	and	CCONJ
iajs-2017	320	5	cancer	cancer	NOUN
iajs-2017	320	6	monitoring	monitoring	NOUN
iajs-2017	320	7	.	.	PUNCT
iajs-2017	321	1	cancer	cancer	PROPN
iajs-2017	321	2	lett	lett	PROPN
iajs-2017	321	3	.	.	PROPN
iajs-2017	322	1	2012	2012	NUM
iajs-2017	322	2	,	,	PUNCT
iajs-2017	322	3	316	316	NUM
iajs-2017	322	4	,	,	PUNCT
iajs-2017	322	5	1	1	NUM
iajs-2017	322	6	,	,	PUNCT
iajs-2017	322	7	6	6	NUM
iajs-2017	322	8	-	-	SYM
iajs-2017	322	9	10	10	NUM
iajs-2017	322	10	.	.	PUNCT
iajs-2017	323	1	28	28	NUM
iajs-2017	323	2	.	.	PUNCT
iajs-2017	324	1	huang	huang	PROPN
iajs-2017	324	2	.	.	PUNCT
iajs-2017	325	1	s.	s.	PROPN
iajs-2017	325	2	;	;	PUNCT
iajs-2017	325	3	lin	lin	PROPN
iajs-2017	325	4	.	.	PUNCT
iajs-2017	326	1	j.	j.	PROPN
iajs-2017	326	2	;	;	PUNCT
iajs-2017	327	1	guo	guo	PROPN
iajs-2017	327	2	.	.	PUNCT
iajs-2017	327	3	n.	n.	PROPN
iajs-2017	327	4	;	;	PUNCT
iajs-2017	327	5	zhang	zhang	PROPN
iajs-2017	327	6	.	.	PUNCT
iajs-2017	327	7	m.	m.	PROPN
iajs-2017	327	8	;	;	PUNCT
iajs-2017	327	9	yun	yun	PROPN
iajs-2017	327	10	.	.	PUNCT
iajs-2017	328	1	x.	x.	PROPN
iajs-2017	328	2	;	;	PUNCT
iajs-2017	329	1	liu	liu	PROPN
iajs-2017	329	2	.	.	PUNCT
iajs-2017	329	3	s.	s.	PROPN
iajs-2017	329	4	;	;	PUNCT
iajs-2017	329	5	skog	skog	PROPN
iajs-2017	329	6	.	.	PUNCT
iajs-2017	330	1	s.	s.	PROPN
iajs-2017	330	2	elevated	elevate	VERB
iajs-2017	330	3	serum	serum	PROPN
iajs-2017	330	4	thymidine	thymidine	PROPN
iajs-2017	330	5	kinase	kinase	PROPN
iajs-2017	330	6	1	1	NUM
iajs-2017	330	7	predicts	predict	VERB
iajs-2017	330	8	risk	risk	NOUN
iajs-2017	330	9	of	of	ADP
iajs-2017	330	10	pre	pre	ADJ
iajs-2017	330	11	/	/	SYM
iajs-2017	330	12	early	early	ADJ
iajs-2017	330	13	cancerous	cancerous	ADJ
iajs-2017	330	14	progression	progression	NOUN
iajs-2017	330	15	.	.	PUNCT
iajs-2017	331	1	asian	asian	PROPN
iajs-2017	331	2	pac	pac	PROPN
iajs-2017	331	3	j	j	PROPN
iajs-2017	331	4	cancer	cancer	NOUN
iajs-2017	331	5	prev	prev	X
iajs-2017	331	6	.	.	PUNCT
iajs-2017	332	1	2011	2011	NUM
iajs-2017	332	2	,	,	PUNCT
iajs-2017	332	3	12	12	NUM
iajs-2017	332	4	,	,	PUNCT
iajs-2017	332	5	2	2	NUM
iajs-2017	332	6	,	,	PUNCT
iajs-2017	332	7	497	497	NUM
iajs-2017	332	8	-	-	SYM
iajs-2017	332	9	505	505	NUM
iajs-2017	332	10	.	.	NOUN
iajs-2017	333	1	29	29	NUM
iajs-2017	333	2	.	.	PUNCT
iajs-2017	334	1	xuewei	xuewei	PROPN
iajs-2017	334	2	.	.	PUNCT
iajs-2017	335	1	li.l	li.l	PROPN
iajs-2017	335	2	.	.	PROPN
iajs-2017	335	3	;	;	PUNCT
iajs-2017	336	1	zhaoyue.w	zhaoyue.w	X
iajs-2017	336	2	.	.	PUNCT
iajs-2017	336	3	;	;	PUNCT
iajs-2017	336	4	xiaofei.q	xiaofei.q	PROPN
iajs-2017	336	5	.	.	PUNCT
iajs-2017	336	6	;	;	PUNCT
iajs-2017	337	1	dongjie	dongjie	X
iajs-2017	337	2	.	.	PUNCT
iajs-2017	338	1	z.	z.	PROPN
iajs-2017	338	2	oxidative	oxidative	ADJ
iajs-2017	338	3	stress	stress	NOUN
iajs-2017	338	4	and	and	CCONJ
iajs-2017	338	5	antioxidant	antioxidant	ADJ
iajs-2017	338	6	status	status	NOUN
iajs-2017	338	7	in	in	ADP
iajs-2017	338	8	immune	immune	ADJ
iajs-2017	338	9	thrombocytopenia	thrombocytopenia	PROPN
iajs-2017	338	10	.	.	PUNCT
iajs-2017	339	1	j	j	PROPN
iajs-2017	339	2	blood	blood	NOUN
iajs-2017	339	3	disord	disord	NOUN
iajs-2017	339	4	transfus.2017	transfus.2017	PROPN
iajs-2017	339	5	,	,	PUNCT
iajs-2017	339	6	8	8	NUM
iajs-2017	339	7	,	,	PUNCT
iajs-2017	339	8	4	4	NUM
iajs-2017	339	9	,	,	PUNCT
iajs-2017	339	10	1	1	NUM
iajs-2017	339	11	-	-	SYM
iajs-2017	339	12	4	4	NUM
iajs-2017	339	13	.	.	PUNCT
iajs-2017	340	1	chemistry	chemistry	NOUN
iajs-2017	341	1	|	|	ADV
iajs-2017	341	2	87	87	NUM
iajs-2017	341	3	ibn	ibn	PROPN
iajs-2017	341	4	al	al	PROPN
iajs-2017	341	5	-	-	PUNCT
iajs-2017	341	6	haitham	haitham	PROPN
iajs-2017	341	7	jour	jour	X
iajs-2017	341	8	.	.	PROPN
iajs-2017	342	1	for	for	ADP
iajs-2017	342	2	pure	pure	ADJ
iajs-2017	342	3	&	&	CCONJ
iajs-2017	342	4	appl	appl	PROPN
iajs-2017	342	5	.	.	PUNCT
iajs-2017	343	1	sci	sci	PROPN
iajs-2017	343	2	.	.	PROPN
iajs-2017	343	3	ihjpas	ihjpas	PROPN
iajs-2017	343	4	https://doi.org/10.30526/31.3.2017	https://doi.org/10.30526/31.3.2017	ADP
iajs-2017	343	5	vol	vol	NOUN
iajs-2017	343	6	.	.	PUNCT
iajs-2017	344	1	31	31	NUM
iajs-2017	345	1	(	(	PUNCT
iajs-2017	345	2	3	3	NUM
iajs-2017	345	3	)	)	PUNCT
iajs-2017	345	4	2018	2018	NUM
iajs-2017	345	5	30	30	NUM
iajs-2017	345	6	.	.	PUNCT
iajs-2017	346	1	sinan	sinan	PROPN
iajs-2017	346	2	.	.	PUNCT
iajs-2017	347	1	a.	a.	PROPN
iajs-2017	347	2	;	;	PUNCT
iajs-2017	348	1	murat	murat	PROPN
iajs-2017	348	2	.	.	PUNCT
iajs-2017	348	3	d.	d.	PROPN
iajs-2017	348	4	;	;	PUNCT
iajs-2017	348	5	cihangir	cihangir	PROPN
iajs-2017	348	6	.	.	PUNCT
iajs-2017	349	1	a.	a.	NOUN
iajs-2017	349	2	;	;	PUNCT
iajs-2017	349	3	yurdagu	yurdagu	PROPN
iajs-2017	349	4	.	.	PROPN
iajs-2017	349	5	m.	m.	NOUN
iajs-2017	349	6	;	;	PUNCT
iajs-2017	349	7	erdal	erdal	PROPN
iajs-2017	349	8	.	.	PUNCT
iajs-2017	350	1	p.	p.	NOUN
iajs-2017	350	2	;	;	PUNCT
iajs-2017	350	3	ali	ali	PROPN
iajs-2017	350	4	.	.	PROPN
iajs-2017	350	5	b.	b.	PROPN
iajs-2017	350	6	;	;	PUNCT
iajs-2017	350	7	hu¨seyin	hu¨seyin	PROPN
iajs-2017	350	8	.	.	PUNCT
iajs-2017	351	1	c.	c.	PROPN
iajs-2017	351	2	;	;	PUNCT
iajs-2017	351	3	ahmet	ahmet	PROPN
iajs-2017	351	4	.	.	PUNCT
iajs-2017	352	1	f.o	f.o	PROPN
iajs-2017	352	2	.	.	PUNCT
iajs-2017	353	1	the	the	DET
iajs-2017	353	2	association	association	NOUN
iajs-2017	353	3	of	of	ADP
iajs-2017	353	4	oxidant	oxidant	ADJ
iajs-2017	353	5	status	status	NOUN
iajs-2017	353	6	and	and	CCONJ
iajs-2017	353	7	antioxidant	antioxidant	ADJ
iajs-2017	353	8	capacity	capacity	NOUN
iajs-2017	353	9	in	in	ADP
iajs-2017	353	10	children	child	NOUN
iajs-2017	353	11	with	with	ADP
iajs-2017	353	12	acute	acute	ADJ
iajs-2017	353	13	and	and	CCONJ
iajs-2017	353	14	chronic	chronic	PROPN
iajs-2017	353	15	itp	itp	PROPN
iajs-2017	353	16	.	.	PUNCT
iajs-2017	354	1	j	j	PROPN
iajs-2017	354	2	pediatr	pediatr	PROPN
iajs-2017	354	3	hematol	hematol	PROPN
iajs-2017	354	4	oncol	oncol	ADJ
iajs-2017	354	5	.	.	PUNCT
iajs-2017	355	1	2010	2010	NUM
iajs-2017	355	2	,	,	PUNCT
iajs-2017	355	3	32	32	NUM
iajs-2017	355	4	,	,	PUNCT
iajs-2017	355	5	277–281	277–281	NUM
iajs-2017	355	6	.	.	PUNCT
iajs-2017	356	1	31	31	NUM
iajs-2017	356	2	.	.	PUNCT
iajs-2017	356	3	polat	polat	NOUN
iajs-2017	356	4	.	.	PUNCT
iajs-2017	357	1	g.	g.	NOUN
iajs-2017	357	2	;	;	PUNCT
iajs-2017	357	3	tamer	tame	ADJ
iajs-2017	357	4	.	.	PUNCT
iajs-2017	358	1	l.	l.	PROPN
iajs-2017	358	2	;	;	PUNCT
iajs-2017	358	3	tanriverdi	tanriverdi	PROPN
iajs-2017	358	4	.	.	PUNCT
iajs-2017	359	1	k.	k.	PROPN
iajs-2017	359	2	;	;	PUNCT
iajs-2017	360	1	gurkan	gurkan	PROPN
iajs-2017	360	2	.	.	PUNCT
iajs-2017	360	3	e.	e.	PROPN
iajs-2017	360	4	;	;	PUNCT
iajs-2017	360	5	baslamisli	baslamisli	PROPN
iajs-2017	360	6	.	.	PUNCT
iajs-2017	361	1	f.	f.	PROPN
iajs-2017	361	2	;	;	PUNCT
iajs-2017	361	3	atik	atik	PROPN
iajs-2017	361	4	.	.	PUNCT
iajs-2017	362	1	u.	u.	PROPN
iajs-2017	362	2	levels	level	NOUN
iajs-2017	362	3	of	of	ADP
iajs-2017	362	4	malondialdehyde	malondialdehyde	NOUN
iajs-2017	362	5	,	,	PUNCT
iajs-2017	362	6	glutathione	glutathione	NOUN
iajs-2017	362	7	and	and	CCONJ
iajs-2017	362	8	ascorbic	ascorbic	NOUN
iajs-2017	362	9	acid	acid	NOUN
iajs-2017	362	10	in	in	ADP
iajs-2017	362	11	idiopathic	idiopathic	ADJ
iajs-2017	362	12	thrombocytopenic	thrombocytopenic	ADJ
iajs-2017	362	13	purpura	purpura	NOUN
iajs-2017	362	14	.	.	PUNCT
iajs-2017	363	1	east	east	PROPN
iajs-2017	363	2	afr	afr	PROPN
iajs-2017	363	3	med	med	PROPN
iajs-2017	363	4	j.2002	j.2002	NOUN
iajs-2017	363	5	,	,	PUNCT
iajs-2017	363	6	79	79	NUM
iajs-2017	363	7	,	,	PUNCT
iajs-2017	363	8	8	8	NUM
iajs-2017	363	9	,	,	PUNCT
iajs-2017	363	10	446–449	446–449	NUM
iajs-2017	363	11	.	.	PUNCT
iajs-2017	364	1	32	32	NUM
iajs-2017	364	2	.	.	PUNCT
iajs-2017	365	1	jin	jin	PROPN
iajs-2017	365	2	.	.	PUNCT
iajs-2017	366	1	c.q	c.q	PROPN
iajs-2017	366	2	.	.	PROPN
iajs-2017	366	3	;	;	PUNCT
iajs-2017	366	4	dong.h.x	dong.h.x	PROPN
iajs-2017	366	5	.	.	PUNCT
iajs-2017	366	6	;	;	PUNCT
iajs-2017	367	1	cheng	cheng	PROPN
iajs-2017	367	2	.	.	PUNCT
iajs-2017	368	1	p.p	p.p	PROPN
iajs-2017	368	2	.	.	PROPN
iajs-2017	368	3	;	;	PUNCT
iajs-2017	369	1	zhou	zhou	PROPN
iajs-2017	369	2	.	.	PUNCT
iajs-2017	370	1	j.w	j.w	PROPN
iajs-2017	370	2	.	.	PROPN
iajs-2017	370	3	;	;	PUNCT
iajs-2017	371	1	zheng	zheng	PROPN
iajs-2017	371	2	.	.	PUNCT
iajs-2017	372	1	b.y	b.y	PROPN
iajs-2017	372	2	.	.	PROPN
iajs-2017	372	3	;	;	PUNCT
iajs-2017	373	1	liu	liu	PROPN
iajs-2017	373	2	.	.	PUNCT
iajs-2017	373	3	f.	f.	PROPN
iajs-2017	373	4	antioxidant	antioxidant	PROPN
iajs-2017	373	5	status	status	NOUN
iajs-2017	373	6	and	and	CCONJ
iajs-2017	373	7	oxidative	oxidative	ADJ
iajs-2017	373	8	stress	stress	NOUN
iajs-2017	373	9	in	in	ADP
iajs-2017	373	10	patients	patient	NOUN
iajs-2017	373	11	with	with	ADP
iajs-2017	373	12	chronic	chronic	PROPN
iajs-2017	373	13	itp	itp	PROPN
iajs-2017	373	14	.	.	PUNCT
iajs-2017	374	1	scand	scand	PROPN
iajs-2017	374	2	j	j	PROPN
iajs-2017	374	3	immunol	immunol	PROPN
iajs-2017	374	4	.	.	PUNCT
iajs-2017	375	1	2013	2013	NUM
iajs-2017	375	2	,	,	PUNCT
iajs-2017	375	3	77	77	NUM
iajs-2017	375	4	,	,	PUNCT
iajs-2017	375	5	6	6	NUM
iajs-2017	375	6	,	,	PUNCT
iajs-2017	375	7	482–487	482–487	NUM
iajs-2017	375	8	.	.	PUNCT
iajs-2017	376	1	33	33	NUM
iajs-2017	376	2	.	.	PUNCT
iajs-2017	376	3	ficicilar	ficicilar	PROPN
iajs-2017	376	4	.	.	PUNCT
iajs-2017	377	1	h.	h.	PROPN
iajs-2017	377	2	;	;	PUNCT
iajs-2017	377	3	zergeroglu	zergeroglu	PROPN
iajs-2017	377	4	.	.	PUNCT
iajs-2017	378	1	a.m.	a.m.	PROPN
iajs-2017	378	2	;	;	PUNCT
iajs-2017	378	3	ersozi	ersozi	NOUN
iajs-2017	378	4	.	.	PUNCT
iajs-2017	379	1	g.	g.	NOUN
iajs-2017	379	2	;	;	PUNCT
iajs-2017	379	3	erdogan	erdogan	ADJ
iajs-2017	379	4	.	.	PUNCT
iajs-2017	380	1	a.	a.	NOUN
iajs-2017	380	2	;	;	PUNCT
iajs-2017	380	3	ozdemir	ozdemir	PROPN
iajs-2017	380	4	.	.	PUNCT
iajs-2017	381	1	s.	s.	PROPN
iajs-2017	381	2	;	;	PUNCT
iajs-2017	381	3	tekin	tekin	PROPN
iajs-2017	381	4	.	.	PUNCT
iajs-2017	382	1	d.	d.	PROPN
iajs-2017	382	2	the	the	DET
iajs-2017	382	3	effects	effect	NOUN
iajs-2017	382	4	of	of	ADP
iajs-2017	382	5	short	short	ADJ
iajs-2017	382	6	-	-	PUNCT
iajs-2017	382	7	term	term	NOUN
iajs-2017	382	8	training	training	NOUN
iajs-2017	382	9	on	on	ADP
iajs-2017	382	10	platelet	platelet	NOUN
iajs-2017	382	11	functions	function	NOUN
iajs-2017	382	12	and	and	CCONJ
iajs-2017	382	13	total	total	ADJ
iajs-2017	382	14	antioxidant	antioxidant	ADJ
iajs-2017	382	15	capacity	capacity	NOUN
iajs-2017	382	16	in	in	ADP
iajs-2017	382	17	rats	rat	NOUN
iajs-2017	382	18	.	.	PUNCT
iajs-2017	383	1	physiol	physiol	PROPN
iajs-2017	383	2	res	res	PROPN
iajs-2017	383	3	.	.	PUNCT
iajs-2017	384	1	2006	2006	NUM
iajs-2017	384	2	,	,	PUNCT
iajs-2017	384	3	55	55	NUM
iajs-2017	384	4	,	,	PUNCT
iajs-2017	384	5	2	2	NUM
iajs-2017	384	6	,	,	PUNCT
iajs-2017	384	7	151	151	NUM
iajs-2017	384	8	-	-	SYM
iajs-2017	384	9	156	156	NUM
iajs-2017	384	10	.	.	PUNCT